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CHAPTER 1 – INTRODUCTION 
 
1.1. Background on Heat Shock Response, Exercise-induced Muscle Damage and Cross-
protection 
 
The heat shock response is characterized by a rapid and intense stress-induced increase in heat 
shock proteins (HSPs) in the cells of all organisms (Lindquist, 1986; Lindquist and Craig, 
1988). The phenomenon was serendipitously observed and reported by Ferruccio Ritossa in 
1962 (Ritossa, 1996), and was originally described as the appearance of new puffs on the 
chromosomes of the salivary gland of a fruit fly, Drosophila busckii, induced by heat shock 
and dinitrophenol (DNP) (Ritossa, 1962). Since the discovery of the heat shock response, 
subsequent studies have made several notable observations (Lindquist, 1986). Among them 
includes the study demonstrated that the presence of these puffs coincided with the synthesis 
of new proteins (Tissieres et al., 1974), which were later identified as HSPs. More 
importantly, the induction of these HSPs has been associated with the acquisition of tolerance 
to more extreme heat shock or other stressful stimuli, in a wide variety of cells and organisms 
(Parsell and Lindquist, 1993). The observed “acquired thermotolerance” or “cross-protection” 
has created a new wave of interest in exercise sciences research, on account of its significant 
implications for exercise-induced heat shock response in health and disease (Locke, 1997). 
Most of the exercise-related studies, to date, have been focused on the cytoprotective roles of 
HSP72, a highly inducible form of HSP70 family. The studies on the other isoforms of 
HSP70 in mammals are limited due to the fact that they are only slightly or not heat stress 
inducible (Locke, 1997). These HSP70 isoforms include the constitutively synthesized 
HSC73 (heat shock cognate 73), glucose-regulated proteins GRP75 (also known as 
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mitochondrial HSP70, mtHSP70) and GRP78 (also known as immunoglobulin heavy-chain 
binding protein, BIP). 
 
Skeletal muscle fibres are highly vulnerable to structural damage following stressful stimuli 
such as eccentric contraction (Armstrong et al., 1983b; Friden et al., 1981; Lieber and Friden, 
2002; Lieber et al., 1996). The functional consequence of such cellular damage is skeletal 
muscle weakness and soreness (Byrnes et al., 1985; Clarkson et al., 1992). The idea of 
exercise-induced muscle damage (EIMD) or “ruptures within the muscle” was first 
hypothesized by Theodore Hough (Hough, 1900; Hough, 1902), who also originally observed 
and reported the phenomena of muscle weakness and soreness in early 1900s (Hough, 1900; 
Hough, 1902). Nevertheless, healthy muscle fibres are capable of recovering from the 
structural and functional impairment following a damaging insult, and transiently adapt to 
limit future damage (Ebbeling and Clarkson, 1989; McHugh, 2003). This so-called “repeated 
bout effect” of eccentric exercise, in part coincides with the induction of HSP72 in skeletal 
muscle (McHugh, 2003). Recent studies have shown that, the increase in HSP72 in skeletal 
muscle was associated with reduced susceptibility to, and enhanced recovery from muscle 
damage induced by both contractile (Kayani et al., 2008a; Liu et al., 2013; McArdle et al., 
2004) as well as non-contractile activity (Maglara et al., 2003; Miyabara et al., 2006). 
However, the precise mechanism whereby HSP72 protects against muscle damage is not 
entirely understood. Hence, we proposed a series of studies using small conscious animals as 
in vivo models to investigate the emerging role of HSP72 in EIMD and its interactive role 
with the cellular Ca2+ regulatory system (Tupling et al., 2008) and heat shock response 
following myofibrillar damage associated with prolonged eccentric exercise (Lewis et al., 
2013; Thompson et al., 2003; Touchberry et al., 2012). 
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It is known that the induction of HSP72 in skeletal muscle is stress-mediated and regulated by 
heat shock transcription factor (HSF) (Liu et al., 2006). Among the members of HSF family, 
HSF1 has been identified as responsible for mediating stress-induced heat shock gene and 
protein expression in the vertebrates (Pirkkala et al., 2001). It is thought that in the unstressed 
condition HSP70 family binds to HSF, preventing the formation of HSF-trimer. Nevertheless, 
under the stressful insult, aggregation of damaging proteins compete HSP70 away from the 
HSP70-HSF complex. Consequently, free HSFs are phosphorylated by protein kinases and 
form the DNA-binding trimer. The HSF-trimer then binds to specific promoter region of 
DNA called heat shock element (HSE), thereby triggering HSP70 production (Morimoto, 
1993). HSP72, the inducible form of HSP70, has been implicated in preventing the damaging 
protein aggregation that occurs during physiological insults. However, the question remains: 
do the skeletal muscles share a similar regulatory mechanism of HSP72 when under 
physiological stress such as an eccentric exercise challenge (e.g. prolonged walking 
downhill)? 
 
At the cellular level, most molecular chaperones (i.e. HSPs) function by recognizing the 
exposed hydrophobic surface of the client proteins and it could be that under a Ca2+ overload 
condition (e.g. EIMD), these proteins do not completely expose the hydrophobic residues to 
attract the chaperones and hence they tend to misfold and aggregate without being corrected 
(Gissel, 2005). It is also commonly known that conventional modalities (e.g., exposure to heat 
or hypoxia) that are efficient in inducing HSP72 synthesis in vivo, in part, usually result in 
protein damage or denature in vivo and in vitro. Hence, on paper, therapeutic application of 
such procedure may be complicated by the paradoxical mechanism of heat shock response 
itself. On the other hand, in reality, it might not be practical in the prevention of multi-
factorial events that cause muscle damage or trauma, such as unaccustomed exercise or 
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eccentrically biased exercise. Therefore, the concept of “cross-protection” and development 
of new pharmacological inducers of heat shock response have provided an alternative to the 
fraternity of exercise and clinical science in their potential use in preventing or treating the 
muscle damage or disease. Several novel compounds in this area have shown promising 
results in animal studies. For example, the HSP70 inducer, 17-(allylamino)-17-
demethoxygeldanamycin (17-AAG) was reported to be effective in protecting against the 
adverse events in EIMD (Kayani et al., 2008a), hindlimb unloading (Lomonosova et al., 
2012) and neurodegenerative disease (Waza et al., 2006). Similarly, the administration of 
glutamine, the known HSP70 inducer in most of the splanchnic cells, was found to reduce the 
markers of muscle damage following ischemia-reperfusion (Murphy et al., 2007), 
inflammatory insult (Meador and Huey, 2009), prolonged exercise (Cruzat et al., 2010) and 
spinal cord injury (Chamney et al., 2013). The current idea is that, if we can mimic a heat 
shock response in the absence of the actual stress, by means of pharmaceutical interventions, 
HSP72 protein synthesis might be upregulated and resolve the protein aggregate-related 
complications. Eventually the magnitude of myofibrillar damage and force deficit resulting 
from EIMD should be limited. 
 
1.2. The Primary Aim and Significance of the Research 
 
This thesis investigates the mechanisms underlying the cellular protective effects of HSP72 in 
limiting tissue disruption and functional impairment. Specifically, we are interested in 
pharmaceutical-mediated HSP72 induction in skeletal muscle and its subsequent role in 
conferring protection against myofibrillar damage and limiting the force deficit. We sought to 
provide further insights on the mechanisms behind these physiological effects with special 
reference to prolonged eccentric exercise-induced muscle damage in a rodent model. 
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The findings from this investigation will provide additional understanding on the interaction 
of the heat shock response and prolonged eccentric exercise, and the potential beneficial 
effect of skeletal muscle HSP72 induction on EIMD. The outcomes of this research will also 
add to the current body of knowledge with regard to: (1) the effect of 17-AAG on skeletal 
muscle HSP72 response in a rodent model of EIMD; (2) the effect of oral glutamine treatment 
on in vivo HSP72 induction, in plasma and striated muscles (red vastus and heart) of rat; (3) 
the effect of oral glutamine on skeletal muscle heat shock response and EIMD; and (4) if there 
is an additive effect of oral glutamine and heat preconditioning on skeletal muscle heat shock 
response, and their effect on EIMD. These outcomes will potentially support the 
pharmacological manipulation of heat shock response, as a novel, non-invasive, cost-effective 
and feasible therapeutic strategy in limiting skeletal muscle damage resulting from EIMD. 
The approach can also be used in preventing the adverse effects of eccentric or any other 
strenuous unaccustomed exercise, and served as an ergogenic aid in human athletic training 
and performance. 
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CHAPTER 2 – LITERATURE REVIEW 
 
2.1. Eccentric Exercise-induced Muscle Damage 
 
EIMD is a well-documented observation since the phenomenon was first reported in the 
scientific literature (Hough, 1900). In the classic study of muscular fatigue and soreness, 
Hough (1900) demonstrated that there was a delayed and transient muscular soreness in an 
untrained flexor muscle of the middle finger, after undertaking a series of contractions against 
the resistance of a strong spring. In a subsequent follow-up study, Hough (1902) suggested 
that the muscular soreness was independent of muscle fatigue, but rather the result of ruptures 
within the muscle. Since then, the physiological consequences following a period of eccentric 
exercise and the mechanistic pathway for muscle damage have been extensively investigated 
and discussed in a number of reviews (Allen, 2001; Allen et al., 2005; Allen et al., 2010; 
Armstrong, 1990; Armstrong et al., 1991; Butterfield, 2010; Clarkson, 1997; Clarkson and 
Hubal, 2002; Clarkson and Sayers, 1999; Friden and Lieber, 1992; Malm, 2001; McHugh, 
2003; McHugh et al., 1999; Morgan and Allen, 1999; Morgan and Proske, 2004; Proske and 
Morgan, 2001). It has been generally accepted that the transient loss of muscle force 
generation or strength and soreness are the hallmarks of the EIMD (Hough, 1900; Hough, 
1902). However, the original hypothesis that these adverse effects of unaccustomed or 
eccentric-biased exercise are the symptoms of muscle morphological disruption has only been 
confirmed in histological and histochemical studies many years later (Friden et al., 1981; 
Friden et al., 1983; Vihko et al., 1979).  
 
There are three major types of muscle contraction. When the muscle activation results in no 
joint movement with the length of the muscle held constant, it is called an isometric 
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contraction. If the muscle activation results in a torque that is greater than the load, the muscle 
shortens and hence it is called a shortening or concentric contraction. When the load applied 
to the muscle is larger than the force it can produce and the activated muscle undergoes 
lengthening, it is called a lengthening or eccentric contraction. This section of the literature 
review aims to outline published research that has employed downhill running as an 
experimental model for investigating the effects of repeated eccentric contractions on skeletal 
muscle morphological changes and contractile function, including the capacity to generate 
force as well as to sustain contraction economy. 
 
2.1.1. Effects of downhill running on muscle morphological changes 
 
Friden et al. (1981) was probably the first to demonstrate the morphological changes within 
human muscle following repeated bouts of down-stair running, which caused the subjects 
severe delayed onset of muscle soreness (Figure 2.1). Similar histological and histochemical 
abnormalities were also reported in other studies using untrained animals undertaking 
exhaustive uphill (Salminen and Vihko, 1983; Vihko et al., 1979) and downhill treadmill 
running (Armstrong, 1990; Chen et al., 2007d; Han et al., 1999; Komulainen et al., 1999; 
Komulainen et al., 1994; McNeil and Khakee, 1992; Takekura et al., 2001). Those 
morphological anomalies found in animal study were also observed immediately after 
downhill running in the human subjects (Feasson et al., 2002). These studies suggest that 
direct histological analysis of muscle fibres is sufficient in providing evidence of substantial 
myofibrillar disruption, in both animal and human downhill running model of EIMD. For 
instance, one of these studies (Armstrong et al., 1983b) reported localized disruption of the 
muscle fibres immediately after the downhill running (Figure 2.2). Another study (Takekura 
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et al., 2001) clearly showed that morphological disruption to myofibrils and ultrastructural 
abnormalities appeared at 24 h after downhill running (Figure 2.3). 
 
 
 
Figure 2.1 Focal abnormalities in muscle fibres from the muscle biopsy obtained 2 days post down-
stair running (left panel, #2). Electron micrographs showing Z-line broadening and streaming is seen 
affecting a single myofibril (upper right panel, #3a) or several sarcomeres and myofibrils (lower right 
panel, #3b). Adapted from (Friden et al., 1981). 
  
The broadening and streaming of Z-line is the most commonly reported morphological 
anomalies in the EIMD. The occurrence of Z-line streaming is thought to be associated with 
the disorganization of contractile elements adjacent to the damaged Z-lines (Friden, 1984); 
and that the Z-line during relatively high force eccentric contraction, constitute a weak link in 
the myofibrillar contractile network (Friden et al., 1981). The histological studies of EIMD 
also lead to a further hypothesis that muscle fibre strain results in an increased Ca2+ influx, or 
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remained unchanged after exercise. In summary, these 
results indicate that there were no signs at cellular level 
either of ischemic fibre necrosis or of fibre rupture in the 
specimens from the sore muscles. Similar findings have 
been made by other workers 5. 
However, at subcellular level abnormalities were seen in 
the biopsies obtained 2 days postexercise. Frequent  focal 
disturbances of the characteristic cross-striated band pat- 
tern were revealed in semithin (l-lam-thick) toluidine-blue 
stained survey sections of plastic embedded specimens 
(fig. 2). The total area showing focal disturbances in 
preparations obtained 2 days postexercise was estimated, by 
means of  morphometric methods, to be at least 3 times 
larger than in comparable sections from control muscles as 
well as in specimens obtained 7 days after exercise. At the 
ultrastructural level the disturbances were found to origi- 
nate from the myofibrillar Z-band which showed a marked 
broadening, streaming and, at places, total disruption 
(fig. 3). In some cases only 1 single Z-band of 1 myofibril  
was affected (fig.3a), whilst there was also evidence for 
involvement of several sarcomeres and myofibrils (fig.3b). 
The myofi lamentous material in sarcomeres adjacent to the 
affected Z-bands was either supercontracted or disorga- 
nized and out of register. The Z-bands,  which normally 
have a regular and complex fine structure 11, were often 
observed to have gaps in their lattice pattern even in areas 
where neither obvious broadening nor  streaming was seen. 
The present findings indicate that a much greater Z-band  
disorganization occurs in biopsies obtained 2 days postexer- 
cise than those obtained prior to exercise. Other workers 
have reported some Z-band  streaming in healthy individ- 
uals who have not undergone any preceeding conscious 
excessive physical effort 12. The immediate  interpretat ion of  
the findings is that the high myofibri l lar  tension developed 
during activation of the contractile material, i.e. the inter- 
digitating arrays of  thin and thick myofilaments,  has 
resulted in some mechanical  disruption of  the Z-bands.  
These Z-bands, or in 3-dimensional  terms, the Z-discs, 
connect adjacent sarcomeres to each other. The findings 
therefore indicate that the Z-bands  during overloading 
constitute a weak link in the myofibril lar  contractile chain. 
A disruption of myofibrils may result in a formation of 
protein components (such as globular proteins and 
degraded Z-proteins) and subsequent  releasing of protein- 
bound  ions which may cause oedema an d thereby give rise 
to exercise-induced muscle soreness. 
The appearance of  delayed muscle soreness has mainly  
been connected with eccentric work 2'5' 13, which is an impor- 
tant component  in most exercises, for example, runn ing  
downstairs. This type of  work causes greater tension per 
active motor unit  than corresponding concentric work and 
may therefore increase the risk for mechanical  damage to 
the myofibrillar material  as has been observed in the 
present work (the Z-discs). 
Our results are not necessarily direct proof for the theory of  
mechanical  Z-disc disruption as we only have data ob- 
tained 2 and 7 days postexercise and no biopsies were taken 
immediately after the work. Therefore, the structural dis- 
turbances may also be secondary resulting from an activa- 
tion of lysosomal enzymes 8'9'14, bringing about a concomi- 
tant inf lammation 6,13,j5. However, it does appear that the 
overloaded muscle fibres seem to have their contractile 
machinery partially distorted. As these fibres are probably 
predisposed to a total fibre rupture the risk for a serious 
rupture of  a larger part of  the muscle might be increased. 
Fig.3. Electron micrographs showing fibres from the specimen 
shown above (fig. 2). The cross-striated myofibrillar band pattern is 
disturbed at places. Z-band broadening and streaming is seen 
comprising either only single Z-bands (a), or several sarcomeres 
and myofibrils (b). The myofilamentous material in sarcomeres 
adjacent to the affected Z-bands, is supercontracted or disorga- 
nized, a • 12,000; b • 7500. 
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A morphological study of delayed muscle soreness 
J. Frid6n, M. Sj6str6m and B. Ekblom 
Departments of Anatomy and Neurology, University of Umeh, S-901 87 Umegt (Sweden), and Karolinska Institutet, Depart- 
ment of Physiology III, LidingOvgigen 1, S-114 33 Stockholm (Sweden), 17 September 1980 
Summary. Biopsies, taken up to 1 week postexercise, from the soleus muscles of 5 healthy males (20-34 years old) suffering 
from pronounced exercise-induced delayed muscle soreness were analyzed morphologically. There was no evidence for 
ischemic tissue injury or mechanical fibre disruption. However, at the subcellular level frequent myofibrillar disturbances, 
especially with regard to the Z-bands, were noted. Thus, the contractile machinery of overloaded muscle fibres seemed to 
be partially distorted several days following exercise. 
Most people, especially those engaged in sporadic physical 
exercise, experience severe muscular discomfort 1-3 days 
after unusual heavy physical exercise. This condition is 
termed 'delayed muscle soreness'. The major symptoms are 
muscular stiffness, tenderness, and pain, especially when 
making active movements. The signs are firm, tender and 
weak musculature. The pathophysiology behind this condi- 
tion is not known, although many theories exist 1-6. 
Previous workers using experimental animals have found 
considerable changes in muscle morphology following ex- 
cessive exercise 7-9. As it is known that running downstairs is 
one type of exercise that gives rise to pronounced delayed 
muscle soreness in calf muscles, it was decided to investi- 
gate whether this type of exercise would cause ischemic 
necrosis of single muscle fibres or mechanical fibre rupture 
in humans. Muscle biopsies from 5 healthy males (age 20- 
34 years) were analyzed by means of morphological techni- 
ques. The men were asked to run rapidly 10 times from the 
10th floor down the stairs to the ground floor. The only 
resting periods consisted of those occasions when the sub- 
jects went up to the 10th floor by the elevator. They all 
suffered from intense calf muscle discomfort during the 
subsequent week, especially during the first 2-3 days fol- 
lowing the exercise program. Biopsies were obtained alter- 
natively from the right and left m. soleus by open surgical 
technique 2 weeks before the exercise and, from the 
contralateral side, 2 and 7 days after exercise. Each biopsy 
was initially divided into 2 halves, one of which was 
prepared for enzyme histochemistry l~ the other for elec- 
tron microscopy. The biopsy part for electron microscopy 
was carefully mounted with nails on a cork plate so that the 
muscle fibres during the fixation remained at their approx- 
imate rest length. This was taken to be the length at which 
the muscular fascia became taut. Prefixation was per- 
formed in glutaraldehyde and post fixation in osmium 
tetroxide. Vestopal was used for plastic embedding. 
The muscle fibres, both before and after exercise, as 
observed in sections specifically stained for oxidative en- 
zymes and myofibrillar adenosine triphosphatase, were 
always seen tightly packed in well organized fascicles 
(fig. 1). Neither frequent focal nor diffuse fibre abnormali- 
ties were observed in any of the specimens. Furthermore, 
there was no evidence for presence of regenerating fibres. 
The relative number of different fibre types and their sizes 
Fig. 1. Soleus muscle biopsy obtained 2 days after unusually heavy 
physical work when the subject experienced a severe muscle 
soreness. The section has been treated for visualization of oxidative 
activity (TPNH). The overall muscle morphology is normal. No 
necrotic fibres, indicating ischemic tissue damage or total fibre 
rupture, are seen. x 125. 
Fig.2. Toluidine blue stained 1-~tm-thick survey plastic section 
showing striated muscle fibres from the same biopsy as in fig. 1. 
The striation pattern is at places disturbed. A segment of 1 fibre 
(upper half of the figure) is severely disorganized. Other fibres 
show freque t focal disturbances, some of which are encircled. 
x 500. 
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disruption of the intracellular Ca2+ store in the sarcoplasmic reticulum (SR), or the disruption 
of T-tubule system or sarcolemma (Lieber et al., 2002). Subsequently, the increased 
intracellular Ca2+ leads to calpain activation and selective hydrolysis of intermediate 
microfilaments. Thereafter, the myofibrillar contractile network is disrupted by repeated 
muscle activation and is unable to develop normal tension (Lieber et al., 2002). This theory 
was supported by the observed swollen T-tubules (Figure 2.3 B and C) in the muscle fibres 
of rats following both level and downhill running (Takekura et al., 2001). Other ultrastructural 
evidence for the role of disrupted SR Ca2+ homeostasis in the early phase of EIMD include 
the presence of crystallized structures within SR lumens (Friden and Lieber, 1996) and the 
loss of SR membrane integrity (Yasuda et al., 1997). 
 
 
Figure 2.2 Cross section of medial head of triceps brachii in rat showing a significant numbers of 
muscle fibres were undergoing localized necrosis at 48 h after downhill running at low (left panel A) 
and high (right panel B) magnifications. Adapted from (Armstrong et al., 1983b). 
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FIG. 10. Cross sections (1 pm) of medial head of triceps brachii 
muscle 48 h after downhill running stained with Lee’s methylene blue- 
basic fuchsin at low (A) and high (B) magnifications. Degenerating 
mononuclear cells appeared to be blastic cells as indi- 
cated by their prominent nucleoli. Developing myofibrils 
were in evidence in the myotubes (Fig. 9D). From 3 to 12 
days the number of cells in the interstitial spaces between 
normal muscle fibers decreased, and by 12 days the 
muscles appeared normal. 
Uphill runners. Soleus muscles taken from rats that 
ran uphill were indistinguishable from those that ran 
downhill after exercise. Some fibroblasts and abundant 
macrophages were observed in the interstitium of the 
muscle samples, and a small percentage (<5%) of the 
muscle fibers underwent necrosis as evidenced by mac- 
rophage invasion. These changes were not apparent in 
other muscles sampled from uphill runners. 
Sedentary control rats. The histological appearance of 
all control rat muscle samples was normal. Increased 
fibroblast and macrophage activity was not noted in any 
muscle from these animals. 
DISCUSSION 
The purpose of these experiments was to study the 
relationship between eccentric-biased treadmill exercise 
and injury to skeletal muscles in rats. We hypothesized 
that running down an incline (eccentric biased) would 
cause more inflammatory or degenerative changes in the 
physiological extensor muscles than running on the level 
(similar amounts of eccentric and concentric) or up an 
incline (concentric biased). The data generally support 
this hypothesis but are not unequivocal. The results 
myofibers are shown beside normal muscle cells. In B, arrow designates 
a mitotic figure that appears to be associated with a normal muscle 
cell. Its position suggests it is a satellite cell. 
clearly support the contention that running downhill 
does more damage to the muscles than running on the 
level but do not as clearly demonstrate a difference 
between the effects of down- and uphill running. 
Plasma Enzymes 
Previous investigators (1, 14) have suggested that ele- 
vations in plasma enzymes following exercise result from 
injury to muscle fibers, but this association has not been 
proven. Nonetheless, our purpose in measuring plasma 
enzyme changes was to provide evidence of muscular 
injury. 
With the exception of the CK activity in the plasma of 
animals that ran uphill, all runners showed significant 
elevations in plasma CK and LDH immediately after 
exercise (0 h). Alterations in plasma enzyme activities 
have been reported in animals following exercise in a 
number of studies beginning with that of Altland and 
Highman in 1961 (l), but this previous work has primarily 
focused on the importance of the intensity or duration of 
the exercise rather than the mode of muscular contrac- 
tions. Our data reveal that at 0 h postexercise, the in- 
crease in CK activity in downhill runners was 2.9-fold 
greater than that for uphill runners (Fig. 5) and 2-fold 
greater than that for level runners (Fig. l), indicating 
that the immediate postexercise elevations in plasma 
enzymes are most probably related to the eccentric con- 
tractile component of the exercise when intensity and 
duration are constant. Furthermore, with the exception 
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Figure 2.3 Longitudinal sections of fast-twitch (FT, panel A to C) and slow-twitch (ST, panel D and 
E) muscle fibre in rat triceps brachii at 1 day after level (panel B and D) and downhill (panel A, C and 
E) running. Adapted from (Takekura et al., 2001). 
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2.1.2. Effects of downhill running on muscle force generation 
 
Detrimental effects of eccentric exercise on force-generating capacity or strength have been 
well documented (Davies and White, 1981; Friden et al., 1983). Strength loss is also widely 
accepted as one of the most reliable indirect markers of functional impairment resulting from 
EIMD (Warren et al., 2002). In this context, strength loss is defined as the decline in maximal 
voluntary isometric contraction (MVIC) torque and maximal isometric tetanic force 
generating capacity. The magnitude and pattern of strength loss following eccentric exercise 
depends largely on the mode of exercise. A prolonged moderate-intensity continuous 
eccentric exercise, such as downhill running usually results in immediate strength loss of 10 
to 30% during MVIC (Sayers and Hubal, 2008). A more intensive eccentric exercise protocol 
such as repeated single-joint resistance exercise typically elicits 30 to 50% of strength loss 
immediately after exercise (Sayers and Hubal, 2008). On the other hand, the maximal 
eccentric contractions can produced an average of 50 to 70% strength loss (Sayers and Hubal, 
2008). The time courses for recovery from this apparent muscle weakness in human subjects 
maybe 7 to 10 days, or up to several weeks in animal models using maximal stimulated 
eccentric contractions (Sayers and Hubal, 2008). 
 
Evidence from a recent study suggests that the maximum decline in MVIC is usually 
observed within 6 h following an acute bout of downhill running, with a magnitude of 11 to 
38% deficit in MVIC being a typical response (Chen et al., 2007a). The reduction in MVIC 
could be extended up to 7 days following the downhill running intervention, and remained 
reduced to the extent of a 19% deficit below the pre-exercise value (Chen et al., 2007a). Such 
observations in strength loss were similar to that reported in other literature (Sayers and 
Hubal, 2008), and could be viewed as an indication of the magnitude of muscle damage 
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induced by submaximal voluntary eccentric exercise such as downhill running/walking, or 
other daily physical activities. The magnitude of muscle damage as implicated in the decline 
in MVIC of knee extensors after downhill running (Figure 2.4) was typically not as large as 
that observed following the maximal eccentric contractions. 
 
 
Figure 2.4 Changes in maximal voluntary isometric contractile strength before and at 0.5, 24, 48, 72, 
96 and 120 h following the first (DHR1) and repeated bout (DHR2) of downhill running, separated by 
5 days. Adapted from (Chen et al., 2007a). 
 
 
2.1.3. Effects of downhill running on contraction economy 
 
Running economy is generally defined as the energy cost of running at a given submaximal 
intensity, and is determined by measuring the steady state oxygen consumption (VO2) for a 
standardized running speed and gradient. Individuals with the ability to consume less oxygen 
per kilogram of body weight during the submaximal run are considered to have a better 
running economy, which is invariably expressed as VO2 per kilogram of body weight (mL-
1O2.kg-1). There has been a growing interest in investigating the effects of eccentric exercise 
on running economy. This interest reflects the time during which running economy was 
12 and 15 consecutive strides from the 10-second
video recordings were analyzed using the APAS. The
elapsed time between the first and the last heel con-
tact was calculated, and SF was obtained by dividing
the number of strides by the time. SL was derived
using the following formula: SL = velocity of the tread-
mill (m·s−1)/SF. ROM-A and ROM-K were determined
by calculating the maximal changes in the angles of
each joint (ankle and knee) during a stride (heel contact
to heel contact), and the mean values of four strides
were used for further analysis (Chen et al. 2007a; Hamill
et al. 1991).
Reliability
The values of the criterion measures (strength, SOR,
Mb, RE parameters) obtained from the 12 subjects
taken on 2 different days before DHR1 were compared
using a paired t test, and analyzed by an intraclass 
correlation coefficient (R). Mean coefficients of varia-
tion (CV) taken from the individual CVs of the 12 sub-
jects were also used to examine the reliability of the
measurements. The paired t test showed no significant 
differences between days for all measures. The R val-
ues fell in a range between 0.86 and 1.00, which is
considered to be high. The CV range w s between
0.0% and 7.8%, with most measures having a CV of
around 6%.
Statistical analysis
Changes in the indicators of muscle damage (strength,
SOR, Mb) related to physiological (V·O2, HR, V
·
E, RER,
RPE, LA) and biomechanical (SL, SF, ROM-A, ROM-K)
RE over time (before, immediately after, and 0.5–120
hours after DHR1 and DHR2) were analyzed using a
two-way repeated-measures analysis of variance. When
a significant (interaction: time×bouts) effect was found,
a Scheffé’s post hoc test was performed. Statistical 
significance was accepted at p <0.05.
Results
Indicators of muscle damage
Isometric strength
Figure 1A presents the changes in MVC of the knee ex-
tensors following DHR1. The average pre-DHR isomet-
ric strength was about 51.0 ±6.5 kg. Isometric strength
decreased by about 11.0 ±3.1 kg at 0.5 hours after
DHR1, and then gradually recovered to baseline by 
120 hours after DHR1. At 0.5 hours after DHR2, strength
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Fig. 1 Changes in: (A) maximal voluntary isometric strength
of the knee extensors (MVC); (B) muscle soreness (SOR); and
(C) plasma myoglobin (Mb) concentration before (pre), and at
0.5, 24, 48, 72, 96 and 120 hours following the first (DHR1)
and repeated (DHR2) bouts of downhill running. *Significant
difference between DHR1 and DHR2 (p <0.05).
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widely accepted as an important determining factor of success in distance running (Braun and 
Dutto, 2003; Sharwood et al., 2000; Sharwood et al., 2002). A summary of human studies 
reporting the effect of downhill running/walking on MVIC and running economy is presented 
in Table 2.1. 
 
Impairment in running economy is one of the delayed transient deficits of muscle function 
resulting from damaging eccentric exercise, e.g. downhill running. Many studies conducted at 
different laboratories have observed a similar trend of increased oxygen cost during 
submaximal horizontal running following a bout of downhill running (Braun and Dutto, 2003; 
Chen et al., 2007b; Chen et al., 2009; Chen et al., 2007c; Chen et al., 2008; Sharwood et al., 
2002). An increase of 2-12% oxygen cost from the baseline values was reported across the 
time course between 10 min and up to 7 days following downhill running (Chen et al., 2009). 
The magnitude of the changes, however, tended to be higher at the acute (within minutes to 
hours, 7-8%) than chronic (>5 days, 2-5%) recovery phase following a downhill run (Chen et 
al., 2009). The highest impairment of running economy reported in the research literature 
(12% increase in oxygen cost) was observed at 2 days following downhill running when the 
running intensity was at 90% of pre-determined VO2max in untrained individuals (Chen et al., 
2009). However, it is interesting that a recent study (Braun and Paulson, 2012) reported a 
small but significant improvement in running economy following a short bout of downhill 
running while several other studies (Gault et al., 2011; Hamill et al., 1991) reported no 
adverse effect (negative impact). 
 
The discrepancy between the research findings of the effect of downhill running on running 
economy could be attributed to the following physiological and biomechanical factors: (1) the 
magnitude of eccentric stress or downhill running-induced muscle damage (Braun and 
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Paulson, 2012; Chen et al., 2009); (2) the intensity of the horizontal running economy test 
(Chen et al., 2009); (3) the changes in the kinematics of running at higher intensity (Chen et 
al., 2009; Tsatalas et al., 2013); and (4) training status (Braun and Paulson, 2012), age (Gault 
et al., 2011) and gender (Hamill et al., 1991) of the subjects.  
 
Collectively, these studies suggest that submaximal voluntary eccentric exercise (i.e. downhill 
running per se or long-distance running involving downhill running) is likely to bring about 
impairment in subsequent running economy. However, the results have been equivocal and 
the detrimental effect appears to be dependent on training status or running experience, age 
and gender of the subjects. To the best of our knowledge, no study has examined the effects of 
downhill running on running economy in humans, with negative workload of running being 
clamped to each subject’s body weight, i.e. the speed and/or gradient of the treadmill to be 
adjusted to obtain each subject’s personalized workload. Several exercise intervention studies 
suggested that there is no beneficial effect of low intensity training improving muscle function 
during submaximal contractions (Chen et al., 2007b; Chen et al., 2008). Furthermore, the 
detrimental effect of eccentric exercise on running economy was found to be reduced when a 
repeated bout of similar eccentric exercise was performed two weeks later (Burt et al., 2013), 
a finding that was associated with a so-called “repeated-bout effect” (Byrnes et al., 1985; 
McHugh, 2003; McHugh et al., 1999). Of further interest is a recent report on the effect of 
glutamine administration on recovery of muscle strength and soreness from eccentric 
exercise-induced muscle damage in humans (Street et al., 2011). However, the beneficial 
effects of glutamine in limiting myofibrillar disruption and impaired whole body muscle 
function, such as exercise economy have not been well documented. The paradoxical findings 
of the research in this area have been controversial and warrant further investigations.  
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Table 2.1 Summary of human studies reporting the effect of downhill running/walking on impaired force generation and/or running economy. 
% Change After Downhill Running/Walking (h) Study Subject 
Characteristics 
Exercise Protocol Criterion Measures 
0-6 24 48 72 96 120 ≥144 
 
Hamill et 
al. (1991) 
Female (n=10), 
23.4±2.8 yr, VO2max 
47.6±4.3 mL.kg-
1.min-1, recreational 
runners (<20 
mile.week-1). 
 
Downhill running: 30 min 
at −26% (−15°) and a 
treadmill running speed 
corresponding to 73.5% of 
maximum heart rate. 
 
VO2 at 80% of VO2max (mean 
treadmill running speed 10.3 
km.h-1). 
- - ND - - ND - 
Balnave 
and 
Thompson 
(1993) 
Control group: 
male (n=4) and 
females (n=3); 
eccentric exercise 
training group: 
male (n=7) and 
female (n=2). 
  
Downhill walking: 40 min 
at −25% and 6.4 km.h-1. 
MVIC at 90° knee joint angle on 
the right quadriceps. 
−25 −20 −15 - - - - 
Sharwood 
et al. 
(2000) 
Male (n=20), 45-50 
yr, veteran distance 
runners, VO2max 
50.8±7.0 mL.kg-
1.min-1. 
 
Downhill running: 40 min 
at −10% (−6°) and 70% of 
peak treadmill running 
speed (15.9±1.5 km.h-1). 
MVIC at 60° knee flexion, 5 s 
MVIC at 60° knee flexion, 25 s 
 
ND 
−12 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
Sharwood 
et al. 
(2002) 
Male (n=17), 45-55 
yr, masters distance 
runners, VO2max 
51.2±6.9 mL.kg-
1.min-1. 
 
 
Downhill running: 20 min 
at −10% (−6°) and 70% of 
peak treadmill running 
speed (16.3±1.8 km.h-1). 
VO2 at 70% of peak treadmill 
running speed (5-min average 
within 10 min before and after 
downhill running). 
+8 - - - - - - 
 
 
  
16 
Table 2.1 Continued 
% Change After Downhill Running (h) Study Subject 
Characteristics 
Exercise Protocol Criterion Measures 
0-6 24 48 72 96 120 ≥144 
 
Braun and 
Dutto 
(2003) 
Male, 31.4±5.4 yr, 
trained 60.4±23.4 
km.week-1, VO2max 
58.4±7.7 mL.kg-
1.min-1, n=9. 
 
Downhill running: 30 min 
at −10% (−6°) and 70% 
pre-determined VO2max. 
 
VO2 at 65%, 75% and 85% of 
VO2max. 
- - +3 - - - - 
Close et al. 
(2004) 
Male, physically 
active, age 
24.9±3.0 yr, mass 
80.6±5.4 kg, 
VO2max 4.6±0.3 
L.min-1 n=8. 
  
Downhill running: 30 min 
at −15% and treadmill 
speed corresponding to 
65% of VO2max. 
MVC (concentric, 1.04 rad.s-1) 
MVC (concentric, 5.20 rad.s-1) 
MVC (eccentric, 2.06 rad.s-1) 
−15 
−11 
−37 
−18 
−14 
−14 
−13 
−8 
−14 
−5 
−6 
+6 
- 
- 
- 
- 
- 
- 
- 
- 
- 
Chen et al. 
(2007c) 
Male, 20.5±1.5 yr, 
VO2max 54.6±4.6 
mL.kg-1.min-1, 
n=10. 
Downhill running: 30 min 
at −15% (−8.5°) and 70% 
pre-determined VO2max. 
MVIC at 70° knee flexion 
VO2 at 178±11 m.min-1 
VO2 at 205±12 m.min-1 
VO2 at 232±14 m.min-1 
−21 
+7 
+7 
+7 
 
−15 
+7 
+7 
+7 
−12 
+6 
+6 
+6 
−11 
+4 
+4 
+4 
−7 
ND 
ND 
ND 
−2 
ND 
ND 
ND 
- 
- 
- 
- 
 
Chen et al. 
(2007b) 
Male, 22.4±0.9 yr, 
n=12. 
Downhill running: 30 min 
at −26% (−15°) and 70% 
pre-determined VO2max. 
MVIC at 70° knee flexion 
VO2 at 85% of VO2peak 
 
 
−38 
- 
−35 
- 
−31 
+6 
−29 
- 
−25 
- 
−23 
+4 
−19 
+2 
Chen et al. 
(2007a) 
Male (n=12), 
20.2±1.3 yr, VO2max 
55.7±4.8 mL.kg-
1.min-1. 
 
Downhill running: 30 min 
at −15% (−8.5°) and 70% 
pre-determined VO2max. 
MVIC at 70° knee flexion 
VO2 at 85% of VO2peak 
−22 
+8 
−16 
+8 
−14 
+8 
−10 
+6 
−8 
ND 
−4 
ND 
- 
- 
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Table 2.1 Continued 
% Change After Downhill Running (h) Study Subject 
Characteristics 
Exercise Protocol Criterion Measures 
0-6 24 48 72 96 120 ≥144 
 
Chen et al. 
(2008) 
Male, 21.1±2.3 yr, 
VO2max 55.3±6.3 
mL.kg-1.min-1, 
n=10. 
 
Downhill running: 30 min 
at −15% (−8.5°) and 70% 
pre-determined VO2max. 
 
MVIC (knee extensors) 
VO2 at 236.6±7.6 m.min-1 
−20 
- 
- 
- 
- 
+5 
- 
- 
- 
- 
−5 
- 
- 
+2 
Chen et al. 
(2009) 
Male, 21±1.6 yr, 
VO2max 49.8±5.4 
mL.kg-1.min-1, 
untrained, n=15. 
Downhill running: 30 min 
at −16% (−9°) and a 
treadmill velocity at 70% 
pre-determined VO2max. 
 
MVIC (knee extensors) 
VO2 at 143.3±20.2 m.min-1 
VO2 at 172.6±23.4 m.min-1 
VO2 at 204.4±25.5 m.min-1 
−28 
- 
- 
- 
−26 
- 
- 
- 
 
−22 
ND 
+7 
+12 
−22 
- 
- 
- 
−19 
- 
- 
- 
 
−17 
ND 
+2 
+5 
- 
- 
- 
- 
 
Gault et al. 
(2011) 
Male, 67±4 yr, 
VO2max 29.6±9.1 
mL.kg-1.min-1, 
n=15 (8 men and 7 
women). 
 
Downhill walking: 30 min 
at −10% (−6°) at self-
selected walking speed, 
SSWP (4.6±0.6 km.h-1). 
 
MVIC (knee extensors) 
VO2 at SSWP 
- 
- 
- 
- 
−15 
ND 
- 
- 
- 
- 
- 
- 
- 
- 
Braun and 
Paulson 
(2012) 
Male (n=7) and 
female (n=8), 
31.1±8.1 yr, 
VO2peak 53.9±9.4 
mL.kg-1.min-1 with 
>6 months regular 
run training. 
 
Downhill running: 10 min 
at −10% (−6°) and a fixed 
speed of 214.4 m.min-1. 
VO2 at 179.4±6.2 m.min-1 ND ND −3 ND - - - 
Note: ND denotes no difference in changes after downhill running.
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2.2. Heat Shock Response in Skeletal Muscle following Eccentric Exercise 
 
The heat shock response in rodent and human skeletal muscle following an acute bout of 
exercise has been well documented since the early 1990s (Feasson et al., 2002; Febbraio and 
Koukoulas, 2000; Hernando and Manso, 1997; Khassaf et al., 2001; Locke et al., 1990; 
Morton et al., 2006; Paroo and Noble, 1999; Paulsen et al., 2009; Paulsen et al., 2007; 
Puntschart et al., 1996; Reichsman et al., 1991; Salo et al., 1991; Skidmore et al., 1995; 
Thompson et al., 2003; Thompson et al., 2001; Tupling et al., 2007; Vissing et al., 2009). Of 
these studies, Locke et al. (1990) was the first to successfully show an enhanced induction of 
stress proteins (of ~65, 72, 90, and 100 kDa) in various tissues, including soleus muscle of the 
rats, which occurred as soon as 20 min into a bout of treadmill running at 24 m.min-1. The 
study found that the physiological stress from exhaustive exercise is a sufficient stimulus to 
induce or significantly enhance the synthesis of 72 and 90 kDa proteins in rat peripheral 
lymphocytes, spleen cells and the soleus muscle (Locke et al., 1990). Reichsman et al. (1991) 
further demonstrated the HSP70 response in human skeletal muscle at 2 days following ~65 
repetitions of maximal eccentric, isokinetic contraction of the elbow flexors. Their study 
found that a bout of high-force eccentric exercise increased the expression of three muscle 
proteins, which appeared on sodium dodecyl sulfate polyacrylamide gels (SDS-PAGE) and 
were suggested to be HSP70 and HSP28 (Reichsman et al., 1991). Five years later, Puntschart 
et al. (1996) clearly showed that a bout of treadmill running at a velocity equivalent to the 
anaerobic threshold increased the mRNA but not the protein level of HSP70 immediately and 
at 0.5-3.0 h post exercise, in untrained human vastus lateralis muscles. Apart from these 
landmark studies on skeletal muscle HSP70 response following an acute bout of exercise, 
there are also published studies investigating the effect of chronic exercise training on skeletal 
muscle HSP70 response in both human and rodent models (Desplanches et al., 2004; 
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Ecochard et al., 2004; Gonzalez et al., 2000; Liu et al., 2000; Liu et al., 1999; Morton et al., 
2009b; Morton et al., 2008; Ogata et al., 2009). However, “non-damaging” exercise and/or 
training-induced skeletal muscle adaptation and heat shock response are beyond the scope of 
this thesis. We are interested in and mainly focused on the skeletal muscle heat shock 
response following “damaging” eccentric exercise. 
 
Table 2.2 and Table 2.3 outline the recent research in animal and human, respectively, which 
have largely focused on the effect of dynamic eccentric-biased exercise or “muscle-
damaging” exercise on HSP70 response in skeletal muscle. Interestingly, there are few studies 
using a small animal in vivo model when compared with experimental trials on human 
subjects. The impetus for the growing interest of research in this area may be due to the 
finding that: (1) eccentric exercise is an effective physiological stimulus to induce HSPs in 
skeletal muscle; (2) positive correlation between the increased HSPs induction and the 
magnitude of acquired thermotolerance; and (3) the important implication of cross-tolerance 
in the protection of skeletal muscle against a variety of stressors, injuries, and pathological 
conditions (De Maio, 1999). The sections 2.2.1. and 2.2.2. below will briefly discuss the 
evidence that skeletal muscle HSP70 content is increased after an acute bout of high-force 
eccentric contractions, as well as low-force dynamic eccentric-biased exercise. 
 
2.2.1. HSP70 response following high-force eccentric contractions 
 
In a mouse experimental model, eccentric contractions by electrical stimulation increased 
extensor digitorum longus (EDL) muscle HSP72 as well as other small heat shock proteins 
immediately after and up to 5 days following the procedure (Ingalls et al., 1998; Koh and 
Escobedo, 2004). Koh (2002) was the first to hypothesize that eccentric exercise increases 
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small heat shock proteins in skeletal muscle, and these small heat shock proteins translocate to 
Z-disks to interact with actin and desmin and eventually protect against cytoskeleton 
disruption during high-force contractions. By using immunofluorescence analysis, Koh and 
Escobedo (2004) demonstrated that both HSP25 and αB-crystallin localize to the Z-disks in 
rat skeletal muscle following the eccentric exercise. In human studies using maximal eccentric 
elbow flexion, the increase in bicep bracii HSP70 level was observed at 2 to 6 days following 
the exercise (Paulsen et al., 2009; Thompson et al., 2003; Thompson et al., 2001). In addition, 
the HSP70 response following isokinetic eccentric knee extension has been reported to 
increase immediately as well as up to 4 days post eccentric-biased exercise (Paulsen et al., 
2007; Tupling et al., 2007), with the peak value of ~10-fold higher than baseline level being 
observed at day 4. With the use of immunohistochemical staining on muscle cross sections, 
Paulsen et al. (2007) also demonstrated the translocation and accumulation of HSP70 to the 
cytoskeletal/myofibrillar proteins after the eccentric exercise, but to a much lesser extent than 
the small heat shock proteins (HSP27 and αB-crystallin). 
 
2.2.2. HSP70 response following downhill running 
 
The HSP70 response following downhill running in the hindlimb muscles of rodents has been 
equivocal. Bombardier et al. (2009) showed that HSP72 expression in rat soleus muscle 
increased at 24 h following the downhill running, whereas Touchberry et al. (2012) did not 
observe any increase in HSP72 expression immediately or at 48 h following the eccentric 
exercise. Recently, Rattray et al. (2013) found an approximately 24-fold increase in HSP72 
content in vastus lateralis of rats subjected to a similar eccentric exercise protocol 
(Bombardier et al., 2009; Touchberry et al., 2012). The discrepancy between the findings in 
these animal studies could be explained by the method used in detecting HSP72 in skeletal 
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muscle, e.g. in the study of Bombardier et al. (2009) the muscle HSP72 content was assayed 
using immunohistochemistry while the later studies (Rattray et al., 2013; Touchberry et al., 
2012) used Western blotting.  
 
In human experimental trials, the HSP70 response in vastus lateralis was not detected until 2 
and 6 days following horizontal running (Morton et al., 2006). Whereas, there was no 
difference in HSP70 expression at 2 days after downhill running when compared with the pre-
exercise level of untrained healthy subjects (Thompson et al., 2003). By using a similar 
downhill running protocol, Peake et al. (2005) observed a 63 to 88% increase in plasma 
HSP70 concentration in well-trained runners and triathletes. Collectively, it is apparent that 
the HSP70 induction following downhill running and its role in EIMD is far from understood. 
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Table 2.2 Summary of studies reporting the effect of a single bout of downhill running or dynamic eccentric exercise on HSP72 response in animal. 
% Change After Eccentric Exercise (%) Study Species Eccentric Exercise 
Protocol 
 
Tissues and HSP 
Analyzed 0-6 h 24 h 48 h 72 h 96 h 120 h ≥144 h 
Ingalls et al. 
(1998) 
Female ICR 
mice, 8-12 week 
–old, 30.9±2.0 g 
(n=80) 
150 eccentric 
contractions by 
electrical 
stimulation at 20 
ms trains of 0.1 ms 
at 300 Hz. 
 
EDL (WB) 
- HSP72 (n=4 for 
each time points) 
 
Increase 
 
Peak 
 
- 
 
Peak 
 
- 
 
Peak 
 
Decline 
Shima et al. 
(2008) 
Female Wister 
rats, 7 week-old, 
140-209 g 
(n=94).  
Downhill running, 
20 m.min-1 at −14°, 
run for 150 min (30 
min × 5 bouts, and 
interspersed with 
30 min rest 
between bouts). 
 
Vastus Intermedius 
- HSP72 mRNA (n=5 
for each time points) 
 
+17,845 
 
+11,236 
 
ND 
 
ND 
 
- 
 
- 
 
ND 
Bombardier 
et al. (2009) 
Ovariectomized 
female Sprague-
Dawley rats, 9 
week-old, 273-
290 g (n=16, 
sham control 
group) 
 
Downhill running, 
17 m.min-1 at 
−13.5°, run for 5 
min and rest for 2 
min for a total of 18 
bouts. 
 
Soleus 
(immunohistochemistry) 
- HSP70 (n=8, Type I 
fibre) 
- HSP70 (n=8, Type II 
fibre) 
 
 
- 
 
- 
 
 
+212 
 
+176 
 
 
- 
 
- 
 
 
- 
 
- 
 
 
- 
 
- 
 
 
- 
 
- 
 
 
- 
 
- 
Touchberry 
et al. (2012) 
Male Wister 
rats, 10 week-
old, ~300-350 g 
(n=48). 
Downhill running, 
18 m.min-1 at −16°, 
run for 5 min and 
rest for 2 min for a 
total of 18 bouts. 
 
Soleus (WB) 
- HSP72 
- Phosphorylated-
HSP25 
 
ND 
+250 
 
- 
- 
 
ND 
ND 
 
- 
- 
 
- 
- 
 
- 
- 
 
- 
- 
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Table 2.2 Continued 
% Change After Eccentric Exercise (%) Study Species Eccentric Exercise 
Protocol 
 
Tissues and HSP 
Analyzed 0-6 h 24 h 48 h 72 h 96 h 120 h ≥144 h 
Rattray et al. 
(2013) 
Male Sprague-
Dawley rats, 9-
11 weeks old, 
361-392 g 
(n=34) 
Downhill running, 
20 m.min-1 at −14°, 
run for 5 min and 
rest for 2 min for a 
total of 18 bouts in 
eccentric-
challenged rats 
(n=8 vs control 
n=9). 
 
Vastus lateralis (WB) 
- HSP72 (n=8) 
 
- 
 
- 
 
+2,398 
 
- 
 
- 
 
- 
 
- 
Lewis et al. 
(2013) 
Male Fischer 
344xBrown 
Norway rats, 
adult 6 months 
old, ~386 g; late 
middle-age 24 
months old, 
~559 g (n=60) 
 
Downhill running, 
60 min at 16 
m.min-1 and −16°. 
Vastus Intermedius 
(WB) 
- HSP72 
 
Gastrocnemius (WB) 
- HSP72 
 
 
 
- 
 
 
- 
 
 
- 
 
 
- 
 
 
+120 
 
 
ND 
 
 
- 
 
 
- 
 
 
- 
 
 
- 
 
 
- 
 
 
- 
 
 
- 
 
 
- 
Note: WB, Western blot; ND, no differences; BB, biceps brachii; VL, vastus lateralis. 
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Table 2.3 Summary of studies reporting the effect of a single bout of downhill running or dynamic eccentric exercise on HSP70 response in human. 
% Change After Eccentric Exercise (%) Study Subject Eccentric Exercise 
Protocol 
 
Tissues and HSP Analyzed 
0-6 h 24 h 48 h 72 h 96 h 120 h ≥144 h 
Thompson 
et al. 
(2001) 
Male and 
female, 
untrained, age 
24.6±6.3 yr, 
n=4 for each 
gender group.  
Maximal eccentric 
elbow flexion: 2 
sets of 25 
repetitions at 15 s 
and 2 min rest 
intervals between 
contractions and 
sets, respectively. 
 
BB HSP27 
 HSP70 
- 
- 
- 
- 
+234 
+1064 
- 
- 
- 
- 
- 
- 
- 
- 
Thompson 
et al. 
(2002) 
Female, 
untrained, age 
22.0±2.2 yr, 
n=10.  
Maximal eccentric 
elbow flexion: 2 
sets of 25 
repetitions at 15 s 
and 2 min rest 
intervals between 
contractions and 
sets, respectively. 
 
BB HSP27 
 HSP70 
- 
- 
- 
- 
+81 
+73 
- 
- 
- 
- 
- 
- 
- 
- 
Thompson 
et al. 
(2003) 
Male, 
untrained, age 
21.5±1.5 yr, 
n=8.  
Downhill running: 
30 min at −10° and 
treadmill speed at 
77% HRmax. 
 
VL HSP27 
 HSC70 
 HSP70 
- 
- 
- 
 
- 
- 
- 
 
ND 
ND 
ND 
- 
- 
- 
 
- 
- 
- 
 
- 
- 
- 
 
- 
- 
- 
 
Hirose et 
al. (2004) 
Male, 
untrained, age 
20.4±2.0 yr, 
n=10.  
Eccentric elbow 
flexion: 6 sets of 5 
repetitions with 2 
min rest interval 
between sets, at 
40% of MVIC. 
 
Plasma HSP60 
  HSP70 
ND 
ND 
ND 
ND 
ND 
ND 
ND 
ND 
ND 
ND 
- 
- 
- 
- 
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Table 2.3 Continued 
% Change After Eccentric Exercise (%) Study Subject Eccentric Exercise 
Protocol 
 
Tissues and HSP Analyzed 
0-6 h 24 h 48 h 72 h 96 h 120 h ≥144 h 
Peake et al. 
(2005) 
Male, well-
trained runners 
and triathletes, 
age 28±3 yr, 
VO2max 61±3 
mL.kg-1.min-1, 
n=10.  
 
Downhill running: 45 
min at −10% and at 
60% of VO2max. 
Plasma HSP70 +63-88 - - - - - - 
Morton et 
al. (2006) 
Male, healthy 
and active, but 
untrained, age 
24±3 yr, 
VO2max 56.3±5 
mL.kg-1.min-1, 
n=8. 
 
Horizontal running: 45 
min at 70% VO2max. 
VL Small HSPs 
 HSP60 
 HSC70 
 HSP70 
 
- 
- 
- 
- 
 
ND 
ND 
ND 
ND 
ND 
ND 
ND 
+179 
ND 
ND 
ND 
ND 
- 
- 
- 
- 
 
- 
- 
- 
- 
 
ND 
ND 
ND 
+178 
Paulsen et 
al. (2007) 
Male, healthy, 
age 28±4 yr, 
n=11.  
Isokinetic eccentric 
knee extension: 300 
unilateral maximal 
contraction at 30°.s-1 
(30 sets of 10 
repetitions, with 30 s 
rest between each set). 
 
VL αB-crystallin mRNA 
 HSP27 cytosol 
 HSP27 mRNA 
 HSP27  
 HSP70 cytosol 
 HSP70 mRNA 
 HSP70  
 
+400 
−51 
+400 
+1490 
ND 
+1500 
+200 
+800 
ND 
+800 
- 
+203 
+1000 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
ND 
- 
+800 
ND 
- 
+1000 
- 
- 
- 
- 
- 
- 
- 
- 
ND 
- 
- 
ND 
- 
- 
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Table 2.3 Continued 
% Change After Eccentric Exercise (%) Study Subject Eccentric Exercise 
Protocol 
 
Tissues and HSP Analyzed 
0-6 h 24 h 48 h 72 h 96 h 120 h ≥144 h 
Tupling et 
al. (2007) 
Male, 
untrained and 
healthy, age 
18.0±0.5 yr, 
n=10.  
Single-legged 
isometric knee 
extension: 30 min 
contractions at 60% of 
maximal voluntary 
contraction with 50% 
duty cycle. 
 
VL HSP70 
 HSP70 (Type I) 
 HSP70 (Type IIa) 
 HSP70 (Type IIax/x) 
ND 
+190 
ND 
ND 
+143 
+300 
+182 
+144 
+140 
+281 
+191 
+160 
+140 
+342 
+200 
+176 
- 
- 
- 
- 
- 
- 
- 
- 
+140 
+257 
+182 
+144 
Mahoney 
et al. 
(2008) 
Male, healthy, 
age 23.4±3.7 
yr, n=15. 
Isokinetic eccentric 
knee extension: non-
dominant leg maximal 
contraction at 120°.s-1 
(30 sets of 10 
repetitions, with 1 min 
rest between each set). 
 
VL hsp70 DNA level 
 HSF4 DNA level 
+1,000 
+600 
- 
- 
ND 
+450 
- 
- 
- 
- 
- 
- 
- 
- 
Vissing et 
al. (2009) 
Male, healthy, 
age 23.8±2.8 
yr, n=20.  
Box stepping: 30 min 
at 60 step.min-1 and at 
110% lower leg 
length. 
VL αB-crystallin mRNA 
 HSP27 cytosol 
 HSP27 cytoskeleton 
 HSP27 mRNA 
 HSP70 cytosol 
 HSP70 cytoskeleton 
 HSP70 mRNA 
 
+290 
ND 
+980 
+290 
ND 
ND 
+890 
+320 
- 
- 
+320 
- 
- 
+180 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
ND 
ND 
ND 
ND 
ND 
+240 
ND 
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Table 2.3 Continued 
% Change After Eccentric Exercise (%) Study Subject Eccentric Exercise 
Protocol 
 
Tissues and HSP Analyzed 
0-6 h 24 h 48 h 72 h 96 h 120 h ≥144 h 
Paulsen et 
al. (2009) 
Male and 
female, 
healthy, age 
21-37 yr, n=24 
(17 men and 7 
women). 
  
Maximal eccentric 
elbow flexion: 14 sets 
of 5 repetitions at 
30°.s-1 with 30-35 s 
rest between sets, 
range of motion 40-
175°. 
 
BB αB-crystallin cytosol 
 αB-crystallin 
cytoskeleton 
 HSP27 cytosol 
 HSP27 cytoskeleton 
 HSP70 cytosol 
 HSP70 cytoskeleton 
  
−50 
+215 
−38 
+130 
ND 
ND 
- 
- 
- 
- 
- 
- 
+150 
+260 
+120 
+130 
+275 
+325 
- 
- 
- 
- 
- 
- 
+150 
+225 
+138 
ND 
+310 
+305 
- 
- 
- 
- 
- 
- 
+175 
+260 
+138 
+115 
+300 
+260 
Mikkelsen 
et al. 
(2013) 
Well-trained 
males, healthy, 
age 23±3 yr, 
n=8. 
 
Isokinetic eccentric 
knee extension: 200 
unilateral maximal 
contractions, 100 at 
30°.s-1  and 100 at 
120°.s-1 (with a range 
of motion 10° to 90°). 
 
VL αB-crystallin mRNA 
 HSP27 mRNA 
 HSP70 mRNA 
  
+360 
+480 
+2600 
+540 
+650 
+340 
 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
ND 
+150 
ND 
Note: BB, biceps brachii; ND, no differences; VL, vastus lateralis. 
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2.3. Induction of HSP70 in Skeletal Muscle 
 
2.3.1. Is acute heat stress effective in inducing muscle HSP70 expression? 
 
Many experiments have shown that passive heat stress can induce in vivo HSP70 expression 
in the skeletal muscle of amphibian and mammalian tissue. Table 2.4 and Table 2.5 outline 
the studies reporting the effect of passive heating on HSP70 and/or HSP25 response in the 
skeletal muscle of animals and humans, respectively. Of these studies, Currie and White 
(1981) were possibly the pioneers in reporting that passive heating of rats exposed to a hot 
plate (55°C), increased HSP70 protein synthesis in skeletal muscle. Some years later 
Skidmore et al. (1995) quantified the HSP70 expression in rat skeletal (gastrocnemius and 
soleus) and cardiac muscles following environmental heat stress. More importantly, their 
finding also showed that exercise-induced HSP70 accumulation in locomotor and left 
ventricle cardiac muscles is tissue-specific and independent of the rise in core body 
temperature (Skidmore et al., 1995). However, muscle temperature was not recorded in this 
study and hence, the effect of exercise and localized heat stress on HSP70 response in 
locomotor muscle was unclear. 
 
Results of animal studies investigating the effect of passive heat stress on HSP70 induction in 
skeletal muscle have been consistently reproduced (Gupte et al., 2009; Gupte et al., 2011; 
Oishi et al., 2002; Oishi et al., 2003). In general, a whole body hyperthermia of 41 to 42.5°C 
(colonic or rectal temperature) for a period of 15 to 30 min, or a localized heating of muscle 
temperature up to 42°C for 20 to 60 min, are effective in increasing HSP70 expression in 
skeletal muscle. The modalities of heating include subjecting the animals to hot ambient 
temperature (Kobayashi et al., 2005; Naito et al., 2000; Oishi et al., 2002; Oishi et al., 2003; 
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Shima et al., 2008; Skidmore et al., 1995), electrically heated blanket (Baumeister et al., 2004; 
Gupte et al., 2011) or pad (Frier and Locke, 2007; Lille et al., 1999), heated lamp/globe 
(Baumeister et al., 2004; Flanagan et al., 1995; Lepore et al., 2000), hot water immersion/bath 
(Garramone et al., 1994; Gupte et al., 2009; Morton et al., 2007), short or microwave 
diathermy (Ogura et al., 2007; Touchberry et al., 2008), as well as administration of 
psychedelic drug, i.e. d-lysergic acid diethylamide (LSD) (Manzerra et al., 1997). In addition, 
the time point of detection of a significant increase in the HSP70 level following the 
treatments varied within 4 h and 48 h, dependent on muscle groups and differed between 
species. As reported in some of these studies, the tissue-specific increase in HSP70 synthesis 
from baseline was in a range of 0.3 to 11-fold. For instance, the HSP72 content in soleus of 
adult female rats exposed to a hot environment for 60 min, still remained elevated at 35% 
higher than that observed in non heat-stressed control rats 8 days following the treatment 
(Naito et al., 2000). It is interesting to note that, despite a thorough examination of the 
published research literature, few of the animal studies have focused on the impact of heat 
stress on the HSP70 response in the quadriceps muscle (i.e., rectus femoris, vastus lateralis, 
vastus intermedius and vastus medialis). Moreover, the classic study of Flanagan et al. (1995) 
reported no increase in HSP70 induction of the quadriceps muscle at 4 h following the heat 
treatment. 
 
To our knowledge, to date, there are only three published studies examining the effect of 
passive heat treatment on HSP70 response in human skeletal muscle (Morton et al., 2007; 
Ogura et al., 2007; Touchberry et al., 2008). These aforementioned human studies employed 
localized heating (for a duration of 20 to 40 min) to increase the muscle temperature of vastus 
lateralis, but the HSP70 response seems inconsistent. For example in healthy young men, 
microwave hyperthermia increased HSP70 expression by ~72% at 1 day following the 
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treatment (Ogura et al., 2007), however, hot water immersion (45°C) failed to elicit a HSP70 
response at 2 and 7 days after the treatment (Morton et al., 2007). Interestingly, the combined 
20-min short wave diathermy and an additional 20 min of moist heating with hydrocollator 
packs significantly increased HSP70 content in healthy females by 58%, but not males 
(Touchberry et al., 2008). These findings suggest that there is a gender effect on diathermia-
induced HSP70 response in human skeletal muscle. This gender effect may be the effect of 
estrogen or more likely the relatively smaller muscle mass in the thigh of female subjects that 
resulted in a larger and deeper contact area of diathermy (Touchberry et al., 2008). 
Alternatively, some of the female subjects may have experienced the luteal phase of the 
menstrual cycle during the heating experiment, which would have contributed to an elevation 
in their body core temperature. A further possible explanation could be related to the amount 
of adipose tissue of the female subjects. Presumably a greater volume of superficial adipose 
tissue would have insulated the women to the extent of showing the rate of cooling once the 
target temperature was reached. Thus, attention needs to be given to a wide range of potential 
confounders when comparing physiological response of men and women to heat stress. 
Certainly, more studies are warranted to clarify the effect of passive heat stress on HSP70 
induction in human skeletal muscle. Time course studies of hyperthermia-induced HSP70 
response in skeletal muscle are relatively limited.  
 
In summary, an acute bout of passive heat stress, regardless of modality of heating, is 
effective in inducing a significant HSP70 expression in most of the skeletal muscles of the 
lower limbs in adult healthy humans or animals, provided that: (1) the core body temperature 
is elevated and maintained at ~41.5°C for ≥15 min; or, (2) the muscle temperature is heated 
and maintained at ≥40 or 42°C for a duration of ≥20 min. 
 
  
31 
Table 2.4 The effect of passive heating on HSP70 and/or HSP25 expression in animal skeletal muscle. 
References Heat Treatment Species/Muscle HSP70 Induction Analytic Method 
 
Currie and White 
(1981) 
Rectal temperature at 42.0-42.5°C 
for 15 min in a warm pad set at 
55°C. 
Adult male Sprague-
Dawley rat (~6 week-old, 
145-155 g). 
 
“There was a striking increase in 
P71 synthesis …”. 
SDS-PAGE. 
 
Currie and White 
(1983) 
Rectal temperature at 42.0-42.5°C 
for 15 min in a warm pad set at 
55°C. 
Adult male Sprague-
Dawley rat (~6 week-old, 
145-155 g). 
P71 accumulation was 
detectable at 2 h to 48 h; P71 
synthesis was detectable only at 
2 h post treatment. 
 
Coomassie brilliant blue R 
staining (P71 accumulation); 
fluorography (P71 synthesis). 
Garramone et al. 
(1994) 
Rectal temperature at 42.5°C for 
20 min in a warm water bath. 
Adult male Sprague-
Dawley rat (~300 g): 
gastrocnemius (n=15). 
 
Induction HSP72 was confirmed 
in heat-shocked muscle tissues. 
 
SDS-PAGE and Western blot. 
 
Skidmore et al. (1995) Colonic temperature at 41°C for 
30 min at variable ambient 
temperature of 36-42°C. 
 
Adult male Sprague-
Dawley rat: left ventricle, 
gastrocnemius, soleus and 
EDL (n=8). 
Higher in gastocnemius, soleus 
and left ventricle at the end of 
30-min recovery period 
following the treatment. 
 
ELISA. 
Flanagan et al. (1995) Colonic temperature was 
increased to 42°C by a lamp and 
hair dryer at heating rates of 
0.166°C.min-1 or 0.045°C.min-1. 
 
Adult male Sprague-
Dawley rat (250-300 g): 
quadriceps (n=4). 
Non-significant increase (2.2 to 
2.5-fold) at 4 h post treatment. 
Western blot. 
Manzerra et al. (1997) Rectal temperature at 42.5±0.3°C 
1 h post 100 µg/kg d-lysergic acid 
diethylamide (LSD) i.v. 
 
Male New Zealand white 
rabbit: multiple tissues. 
Maximal at 5 h post treatment 
with slight decrease at 10 h and 
24 h. 
Western blot. 
Lille et al. (1999) Rectal temperature at 41.5-42.5°C 
for 20 min with a heating pad.  
 
Male Wister rat: gracilis 
muscle (n=7). 
Peaked at 24 h (11.2±3.4-fold), 
sustained at 48 h (8.9±2.6-fold) 
and 72 h (9.1±3.1-fold) post 
treatment. 
 
Western blot. 
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Table 2.4 Continued 
References Heat Treatment Species/Muscle HSP70 Induction Analytic Method 
 
Thomas and Noble 
(1999) 
Rectal temperature at 41.5°C for 
15 min with a heating pad.  
 
Adult make Sprague-
Dawley rat: left plantaris 
(n=6) 
Increased by 6.9 and 3.6-fold at 
1 and 4 days, respectively, after 
the treatment. 
 
Western blot. 
Naito et al. (2000) Colonic temperature of 
41.6±0.1°C at the end of 60 min 
exposure to ambient temperature 
of 41.0±0.1°C in a heat chamber. 
 
Adult 6 month-old female 
Sprague-Dawley rat: 
soleus (n=10) 
Increased by 35% at 8 day after 
the heat treatment. 
Western blot. 
Lepore et al. (2000) Muscle temperature at 42°C for 
20 min with 75W globe. 
 
Rat: gastrocnemius and 
tibialis (n=3). 
Marked induction at 24 h post 
treatment. 
Western blot. 
Oishi et al. (2002) Muscle temperature at 42°C for 
60 min with 56±2°C hot air 
temperature. 
 
Adult male Wister rat: 
soleus and plantaris 
(n=5). 
Peaked at 4 h (2.2-fold, soleus); 
at 48 h (6.8-fold, plantaris). 
 
Western blot. 
Oishi et al. (2003) Muscle temperature at 42°C for 
60 min with 56±2°C hot air 
temperature. 
 
Adult male Wister rat: 
gastrocnemius, soleus and 
plantaris (n=5). 
Peaked at 8 h (1.8-fold, deep 
gastro) and at 36 h (~10-fold, 
superficial gastro); at 4 h (2.2-
fold, soleus); at 48 h (6.8-fold, 
plantaris) 
 
SDS-PAGE and Western blot. 
Baumeister et al. 
(2004) 
Core temperature was increased to 
37°C by a heating lamp, and 
further increased and maintained 
at 42°C in a heating blanket for 5 
min. 
 
Lewis rats (7-11 week 
old): anterior tibialis of 
hindlimb (n=10). 
Increased by 300% at 24 h post 
treatment; remained elevated at 
48 h and 72 h (~200%). 
Western blot. 
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Table 2.4 Continued 
References Heat Treatment Species/Muscle HSP70 Induction Analytic Method 
 
Selsby and Dodd 
(2005)  
Rectal temperature at 41-41.5°C 
for 30 min with thermal blanket 
every other day during 8 days of 
hindlimb immobilization.  
 
Male Sprague-Dawley rat: 
soleus (n=9). 
Increased by 7-fold in heated 
and immobilized animals at 48 h 
after the last heat treatment. 
Western blot. 
Kobayashi et al. 
(2005) 
Exposure to 41.0±0.1°C in a heat 
chamber for 60 min with expected 
colonic temperature of 41°C. 
Adult male Wister rat: 
soleus and EDL (n=15). 
Increased by ~40%, ~88% and 
33.3% (soleus); 83%, 36.7% and 
83.8% (EDL) at 1, 7 and 14 
days, respectively. 
 
SDS-PAGE and Western blot. 
Frier and Locke 
(2007) 
Rectal temperature was 
maintained at ~42°C for 15 min 
with a heating pad. 
 
Male Sprague-Dawley rat: 
plantaris (n=5). 
Increased by ~4 to 5-fold at 1, 2, 
3, 5 and 7 day after the 
treatment. 
Western blot. 
Shima et al. (2008) Exposure to 42.0±0.1°C in a heat 
chamber for 60 min with colonic 
temperature >41°C for 20 min. 
 
Female Wister rats (7 
week old, 140-209 g):  
hsp72 mRNA increased 
immediately after the treatment 
by 1,750±1,914%). 
Reverse-transcribed PCR. 
Gupte et al. (2009)  Rectal temperature at 41-41.5°C 
for 20 min with lower body 
immersed in a 43°C water bath, 
once a week for 12 weeks. 
 
Male Wister rats on 12 
weeks of high fat diet: 
soleus and EDL. 
 
Higher at 48 h after the last 
treatment in soleus (1.64 vs 1.29 
AU) and EDL (1.82 vs 0.29 AU) 
vs sham control. 
Western blot. 
Nonaka et al. (2011) Hot (41.5±0.5°C) water 
immersion for 20 min.  
 
Male ICR mice (8 week 
old). 
HSP25 increased significantly at 
24 h after thermal treatment 
(1.2-fold higher than control). 
 
Western blot. 
Gupte et al. (2011) Rectal temperature at 41-41.5°C 
for 20 min with thermal blanket. 
 
24 month-old male 
Fischer 344 rats: soleus 
(n=7). 
Higher at 24 h post treatment 
was 1.5 AU (vs ~0.6 AU of 
sham control). 
 
Western blot. 
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Table 2.5 The effect of passive heating on HSP70 expression in human skeletal muscle. 
References Heat Treatment Species/Muscle HSP70 Induction Analytic Method 
 
Ogura et al. (2007) Muscle temperature was 
increased and remained at 4-5°C 
(~40°C) above baseline for 20 
min by microwave 
hyperthermia. 
 
Untrained healthy men: 
vastus lateralis (n=4). 
Increased by 71.7±27.7% at 1 
day after the microwave 
hyperthermia. 
Western blot. 
Morton et al. (2007) Muscle temperature increased 
from 35.9±0.2°C to 39.5±0.2°C; 
core temperature from 
37.4±0.2°C to 38.9±0.2°C via 
hot water (45°C) immersion. 
  
Physically active young 
men: vastus lateralis (n=7). 
No induction at 48 h and 7 
days post treatment. 
SDS-PAGE. 
Touchberry et al. (2008)  20 min short wave diathermy 
and followed by 20 min of moist 
heat with hydrocollator packs. 
 
Healthy men and women: 
vastus lateralis. 
Significantly increased in 
female by 58% but not 
significantly increase in male 
by 35% at 24 h after the 
treatment. 
 
SDS-PAGE and Western blot. 
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 2.3.2. Is 17-AAG effective in inducing muscle HSP70 expression? 
 
17-AAG is a geldanamycin analogue also known as tanespimycin or KOS-953. It belongs to a 
class of HSP90 molecular chaperone inhibitors that was first introduced into clinical trials as a 
potent cancer chemotherapeutic agent (Kim et al., 2009; Neckers, 2002; Neckers and 
Workman, 2012; Usmani et al., 2009). 17-AAG achieves its anti-cancer activity by disrupting 
HSP90-activated protein kinase, binding with the N-terminal nucleotide-binding domain of 
HSP90 to inhibit the ATP/ADP exchange, which is essential for the formation of the mature 
HSP90 chaperone complex (Roe et al., 1999). As a result, this leads to the molecular signature 
of HSP90 inhibition: proteasomal degradation of HSP90 client proteins that do not achieve 
their functional conformation, and dissociation of HSF1 complexes followed by a robust 
induction of co-chaperone HSP70 (Kamal and Burrows, 2004; Powers and Workman, 2007; 
Taipale et al., 2010; Whitesell et al., 2003). 
 
An increase in HSP70 expression and ensuing cytoprotection in vitro by 17-AAG is evident in 
apoptotic-prone human leukemia cell lines such as HL60 and U937 (Demidenko et al., 2006). 
In a phase 1 clinical trial, it has been demonstrated that the combination of 17-AAG with 
trastuzumab had an anti-tumor activity in patients with human epidermal growth factor 
receptor 2 (HER-2+) breast cancer, which paralleled reactive induction of the HSP70 level in 
peripheral-blood lymphocytes (Modi et al., 2007). A phase 1/2 trial further revealed that 17-
AAG when treated with bortezomib in patients with relapsed or refractory multiple myeloma, 
was effective in inhibiting proteasome activity and increasing HSP70 expression in peripheral 
blood mononuclear cells (Richardson et al., 2011). These cytoprotective effects of 17-AAG 
have generated the interest of many researchers to hypothesize that 17-AAG treatment should 
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provide a new therapeutic agent for clinical use beyond oncological disease (Kamal and 
Burrows, 2004; Georgakis and Younes, 2005).  
 
To our knowledge, investigations of the effect of 17-AAG on HSP70 expression in vivo and 
its cytoprotection are scarce (Kayani et al., 2008a; Lomonosova et al., 2012; Waza et al., 
2005). In a transgenic mouse model, administration of 17-AAG (50 µL intraperitoneal 
injection at 25 mg.kg-1, three times a week for 20 weeks) increased the gastrocnemius muscle 
HSP70 content by 29.2% and markedly ameliorated motor impairments in the spinal and 
bulbar muscular atrophy mice (Waza et al., 2005). Recently, a rodent model revealed that 17-
AAG administration (60 mg.kg-1) attenuates soleus muscle atrophy and led to a much greater 
level of HSP70 mRNA expression in hindlimb-unloaded animals (Lomonosova et al., 2012). 
More interestingly, Kayani et al. (2008a) showed that treating (24-26 months) old mice with 
17-AAG (a single intraperitoneal injection at 40 mg.kg-1) resulted in improved recovery of 
EDL muscle force generation in situ. The HSP70 content was known at the stage of induction 
of the muscle damage, when the cytoprotection was likely to be most functional (Kayani et 
al., 2008a).  
 
Collectively, these studies provide an insight that 17-AAG appeared to be effective in 
enhancing HSP70 protein and mRNA expression in skeletal muscle, subsequently leading to 
functional improvements in various pathological conditions. Nevertheless, whether the 
induction of HSP70 protein content in skeletal muscle by the treatment of 17-AAG confers 
functional and structural protection against eccentric exercise-induced muscle damage in vivo 
remains unresolved. 
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2.3.3. Is glutamine effective in inducing muscle HSP70 expression? 
 
Glutamine is known as a non-essential amino acid, an important constituent of proteins and a 
central metabolite for amino acid transamination. Glutamine is mainly synthesized in the 
skeletal muscle and partly in the lung; it is then released and delivered to intestines, liver, 
kidneys, blood cells and all other organs of body. Glutamine is necessary for nutritional 
metabolism, regulation of cellular proliferation and apoptosis, and promoting the synthesis of 
specific proteins. Our research interest focused on the influence of glutamine administration 
on HSP70 induction and its potential protective effect on skeletal muscle following eccentric 
exercise-induced muscle damage. 
 
Sanders and Kon (1991) were the earliest to demonstrate that glutamine is required for 
maximal induction of heat shock protein in Drosophila Kc cells under heat stress. This 
pioneering discovery linking glutamine administration to HSP induction was supported by a 
report from Cai et al. (1991) that show glutamine is necessary for the induction of HSP in 
Chinese hamster ovary cells without heating. The effect of glutamine on HSP70 protein and 
mRNA induction had also been shown in other cultured-cell models exposed to heat-shocked 
conditions, such as opossum kidney (Nissim et al., 1993) and rat intestinal epithelial (IEC-6) 
(Ehrenfried et al., 1995) cells.  
 
In 1997, it was demonstrated for the first time, that glutamine alone (at concentrations greater 
than 2 mM.L-1) is capable of inducing HSP72 mRNA and protein expression in unstressed 
IEC-18 cell 2 h after treatment (Wischmeyer et al., 1997). The novel finding of this widely 
cited study was that glutamine-induced HSP72 expression is protective against lethal heat 
stress and oxidative injury in IEC-18 cells; the protective effect of glutamine was significantly 
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blunted when HSP72 mRNA and protein expression was inhibited with direct antisense 
inhibition of the hsp72 gene and a blockade of the HSP70 transcriptional factor via quercetin 
treatment, respectively. Subsequently, Wischmeyer et al. (1997) and other laboratories have 
been able to reproduce their results, which show an association between glutamine 
administration and HSP70-induced cytoprotection in IEC cell lines (Musch et al., 1998; Chow 
and Zhang, 1998), but this association was not observed in Caco-2 cells of human origin 
(Lindemann et al., 2001). On the other hand, glutamine deficiency was associated with an 
impaired HSP70 expression in both laboratory and clinical experiments (Weingartmann et al., 
1999). 
 
Zhou and Thompson (1997) were the first to clearly demonstrate in the heat-shocked L8 
skeletal myotubes, that the effect of glutamine on protein synthesis is dose-dependent. These 
L8 cells were differentiated from the L8 myoblast cell line derived from rat skeletal muscle. 
The study reported a 7.5-fold increase in HSP72 expression when glutamine concentration 
was increased from 0 to 10 mM and the solution was added into the culture media of L8 cells. 
Brief reviews on the in vitro and in vivo evidence of the protective effects of glutamine 
administration and their association with HSP72 expression can be found elsewhere 
(Wischmeyer, 2002; Roth et al., 2002). Of the studies reviewed, we were particularly 
interested in the report that glutamine infusion over a range of doses from 0.15 to 0.75 g.kg-1 
significantly increased HSP72 and HSP25 expression in the heart tissue of unstressed animals 
(Wischmeyer et al., 2001; Chamney et al., 2013). More interestingly, it appeared that the 
induction of HSP72 in the heart tissue of unstressed animals is dose-dependent (Wischmeyer 
et al., 2001). However, it is to our surprise that in vivo evidence on the effect of glutamine on 
HSP70 expression in the skeletal muscle of intact and unstressed animals has been limited.  
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Most of the studies investigating the effect of glutamine on HSP70 induction were carried out 
in stressed animals. In Table 2.6, we present a list of published studies investigating the effect 
of glutamine treatment on HSP70 and/or HSP25 induction in striated muscle of stressed 
animals. These studies have shown that glutamine has an influence on the HSP70 proteins and 
mRNA level in several striated muscles (i.e. heart, gastrocnemius and soleus) exposed to a 
variety of physiological insults, such as Escherichia coli lipopolysaccharide (LPS) induced 
endotoxemia (Cruzat et al., 2014; Meador and Huey, 2009; Wischmeyer et al., 2001), surgical 
injury (Chamney et al., 2013; Hayashi et al., 2002), ischemia-reperfusion injury (Murphy et 
al., 2007) or exercise training (Petry et al., 2014). None of these studies reported an increase 
in skeletal muscle HSP70 expression of glutamine-pretreated animals, prior to the given 
stressors. Glutamine treatment seems to be effective in attenuating the increase in muscle 
HSP70 content in the animals exposed to endotoxemia (Cruzat et al., 2014; Meador and Huey, 
2009) as well as surgical injury (Chamney et al., 2013). On the contrary, it seems that skeletal 
muscle HSP70 induction is augmented following the ischemia-reperfusion (Murphy et al., 
2007) and exercise training (Petry et al., 2014) in glutamine-pretreated animals. 
 
Taken together, it is reasonable to suggest that the effect of glutamine on HSP70 protein 
synthesis in skeletal muscle is stress-dependent. However, it is unclear whether glutamine 
pretreatment has an impact on the skeletal muscle HSP70 response following an acute bout of 
prolonged eccentric exercise. This is despite evidence of an association between glutamine 
treatment and a reduction in the magnitude of muscle damage as well as an inflammatory 
response in trained-animals submitted to prolonged exercise such as swimming (Cruzat et al., 
2010; Lagranha et al., 2005; Lagranha et al., 2004) or those untrained following the treadmill 
running (Lagranha et al., 2005; Lagranha et al., 2004). It should be noted that the beneficial 
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effect of glutamine treatment on eccentric exercise-induced muscle damage in human studies 
is equivocal (Ramallo et al., 2013; Street et al., 2011).
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Table 2.6 The effect of glutamine treatment on HSP70 and/or HSP25 expression in skeletal/cardiac muscle of stressed animals. 
Reference 
 
Muscle Insults/Stressors Glutamine Treatment Tissue Sampling Outcome Measures 
Wischmeyer et al. 
(2001) 
Multiple tissues of 
male Sprague-Dawley 
rats (heart, lung, 
kidney, colon, ileum). 
Escherichia coli 
lipopolysaccharide (LPS), 
5 mg.kg-1 i.v. 
Glutamine (0.75 g.kg-1) 
infusion via lateral tail 
vein at 0.5 mL.min-1 
concomitantly with LPS. 
 
At 6 h after LPS. Increased HSP72 in 
heart, lung, colon and 
kidney; HSP25 in heart, 
liver and colon. 
Hayashi et al. (2002) Multiple tissues of 
adult male Sprague-
Dawley rats (heart, 
lung, and liver). 
Cardiopulmonary bypass 
surgery (CPB). 
Intravenous injection of 
0.1 g.kg-1 glutamine via 
the right jugular vein, 3 
times per day for 1 week 
and prior to CPB. 
 
At 3 h after the 
termination of CPB. 
Increased HSP72 
content in heart and 
further increase 
following CPB. 
Murphy et al. (2007) Gastocnemius of adult 
male Sprague-Dawley 
rats. 
Ischemia and reperfusion 
injury: 2 h of hindlimb 
ischemia (applying 
tourniquet restriction 
above greater trochanter) 
followed by 2 h of 
reperfusion (removing the 
torniquet). 
  
Lateral tail vein infusion 
of glutamine at 0.5 g.kg-1 
over 30 min, 24 h prior to 
injury. 
At the conclusion of 2 h 
reperfusion. 
Upregulation of HSP70 
in gastrocnemius of 
glutamine-pretreated 
animals. 
Meador and Huey 
(2009) 
Gastrocnemius of 
adult C57BL/6J mice. 
LPS, 5 mg.kg-1 i.p. 
 
Intraperitoneal injection 
of 1.0 g.kg-1 glutamine 
concurrently with LPS 
injection. 
   
At 2 h post 
administration of LPS 
with GLN. 
Reduced HSP70 protein 
level in gastrocnemius 
by 47% in LPS mice. 
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Table 2.6 Continued 
Reference 
 
Muscle Insults/Stressors Glutemine Treatment Tissue Sampling Outcome Measures 
Chamney et al. 
(2013) 
Gastrocnemius and 
heart muscles of adult 
male C57BL/6J mice. 
Complete spinal cord 
transection surgery (ST). 
Intraperitoneal injection 
of 1.0 g.kg-1.day-1 
glutamine for a total of 7 
days following the 
surgery. 
  
At 24 h after the last 
glutamine injection. 
Attenuated ST-induced 
increase in HSP70 and 
HSP25 in 
gastrocnemius. 
Increased HSP70 
protein level in cardiac 
muscle of sham-control 
mice. 
 
Petry et al. (2014) Soleus and 
gastocnemius of adult 
male Wistar rats. 
Progressive treadmill 
running 20 – 60 min.day-
1, 15 – 25 m.min-1, 5 days 
a week for 8 weeks. 
Oral gavage L-glutamine 
(1 g.kg-1.day-1) plus L-
alanine (0.67 g.kg-1.day-1) 
or L-alanyl-L-glutamine 
dipeptide (1.5 g.kg-1.day-
1) for the last 21 days of 
the training. 
 
At 10 h after the last 
treadmill running 
session. 
Increased cytosolic and 
nuclear HSP70 in 
soleus but only 
cytosolic HSP70 in 
gastrocnemius 
following exercise 
training. 
 
Cruzat et al. (2014) Gastrocnemius of 8-
week old male 
B6.129F2/J mice. 
LPS, 5 mg.kg-1 i.p. Oral gavage L-glutamine 
(1 g.kg-1.day-1) plus L-
alanine (0.61 g.kg-1.day-1) 
or L-alanyl-L-glutamine 
dipeptide (1.49 g.kg-1.day-
1) for 2 days following 
endotoxemia. 
 
At 48 h post 
endotoxemia. 
Attenuated LPS-
induced increase in 
HSP70. 
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2.4. Does Induction of HSP70 Protect Against EIMD?  
 
2.4.1. Structural damage  
 
Many in vivo studies have focused on the effect of HSP70 induction in skeletal muscle and 
the associated ultrastructural changes with repeated eccentric contractions as evidenced in 
histological analysis. Garramone et al. (1994) demonstrated with electron microscopy that in 
rat gastrocnemius muscles expressing the inducible form of HSP70, there appeared to be 
mitochondrial swelling without disruption of cristae and only an occasional autophagic 
vacuole; whereas the control rats experienced several typical changes of ischemic injury, 
including mitochondrial swelling with disruption of cristae and the presence of membrane 
lined vacuoles. With the use of the histochemical stain (nitroblue tetrazolium) for 
mitochondrial oxidative enzyme activity, Lepore et al. (2000) found that the viability of 
gastrocnemius and tibialis anterior muscles of rats with marked induction of HSP70 (86±2%) 
was significantly higher than control rats (11±1%) after 2 h of ischemia followed by 24 h of 
reperfusion. In a transgenic mouse model, using light microscopy quantification, McArdle et 
al. (2004) showed that there was a significantly higher percentage of undamaged fibres 
remaining in the EDL muscle of adult HSP70 over-expressed mice (>40%) when compared 
with the EDL muscle of adult wild-type controls (<30%), 3 days following 450 eccentric 
contractions. Similarly, Miyabara et al. (2006) have shown significantly fewer signs of 
cryolesion-injured soleus and tibialis anterior muscles in HSP70-overexpressing mice 
(23.1±2.2% and 18.1±4.6%, respectively) compared with wild-type controls (39.4±2.3% and 
38.9±4.3%, respectively) 1 day after the cryolesioning. Miyabara et al. (2006) further 
demonstrated fewer necrotic myofibres in wild-type mice with radicicol-induced HSP70 
expression (24.9±5.4% and 17.5±3.6%, respectively) 1 day after cryolesioning, suggesting 
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racicicol might be a useful skeletal muscle protective agent. A significantly lower incidence 
of muscle necrosis was also observed in a previous study of ischemic-induced injury in rat 
tibialis anterior, when heat-shocked rats (35.54% necrosis) were compared with untreated 
control rats (68.34% necrosis) (Baumeister et al., 2004).  
 
On the other hand, in an in vitro model, Maglara et al. (2003) previously demonstrated that 
increased HSP content provides cytoprotection against calcium-induced damage to myotubes 
in culture. They observed a significant reduction in the release of creatine kinase activity 
without the loss of plasma membrane integrity when the myotubes were treated with the 
calcium ionophore A23187 at the time of maximal content of HSPs. 
 
2.4.2. Functional impairment  
 
The novel transgenic mice study of McArdle et al. (2004) showed that there was age-related 
loss of maximal tetanic force generation but the 10-20-fold increase in HSP70 content of EDL 
muscle did not prevent a loss of force generating capacity of skeletal muscle. However, the 
striking finding of the study was that, both young adult and older HSP70 over-expressing 
transgenic mice were able to recover much sooner in their capacity to develop maximum 
force after severe lengthening contraction-induced damage (McArdle et al., 2004). This 
apparent improvement was observed particularly in old HSP70 over-expressing transgenic 
mice in contrast to the persistence of a 44% force deficit of the EDL muscle 28 days 
following the repeated eccentric contraction protocol (McArdle et al., 2004). Kayani et al. 
(2008b) demonstrated that maximal force generated by the EDL muscle of aged mice with 
abundance of HSP70 in the quadriceps muscle had returned to near pre-treatment maximum 
force values (83.6±9.6% of baseline) by 28 days following the damaging lengthening 
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contractions compared with age-matched control mice (48.3±8.2% of baseline). In a recent 
study, it was demonstrated that a 3-fold increase in HSP10 content in the gastrocnemius 
muscle of HSP10 over-expressing old transgenic mice offered a significant protection to EDL 
muscle against repeated eccentric contraction-induced damage (Kayani et al., 2010). It was 
further shown that maximum tetanic force generated by the EDL muscle of both adult and old 
HSP10-overexpressing transgenic mice was 21-25% higher (as a percentage of pre-damaged 
force) at 3 h following the repeated eccentric contraction protocol (Kayani et al., 2010).  
 
Nevertheless, the studies of the protective role of HSP70 on functional preservation in skeletal 
muscle cells have been conflicting with some negative findings. Nosek et al. (2000) showed 
that elevated HSP72 in transgenic mice does not influence the basic isometric contractile 
properties of EDL, soleus and the diaphragm muscles. Furthermore, these muscles were not 
protected from the acute effects of 5-min intermittent fatiguing stimulation (Nosek et al., 
2000).  
 
2.4.3. Is there any evidence of induction of skeletal muscle HSP70 protein with no 
ensuing cellular protection?  
 
By using intra-vital microscopy analysis, Lille et al. (1999) confirmed that a marked induction 
of HSP72 in skeletal muscle did not produce any benefit to rat gracilis muscle subjected to 
severe ischemia/reperfusion injury at 24 and 48 h following heat stress, when the 
augmentation of HSP72 was at peak and elevated levels, respectively. The research group 
observed no difference with regard to the degree of muscle edema, as well as neutrophil 
rolling, adherence, emigration and arteriole diameter at all times following ischemia between 
the heat-stressed and non-heat-stressed rats (Lille et al., 1999). In a recent study by Kayani et 
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al. (2008a), the HSP90-inhibitor 17-AAG was used to elicit the expression of HSP70 content 
of quadriceps muscle in adult and old mice. They reported a two to four-fold increase in the 
skeletal muscle HSP70 content was sufficient to enhance recovery of force generation, but not 
to facilitate myofibres regeneration in the muscle of old mice at 28 days following the 
damaging eccentric contraction protocol (Kayani et al., 2008a).  
 
2.4.4. Is there any evidence of heat stress-mediated cellular protection without skeletal 
muscle HSP70 protein induction?  
 
In cardiotoxin-injured anterior tibialis of rat skeletal muscle, the regeneration process was 
facilitated with more newly formed regenerating myotubes that were observed in heat-
preconditioned muscles compared with the non heat-preconditioned controls (Kojima et al., 
2007). In their study, Kojima et al. (2007) concluded that there was no direct relationship 
between HSP72 expression and the muscle protein content in the muscle, which further 
suggests that HSP72 may not be contributing to protein synthesis during the necrosis-
regeneration process. In addition, by using light microscopy, Shima et al. (2008) showed that 
there were significantly less degenerated muscle fibres of the quadriceps femoris in heat-
stressed rats compared with non-heated exercise controls at 2 (2.8±1.6 vs 0.8±1.0), 3 (1.8±1.6 
vs 0.8±1.0) and 7 (0.3±0.6 vs 0) days following a bout of prolonged intermittent downhill 
running. This histological data was consistent with reduced leukocyte counts at 2 (104.6±32.5 
vs 70.2±41.6) and 7 (95.4±28.6 vs 55.7±18.0) days post exercise. However, it should be noted 
that Shima et al. (2008) did not measure the content of HSP70 in rat skeletal muscle, however 
they reported a remarkable increase in intramuscular hsp72 mRNA level immediately after 
the heat stress while transcriptional factors remained insignificantly elevated more than two-
fold from control rats in the following 3 days. 
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In a non-hyperthermia model, Jackson et al. (2002b) showed that brief ischemia coupled with 
reperfusion preconditioning significantly protected the tibialis anterior muscle of rats against 
ultrastructural damage induced by a subsequent prolonged ischemia and reperfusion. In their 
companion study, however, Jackson et al. (2002a) reported no evidence of induction of HSPs 
(HSP60, HSP70 an HSC70) when repeating their short ischemia-reperfusion protocol. The 
ischemic preconditioning protocol of Jackson et al. (2002b) profoundly reduced the damaged 
sites of reperfused muscle to 31.1% when compared with varying periods of ischemic-
reperfusion preconditioning protocols (48.1-69.0%). 
 
In summary, whether HSP70 induction in skeletal muscle confers protection against muscle 
damage remains to be investigated as the results of current studies are varied even from the 
same laboratory. The discrepancy of findings between these studies is likely to be due to the 
level of HSP70 induction and the nature of damaging insult. Further research concerning the 
relationship of HSPs induction in skeletal muscle and the protective effect against eccentric 
exercise-induced muscle damage is warranted. The question remains whether the expression 
of HSPs is an adaptation to the damaging insults or a reflection of the muscle damage. A 
summary of studies investigating the protective effects of HSP70 and/or small HSPs in 
skeletal muscle following contraction (n=9) and non-contraction (n=9) induced cell damage is 
presented in Table 2.7. 
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Table 2.7 Summary of studies investigating the protective effects of inducible HSP70 (and/or small HSPs) in skeletal muscle following contractiona (n=9) and 
non-contractionb (n=9) induced cell damage.  
Study Hypothesis Species Exposure Measures Outcome Measures 
 
b Garramone et 
al. (1994) 
Prior heat shock 
preconditioning would protect 
against ischemic injury in rat 
skeletal muscle. 
Adult male 
Sprague-Dawley 
(n=40). 
Presence of HSP72 in gastrocnnemius 
muscle of rats subjected to heat shock 
preconditioning in warm water bath by 
elevating and maintaining core 
temperature at 42.5°C for 20 min. 
Mitochondria swelling without 
disruption of cristae and only 
occasional authophagic vacuole 
following 90 min of complete ischemia 
in rats with heat shock preconditioning 
and 12 h recovery. 
 
b Lille et al. 
(1999) 
Whether prior induction of 
HSP72 by mild hyperthermia 
confers skeletal muscle 
tolerance against 
ischemia/reperfusion injury. 
Male Wister rats 
(n=42, 180-220 g). 
Thermal treatment of anesthetized rats in 
humidified heat chamber and maintained 
the core temperature at 41.5-42.5°C for 
20 min increased the HSP72 levels in 
skeletal muscle by 11.2±3.4-fold at 24 h, 
8.9±2.6-fold at 48 h and 9.1±3.1-fold at 
72 h. 
 
Induction of HSP72 failed to provide 
protection against 4-h ischemia with 3-
h reperfusion injury in rat gracilis 
muscle. 
a Nosek et al. 
(2000) 
Increased synthesis of HSPs 
will prevent oxidant damage or 
assist in repair of damaged 
proteins during repeated 
muscle contractions. 
Male and female 
B6×SJL transgenic 
HSP72-
overexpressed 
mice. 
HSP72 content in EDL and soleus 
muscles of transgenic HSP72-
overexpressed mice was >1.5 and >1.1-
fold higher than controls, respectively. 
Over-expression of HSP72 did not alter 
contractile properties of or protect EDL 
and soleus muscles from short-term 
acute effects of 5-min fatiguing 
stimulation, but may influence the 
excitation-contraction coupling in EDL 
muscle (i.e. greater sensitivity to 
caffeine stimulation). 
 
 
 
 
 
 
 
  
49 
Table 2.7 Continued 
Study Hypothesis Species Exposure Measures Outcome Measures 
 
b Lepore et al. 
(2000) 
Whether heat stress-induced 
HSP70 expression in rat 
skeletal muscle is correlated 
with improved muscle survival 
after ischemia-reperfusion 
injury in vivo. 
Whether the expression of 
HSP70 in myoblasts or 
myocytes is protective against 
mediators of ischemia-
reperfusion injury in vitro. 
 
In vivo study, 14 
male Sprague-
Dawley rats (240-
290 g). 
In vitro study, rat 
L-6 myoblasts 
culture. 
 
Anesthetized left hindlimb was heated to 
42°C for 20 min, western-blot confirmed 
expression of HSP70 (n=3) 24 h after 
heat stress. 
L-6 myoblasts treated with a retrovirus 
encoding human HSP70 to express 
HSP70 in single-cell clones. 
Viability of gastrocnemius and tibialis 
muscles after 2 h ischemia followed by 
24 h reperfusion was 86±2% for heat-
stressed rats (n=5) and 11±1% for 
controls (n=6). 
Higher survival in cultured myoblasts 
but not myocytes expressing HSP70 in 
response to heat stress (45°C) at 60-80 
min.  
b Jackson et al. 
(2002b) 
Induction of HSP72 as 
potential mechanisms for the 
protective effect of ischemia 
preconditioning in preventing 
muscle damage following 
ischemia reperfusion. 
 
Adult male Wister 
rats (n=22). 
5 min ischemia with 5 min reperfusion 
preconditioning did not induce HSP72 
in tibialis anterior muscle.  
Ischemia preconditioning reduced 
ultrastructural damage to skeletal 
muscle and reduced the rise in HSP72 
that followed a subsequent 
ischemia/reperfusion insult.  
b Maglara et al. 
(2003) 
A period of hyperthermia to 
myotubes in culture would 
increase the content of HSPs 
that associated with protection 
against A23187- or DNP-
induced damage. 
 
Cultured C2C12 
cells that derived 
from a mouse cell 
line. 
Myotubes exposed to 42°C for 30 min 
significantly increase skeletal muscle 
HSP25, HSP60, HSC70 and HSP70; and 
peaked by 12-18 h following 
hyperthermia. 
Significant reduction in the release of 
CK activity from myotubes treated 
with A23187 and DNP following the 
heat stress. 
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Table 2.7 Continued 
Study Hypothesis Species Exposure Measures Outcome Measures 
 
a McArdle et al. 
(2004) 
Lifelong expression of HSP70 
would protect against 
contraction-induced damage 
and subsequently facilitate a 
rapid and complete recovery 
for muscle of old mice. 
Adult (10-12 
months) and old 
(26-28 months) 
male and female 
wild-type B6×SJL 
and HSP70 
transgenic mice. 
 
HSP70 content of EDL muscle in adult 
and old HSP70-overexpressed 
transgenic mice were increased by ~10 
to 20-fold. 
Complete recovery of EDL force 
generating capacity by 14 days 
following damaging contractions in 
adult and old transgenic mice; a higher 
percentage of undamaged muscle fibres 
in adult HSP70 transgenic mice. 
b Baumeister et 
al. (2004) 
Heat stress preconditioning 
would reduce the skeletal 
muscle injury in composite 
tissue allo-transplantation in 
rats. 
Lewis (7-11 weeks, 
n=10) rats as hind-
limb donors; 
Brown-Norway 
(11-15 weeks, n=10 
each) rats as 
recipients and 
controls. 
 
Anesthetized Lewis rats were placed 
under the heating lamp until the rectal 
temperature reached 37°C and then were 
wrapped into a heating blanket for 30 
min (±5 min) until 42°C. Heat stress led 
to a rectal temperature of 42°C in rats 
for a maximum of 5 min and HSP70 in 
tibialis anterior was ~300% higher at 24 
h post heating. 
Nitroblue tetrazolium staining showed 
a significant reduction of necrotic 
muscle in heat stress preconditioning 
Lewis rats (35.54% necrosis) as 
compared to Brown-Norway rats 
without heat stress (68.34% necrosis). 
Wet-to-dry muscle ratio is lower in 
Lewis rats (5.22) than Brown-Norway 
rats (5.88). 
 
b Escobedo et 
al. (2004) 
HSP25 protects skeletal 
muscle cells from ROS-
induced damage by increasing 
glutathione levels. 
 
Cultured C2C12 
myoblasts derived 
from mouse 
skeletal muscle 
satellite cells. 
Overexpression of HSP25 in stably 
transfected C2C12 myoblasts. 
Differentiation of the C2C12 cells 
resulted in ~80% increase in expression 
of HSP25 in myotubes at 2 and 4 days 
after the switch to differentiation 
medium. 
 
Both overexpression of HSP25 (in 
dose-dependent manner) and 
differentiation-induced HSP25 
expression protect against H2O2-
induced cell damage, and associated 
with increase total glutathione and 
glutathione peroxidase activity. 
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Table 2.7 Continued 
Study Hypothesis Species Exposure Measures Outcome Measures 
 
b Miyabara et al. 
(2006) 
HSP70 is involved in skeletal 
muscle protection against 
damage and regeneration in 
mice subjected to the 
cryolesion. 
3-month old male 
HSP70-
overexpresssing 
transgenic mice 
(n=35) and wild-
type CB6F1 mice 
(n=27). 
 
HSP70 was highly expressed in the 
tibialis anterior muscle of HSP70-
overexpressed transgenic and radicicol-
treated mice, with exact values went 
unreported. 
Both HSP70-overexpressed transgenic 
and radicicol-treated mice had 
significant fewer signals of lesions at 1 
day after the cryolesions. 
b Kojima et al. 
(2007) 
Heat stress would facilitate the 
regeneration of cardiotoxin-
induced skeletal muscle injury 
in rats. 
7-week old male 
Wister rats. 
Exposure to heat chamber at 41°C for 60 
min, with a colonic temperature of 41°C. 
HSP72 expression in heated rats with 24 
h prior or immediately after the saline 
injection insignificantly increased at day 
1 but further increased significantly at 
day 3. 
Heat stress stimulates proliferation of 
satellite cells and protein synthesis in 
cardiotoxin-injured skeletal muscle 
during regeneration, implying 
enhanced recovery. There was no 
direct relationship between the muscle 
protein synthesis and HSP expression. 
 
a Kayani et al. 
(2008b) 
Prolonged treadmill training 
would increase muscle HSP70 
and this would improve the 
recovery of old mice from 
lengthening contraction-
induced muscle damage. 
 
Adult (12-14 
months) and old 
(24 months) male 
C57BL6/J mice. 
Treadmill running at 0% gradient at 15 
m.min-1 for 15 min.day-1 and 3 
days.week-1, for 10 weeks (adult/old 
mice) and 12 weeks (old mice). 33% 
increase in HSP70 in quadriceps muscle 
of adult mice. 
Similar level of serum CK at 3 h after 
damaging exercise; similar number of 
regenerating fibres and force deficit 
when compared with untrained mice. 
a Shima et al. 
(2008) 
Heat shock preconditioning 
would reduce muscle injury 
after downhill running due to 
increased ROS scavenging 
activity in rats. 
7-week old female 
Wister rat (n=94). 
An exposure of rats in the heat (42±1°C) 
for 60 min without anesthesia resulted in 
peak colonic temperature of 41.6±0.7°C 
(3.6°C increase) at the end of the 
treatment and 1,750±1,914% increase in 
HSP72 mRNA immediately after the 
treatment. 
 
Reduced accumulation of leukocytes 
and degenerated muscle fibres in heat 
shock preconditioned rats, which 
associated with increased ROS 
scavenging activity.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              
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Table 2.7 Continued 
Study Hypothesis Species Exposure Measures Outcome Measures 
 
a Kayani et al. 
(2008a) 
Treatment with HSP90 
inhibitor would result in 
increased levels of HSP70 in 
mice skeletal muscle and 
would facilitate complete 
recovery of force generation in 
old mice following damaging 
contractions. 
Adult (12-14 
months) and old 
(24-26 months) 
male and female 
C57BL6/J mice 
(n=48). 
A single injection of 40 mg.kg-1 17-
AAG increased HSP70 content of EDL 
of adult mice 24 h following treatment, 
recorded an increase of 218.7±29.2% in 
western-blot in 3 days and remained 
elevated for 10 days. 
Four weekly injection of 17-AAG at 40 
mg.kg-1 resulted in a four and two-fold 
increase in the HSP70 content of 
quadriceps muscles of adult and old 
mice, respectively. 
 
Maximal tetanic force generation of 
17-AAG-treated old mice had 
recovered to 83.6±9.6% of the pre-
damage values when compared with 
48.3±8.2% in control mice, 28 days 
after the 450 damaging lengthening 
contractions at 150 Hz. 
a Kayani et al. 
(2010) 
Overexpression of HSP10 may 
preserve skeletal muscle 
function during ageing by 
preserving mitochondrial 
function by protecting against 
mitochondrial oxidative injury. 
Adult (10-12 
months) and old 
(26-28 months) 
HSP10 and HSP60 
over-expressed 
transgenic mice 
(n=32). 
 
HSP10 content in gastrocnemius 
muscles was 3-fold higher in both adult 
and old transgenic mice.  
No significant difference in force 
generation of EDL muscles of wild-
type vs transgenic mice (adults: 
92.3±10.1% vs 90.4±3.6%; old: 
66.9±6.2% vs 68.1±9.6% pre-damaged 
force) after 28 days recovery from 225 
lengthening contraction. 
a Nonaka et al. 
(2011) 
The increase in HSP25 caused 
by thermal preconditioning 
would attenuate exercise-
induced muscle injury. 
8-week old male 
ICR mice (n=40). 
Hot water immersion (41.5 ± 0.5°C) for 
20 min.  
Downhill running (22 m.min-1 at -14°, 
150 min) at 24 h post thermal 
preconditioning. 
HSP25 protein level in quadriceps 
femoris was 1.2-fold higher than 
control at 24 h following thermal 
treatment. Lower level of G6PD in 
heat-treated animals at 24, 48 and 72 h 
following downhill running.  
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Table 2.7 Continued 
Study Hypothesis Species Exposure Measures Outcome Measures 
 
a Touchberry et 
al. (2012) 
A single heat stress 
pretreatment 48 h prior to 
downhill running would 
increase markers of 
regeneration, increase 
activation of the Akt/MAPK, 
and reduce the severity of 
muscle injury. 
 
Adult (10 weeks 
old, ~300-350 g) 
male Wister rats 
(n=48).  
Passive heat shock pretreatment in 43°C 
water bath immersion, core temperature 
to be maintained at 41.0 to 41.5°C for 20 
min. 
Downhill running (18 m.min-1 at −16°, 
18 × 5-min bout with 2 min recovery) at 
48 h post heat shock. 
Significant increase in HSP72 in the 
soleus muscle at 48 h following 
hyperthermia. Plasma creatine kinase 
and monocuclear cell infiltration were 
lower at 2 h and 48, respectively, 
following the downhill running. 
a Liu et al. 
(2013) 
Lifelong over-expression of 
HSP72 in skeletal muscle 
would prevent exhaustive 
exercise-induced muscle 
fatigue and damage. 
Adult (8 weeks old) 
transgene-positive 
([+]HSP72) and 
transgene-negative 
([−]HSP72) mice. 
 
HSP72 in quadriceps of [+]HSP72 mice 
was ~45-fold higher than [−]HSP72 
control samples.  
The percentage of undamaged muscle 
fibres under hematoxylin-eosin staining 
were ~35% higher in [+]HSP72 than 
[−]HSP72 mice. 
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2.5. The Mechanisms by Which HSP70 Protects Against EIMD 
 
2.5.1. Maintenance of cellular structure and function 
 
McArdle et al. (2004) showed that the maximum tetanic force normalized to muscle cross-
sectional area in old wild-type mice was significantly less (26%) than that of the young adult 
littermates; whereas, there were no differences between old and adult HSP70 over-expressing 
transgenic mice. These data support the hypothesis that over-expression of HSP70 in the 
skeletal muscle preserves the capability of muscle fibres to generate force per unit of cross-
sectional area in old animals; and that a proportion of contraction-damaged muscle fibres may 
be repaired more readily with an increased content of HSP70 in the skeletal muscle of old 
transgenic mice (McArdle et al., 2004). It has been commonly known that HSP70 is an 
essential component for structural and functional remodeling of skeletal muscle (Liu et al., 
2006; Liu and Steinacker, 2001). In addition, Kayani et al. (2010) further showed that over-
expression of mitochondrial HSP10 prevented atrophy of EDL muscle and subsequently 
preserved maximum force generation in the muscle of old mice. Interestingly, the body mass, 
muscle mass and cross-sectional area of EDL muscles in HSP70 over-expressing transgenic 
mice were all significantly smaller than their wild-type littermates regardless of age (McArdle 
et al., 2004); however, it was not the case in the HSP10 over-expressing transgenic mice 
(Kayani et al., 2010) implying that unlike HSP70, the effect of HSP10 is independent of age. 
Nevertheless, the study of Nosek et al. (2000) reported the total body weight of HSP72 over-
expressing transgenic mice (34.5±1.3 g) was on average 17% larger than the controls 
(29.5±1.3 g). 
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In order to explain the ~8-fold increase in muscle viability observed after the ischemia-
reperfusion in rats with HSP70 induction, Lepore et al. (2000) conducted an in vitro study to 
examine if the muscle survival in vivo is due to protection of the skeletal muscle pre-cursor 
cells (the myoblasts). The findings were somewhat unexpected in that expression of HSP70 in 
cultured myoblasts protected against both thermal injury and mediated against ischemia-
reperfusion injury (in the form of chloride or H2O2); whereas the expression of HSP70 did not 
protect differentiated myocytes from either thermal or ischemia-reperfusion injury (Lepore et 
al., 2000). According to Lepore et al. (2000), it is plausible that HSP70 expression per se is 
not sufficient to confer cytoprotection and that a further process in addition to HSP70, may 
play a role in the protective effect of heat stress against skeletal muscle injury. 
 
2.5.2. Improved calcium regulation  
 
Although Nosek et al. (2000) found that over-expression of HSP72 in the skeletal muscle of 
transgenic mice did not increase the recovery rate from repetitive fatiguing electrical 
stimulation, they observed an enhanced caffeine sensitivity in EDL muscle of HSP72 over-
expressing transgenic mice. They speculated that HSP72 might either affect the Ca2+ loading 
capacity of the sarcoplasmic reticulum (via an increased activity of the sarcoplasmic 
reticulum Ca2+ ATPase pump) or the calcium sensitivity to calcium induced calcium release 
(either by a direct effect on the ryanodine receptor or via modulation of accessory 
sarcoplasmic reticulum proteins, such as FKBP12, calmodulin, or triadin) in fast-twitch 
muscles (Nosek et al., 2000). 
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2.5.3. Mitochondria function and metabolic pathway  
 
Garramone et al. (1994) suggested that HSP72 protects the skeletal muscle from ischemic 
injury by preserving the creatine phosphate levels, which seems to be plausible. It has also 
been demonstrated that the heat shock response stimulates glycogen synthesis in cultured L6 
myocytes (Moon et al., 2003) although such a finding was not evident in vivo. In examining 
the susceptibility to and recovery from contraction-induced skeletal muscle damage, Kayani 
et al. (2010) found that over-expression of HSP10 had no effect on mitochondrial number in 
the EDL muscle and no significant difference was observed in succinate dehydrogenase 
(SDH) activity in the gastrocnemius muscle of adult and old wild-type HSP10 over-expressed 
transgenic mice. 
 
2.5.4. Antioxidant capacity  
 
The relative contribution of the antioxidant defense system has received considerable 
attention when examining the protective roles of heat shock proteins in skeletal muscle 
damage. Miyabara et al. (2006) hypothesized that HSP70 might exert a positive effect on 
glutathione peroxidase (GPX) activity, which could protect skeletal muscle against injury, by 
removing reactive oxygen species (ROS) produced in the cytosol or mitochodria of damaged 
myofibres. Miyabara et al. (2006) observed a significant elevation of GPX activity in tibialis 
anterior of HSP70 over-expressing mice 10 days after cryolesioning compared with the 
muscle of wild-type mice. However, Shima et al. (2008) used an electron spin resonance 
method in evaluating the effect of heat shock response on ROS scavenging activity in skeletal 
muscle. The study demonstrated a significant increase (151±18%) in manganese superoxide 
dismutase (MnSOD) activity in rat quadriceps femoris at 3 days after the heat shock 
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preconditioning; which together with enhanced transcriptional adaptation of HSP72 mRNA 
and lesser degenerated myofibres, suggests that heat shock preconditioning may protect the 
skeletal muscle against injury via an antioxidant defense system which could be activated in 
response to the free-radical mediated inflammatory response following their downhill running 
protocol. Although the direct involvement of HSP72 in this protective mechanism against 
muscle injury remains to be determined, it is speculative that HSP72 induction in skeletal 
muscle may facilitate the maturation of SOD (Shima et al., 2008). It has also been speculated 
that the preservation of skeletal muscle function (i.e. improved recovery of force generation 
following damage) in HSP70 abundant mice was a result of maintenance of the ability to 
activate NF-κB-mediated transcription following the initial stress from damaging exercise 
(Kayani et al., 2008b). A recent study by Kayani et al. (2010) suggests that the preservation of 
force and muscle cross-sectional area in transgenic mice overexpressing mitochondrial HSP10 
was associated with protection against age-related accumulation of oxidized mitochondrial 
proteins (a significant 60% increase in the carbonyl content of mitochondrial proteins in old 
wild-type mice compared with adult littermates).   
 
2.5.5. Paradox of “conferred protection” versus “improved recovery”  
 
It is still open for discussion whether heat shock proteins provide protection or facilitate 
regeneration of myofibres following damaging stimulus. Lepore et al. (2000) and Kojima et 
al. (2007) suggested that HSP70 expression in skeletal muscle per se might not account for 
cytoprotection prior to protein synthesis or fibre regeneration in the necrosis-regeneration 
process following damaging insults. However, Miyabara et al. (2006) contended that HSP70 
expression in skeletal muscle appears to provide myofibrillar protection against damage rather 
than facilitating myofibres regeneration following injurious insults. The results of their study 
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clearly showed a lower number of satellite cells in tibialis anterior muscles of HSP70 over-
expressing transgenic mice at 1 day after cryolesion-induced injury. The expression of 
developmental/neonatal myosin heavy chain (MHCd/n) was significantly fewer in HSP70 
over-expressing transgenic mice (27±5%) than wild-type mice (42±3%) (Miyabara et al., 
2006), implying that myofibres of HSP70 over-expressing transgenic mice were partially 
spared from cryolesion-induced injury and required less activation of satellite cells to restore 
cytoskeleton profiles. Over-expression of HSP10 may protect against skeletal muscle damage 
in mice independent of age (Kayani et al., 2010) while not improving the recovery process 
when the damage occurred, which had previously been shown in HSP70 over-expressing 
transgenic mice (McArdle et al., 2004).  
 
2.6. Summary and Research Hypotheses 
 
Collectively, the data suggests that the protective effect of the inducible form of HSP70 in 
skeletal muscle is equivocal. In the event that HSP70 is protective in vivo, it might be due to 
the synergy of HSP70 and other inducible proteins within the skeletal muscle rather than 
HSP70 per se conferring cellular protection against injurious insults. The role of HSP70 in 
skeletal muscle has not been entirely understood. Evidence suggests that HSP70 serves as an 
important molecular chaperone and stress sensor in the cellular process relating to skeletal 
muscle function and adaptation (Liu et al., 2006). Although very little is known about the role 
of small HSPs in skeletal muscle damage, recently it has been convincingly demonstrated that 
induction of mitochondrial HSP10 and HSP25 in skeletal muscle seems to protect the skeletal 
muscle from injury via interaction with cytoskeleton elements and/or the glutathione system 
(Kayani et al., 2010; Koh, 2002).  
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We hypothesized that increased induction of HSP70 in skeletal muscle would modulate the 
recovery process of damaged muscle by enhancing the cellular stress response. Further, we 
hypothesized that the presence of HSP25 and HSF1, in addition to the abundance of HSP70 in 
skeletal muscle, would confer cytoprotection against muscle damage by stabilizing 
myofibrillar integrity (Figure 2.5). 
 
 
Figure 2.5 Schematic mechanisms of HSPs in protecting against skeletal muscle damage. 
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CHAPTER 3 – THESIS STUDY DESIGN AND AIMS 
 
3.1. Thesis Research Design 
 
Four interlinked animal studies were designed to test the hypothesis that induction of skeletal 
muscle HSP72 by pharmaceutical interventions would limit myofibrillar disruption and force 
deficit following an acute bout of prolonged eccentric exercise. The known HSP72 inducers, 
17-AAG and L-alanyl-L-glutamine dipeptide were administrated to the male adult rats in the 
separate studies via intra-peritoneal injection and oral gavage, respectively. We employed 
downhill treadmill running as an eccentric exercise protocol to induce skeletal muscle damage 
in the animals, with a specific focus on vastus intermedius or red vastus muscle.  
 
An overview of the thesis research design is outlined in Table 3.1. The experimental protocol 
and procedures of each study are detailed in the following chapters (Chapter 4 to 7). 
 
3.2. Research Aims and Hypothesis 
 
3.2.1. Study 1 – Effect of 17-AAG on skeletal muscle HSP72 response following 
prolonged eccentric exercise 
  
The aim of this study was to investigate the acute skeletal muscle HSP72 response following 
a bout of prolonged eccentric exercise in rats treated with and without 17-AAG. Previously, 
17-AAG has been shown to induce abundant HSP72 expression in skeletal muscle of mice 
(Kayani et al., 2008a) and subsequently protect against muscle damage. We hypothesized 
that: 
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• A single intra-peritoneal injection of 17-AAG (40 mg.kg-1 body weight) would 
increase HSP72 content in rat red vastus muscle at 24 h following the treatment. 
• The increased muscle HSP72 expression would reduce the signs of myofibrillar 
disruption as indicated by histological analysis and impairment of muscle force 
generation as measured by a hindlimb grip strength test. 
• The muscle HSP72 response would be associated with reduced intracellular Ca2+ 
levels as shown by increased sarcoplasmic reticulum Ca2+ ATPase activity and 
inactivation of calpain activity. 
 
3.2.2. Study 2 – Dose-response of glutamine on HSP72 expression in plasma, skeletal and 
cardiac muscles 
 
The aim of this study was to investigate the dose-response relationship of oral glutamine 
administration on heat shock response in rat plasma (HSP72), cardiac (HSP72 and HSP25) 
and skeletal (HSP72, HSP25 and HSF1) muscle. Animals were treated with either a placebo 
(purified water), low (0.5 g.kg-1.day-1), or high (0.9 g.kg-1.day-1) dose of glutamine for one or 
five consecutive days. We hypothesized that: 
• Five once daily treatments of high-dose glutamine would induce a higher HSP72 
expression in the tissues. 
• The increased tissues HSP72 expression would be associated with an increase in 
plasma glutamine concentration, as well as skeletal muscle HSP25 and HSF1 levels. 
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3.2.3. Study 3(a) – Effect of glutamine on heat shock response and EIMD 
 
The aim of this study was to investigate if multiple doses of glutamine administration and 
ensuing heat shock response would confer the rat skeletal muscle tolerance to EIMD. To 
determine the effect of glutamine and heat shock response in vivo, we gavaged rats with five 
once daily dose of glutamine (0.9 g.kg-1.day-1) or a placebo (an equivalent amount of purified 
water), prior to a prolonged bout of downhill running. We hypothesized that: 
• Five once daily treatments of glutamine would increase plasma and red vastus muscle 
HSP72 expression in rats. 
• The increased plasma and red vastus HSP72 would be associated with reduced signs 
of myofibrillar disruption, as indicated by histological analysis, and impairment of 
muscle force generation, as measured by a hind-limb grip strength test. 
• The increase in red vastus muscle HSP72 response would be paralleled by an increase 
in HSP25 and HSF1 levels in the muscle. 
 
3.2.4. Study 3(b) – The additive effect of glutamine and passive heating on heat shock 
response and EIMD 
 
The aim of this study was to investigate the additive effects of multiple doses of glutamine 
administration and passive heat preconditioning on plasma and skeletal muscle heat shock 
response in rats, following an acute bout of damaging eccentric exercise. To determine the 
additive effect of glutamine and passive heating, the rats were subjected to a session of 
passive heating (rectal temperature was elevated to and maintained at ~42 °C for 20 min) and 
five once daily oral gavages of glutamine (0.9 g.kg-1.day-1) or a placebo (an equivalent 
volume of purified water), prior to eccentric exercise. The passive heating procedure was 
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undertaken an hour following the penultimate glutamine or placebo treatment, which 
coincided with the 24 h time point prior to the prolonged eccentric exercise bout. We 
hypothesized that: 
• Glutamine treatment would induce more plasma and red vastus muscle HSP72 
expression than placebo, in passive heat-preconditioned rats. 
• The additive effects of glutamine and passive heat treatments and ensuing plasma and 
muscle HSP72 response, would be associated with a reduction in the magnitude of 
myofibrillar disruption and muscle force deficit in rats following an acute bout of 
prolonged eccentric exercise. 
• Glutamine-mediated HSP72 expression would be associated with an increase in 
HSP25 and HSF1 expression in the red vastus muscle of heat-preconditioned rats. 
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Table 3.1 Overview of thesis research design and aims. 
 Study 1 (Chapter 4) Study 2 (Chapter 5) Study 3(a) (Chapter 6) Study 3(b) (Chapter 7) 
 
Aim Effect of 17-AAG on skeletal 
muscle HSP72 response 
following prolonged eccentric 
exercise in rats. 
Dose-response of glutamine 
treatment on HSP72 response in 
plasma, skeletal and cardiac 
muscle of rats. 
Effect of glutamine treatment on 
heat shock response and 
eccentric exercise-induced 
muscle damage in rats. 
Effect of glutamine treatment 
and passive heat preconditioning 
on heat shock response and 
eccentric exercise-induced 
muscle damage in rats. 
 
Intervention 1. A single intra-peritoneal 
injection of 17-AAG. 
2. A bout of prolonged 
treadmill downhill running. 
 
1. Single or multiple (five once 
daily) treatments of 
glutamine at low or high 
dose. 
1. Five once daily treatments of 
glutamine. 
2. A bout of prolonged 
treadmill downhill running. 
 
1. Five once daily treatments of 
glutamine. 
2. A session of passive heating. 
3. A bout of prolonged 
treadmill downhill running. 
 
Key outcome 
measures 
• Red vastus HSP72. 
• Histological analysis: electron 
microscopy. 
• Hindlimb grip strength. 
• Red vastus SR Ca2+ ATPase 
and calpain activity. 
 
• Red vastus HSP72, HSP25 
and HSF1.  
• Heart HSP72 and HSP25. 
• Plasma HSP72 and glutamine 
concentrations. 
 
• Plasma HSP72 
• Red vastus HSP72, HSP25 
and HSF1. 
• Histological analysis: light 
microscopy. 
• Hindlimb grip strength. 
• Plasma HSP72 
• Red vastus HSP72, HSP25 
and HSF1. 
• Histological analysis: light 
microscopy. 
• Hindlimb grip strength. 
• Rectal and vastus lateralis 
temperatures. 
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CHAPTER 4 – STUDY 1 
 
4.1. Introduction 
 
Eccentric exercise results in microscopic disruption to the myofibrils, leading to loss of 
cellular integrity, disrupted calcium homeostasis, and cell necrosis (Armstrong et al., 1991). 
Eventually, these events result in impaired muscle function, e.g. strength loss and delayed 
onset of muscle soreness. Despite the fact that there have been many studies on eccentric 
exercise-induced muscle damage, there is no conclusive evidence that any specific 
intervention or treatment to this type of injury is effective (Black et al., 2002). Research 
evidence suggests there is no one mechanism that is solely responsible for eccentric exercise-
induced muscle damage (Clarkson and Sayers, 1999; Proske and Morgan, 2001). A prevailing 
hypothesis is that several processes may be acting together at the cellular and molecular levels 
with the initial ultrastructural damage being caused by mechanical stress and the subsequent 
functional impairment being exacerbated by subcellular disturbances, e.g. cytosolic and 
mitochondrial calcium overload (Clarkson and Sayers, 1999; Tupling et al., 2008). 
 
The inducible form of HSP70, i.e. HSP72, has been consistently reported to confer 
cytoprotection in human and animal studies via the heat shock response (Alsbury et al., 2004; 
Latchman, 2001). While the cytoprotective role of HSP72 in other tissues such as cardiac 
muscle have been investigated, less is known about the protective effect of HSP72 in 
eccentric exercise-induced muscle damage. The multi-component and multi-target heat shock 
response provides the basis for investigating the role of skeletal muscle HSP72 in the 
prevention of structural and functional impairments following eccentric exercise. However, 
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the precise mechanism by which HSP72 contribute to the protection of muscle against 
ultrastructural damage is not well understood. 
 
A series of studies examining the protective role of HSP70 in skeletal muscle damage 
(McArdle et al., 2004) discovered that a 10- to 20-fold increase in skeletal muscle HSP70 of 
transgenic mice gave protection against the development of age-related muscle function 
deficits (McArdle et al., 2004). However, the protective effect was not evident when HSP70 
increased by 2-fold following prolonged treadmill training in naïve animals (Kayani et al., 
2008b). Later, it was demonstrated that administration of 17-AAG could induce HSP70 in 
skeletal muscle by 2- to 3-fold and enhanced recovery of old mice following exercise 
involving lengthening contractions (Kayani et al., 2008a). These data suggest that the 
functional role of inducible HSP70 in exercise-induced muscle damage does conform to a 
dose-response relationship, is tissue-specific and is likely to occur following ultrastructural 
damage. Nevertheless, it is still unclear how the preservation of muscle function would be 
affected by HSP72 expression and whether the pharmacological-induced protective effect of 
HSP72 is species specific. Recently, it has been proposed that HSP70 might protect both 
cardiac and skeletal muscle against damage by maintaining cellular calcium homeostasis, 
thereby preventing the initiation of apoptosis (Tupling et al., 2008). Therefore, we sought to 
increase skeletal muscle HSP72 content by means of pharmacological intervention (by 17-
AAG, a HSP70 inducer) and investigate the role of increased HSP72 in protecting against 
eccentric exercise-induced ultrastructural damage using a downhill running rat model. We 
further sought to investigate the association between myofibrillar disruption, muscle function 
and SR calcium regulation.  
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We hypothesized that administration of a dose of 17-AAG will result in a greater abundance 
of HSP72 in rat skeletal muscle, and that an increased cellular content of HSP72 will reduce 
the magnitude of myofibril disruption and impairment of both muscle contractile and SR 
function at the initial stages of injury. 
 
4.2. Materials and Methods 
 
4.2.1. Animal handling and experimental protocol 
 
A total of 48 adult male Sprague-Dawley rats (Rattus norvegicus, 7 weeks old) with an initial 
weight of approximately 250 to 300 g were used in this study. Rats were kept in a 12:12-h 
light-dark cycle in a temperature-controlled (~22°C) animal house, provided with standard rat 
chow and tap water ad lib. They were acclimatized to this new environment for 
approximately one week. Thereafter, the rats were randomly divided into two groups: half of 
the rats were treated with a single intra-peritoneal injection of 17-AAG of 40 mg.kg-1 body 
weight in 50 µL of dimethyl sulfoxide (17-AAG-treated group) while the other group served 
as a control and received an injection of dimethyl sulfoxide (DMSO-treated group) of similar 
amount. This dose of 17-AAG was selected based on the previous finding that skeletal muscle 
HSP70 content of laboratory mice increased at 24 h after a single injection of 17-AAG and 
remained elevated for the following 10 days (Kayani et al., 2008a).  
 
Approximately 24 h after the treatment, rats from each of the experimental treatment groups 
were further randomly assigned into one of three sub-groups: which were euthanized before 
(non-exercise, Non-EX), or at 24 h (24 h post exercise, EX+24h) or 48 h (48 h post exercise, 
EX+48h) following the eccentric exercise. In addition, all rats were subjected to a muscle 
  68 
strength test before they were euthanized for subsequent tissues sampling (at the average age 
of 9.6±0.1 week-old).  
 
A schematic design of the study is presented in Figure 4.1. The study was conducted in 
compliance with the Australian Code of Practice for the Care and Use of Animals for 
Scientific Purposes and the experimental protocol was approved by Animal Ethics Committee 
of the University of Sydney (Approval Number: C42/12-2010/1/5430). 
 
 
Figure 4.1 The schematic outline of experimental design. Non-EX = non-exercising control group; 
EX+24h = 24 h post eccentric exercise condition; EX+48h = 48 h post eccentric exercise condition. 
 
Test/Procedure 
Rats were subjected 
to muscle strength 
test prior to being 
euthanased for 
tissues sampling. 
Treatment 2 
Rats undertook 
either no exercise or 
a prolonged bout of 
downhill running 24-
h post treatment. 
Treatment 1 
Rats were injected 
either with a single 
dose (40 mg.Kg-1 
body weight) of 
17AAG or DMSO. 
Animal 
A total of 48 male 
Sprague-Dawley rats 
were acquired at 7-
week old with initial 
weight of ~300 g. 
Male Sprague-
Dawley Rat 
(n = 48) 
17AAG-treated 
(n = 24) 
Without 
Exercise 
Non-EX 
(n = 8) 
Eccentric 
Exercise 
EX+24h 
(n = 8) 
EX+48h 
(n = 8) 
DMSO-treated 
(n = 24) 
Without 
Exercise 
Non-EX 
(n = 8) 
Eccentric 
Exercise 
EX+24h 
(n = 8) 
EX+48h 
(n = 8) 
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4.2.2. Assessment of muscle contractile function  
 
The muscle force-generating capacity of the rat’s hindlimbs was evaluated using the grip 
strength meter and protocol modified from previous studies (MacArthur et al., 2008; Nevins 
et al., 1993; Rogers et al., 1997; Ross et al., 1997). Each rat was held by the base of the tail 
and lowered toward the metal mesh grid that was mounted on a force transducer and allowed 
to grasp the grid with its paws of the hindlimbs (Figure 4.2). Thereafter, the rat was pulled 
backwards by the tail away from the grid until the rat’s hindlimb grip was released. It is 
commonly known that when pulled by the tail, rats will instinctively grab anything they can 
until the pulling force overcomes their hindlimb grip strength. The lateral force exerted on the 
grid at the time or before the rat loses the grip was recorded as peak force in Newton (N). 
Each rat was given at least 5 trials with approximately 3 min rest interval between each trial. 
The highest lateral force was used as the maximal muscle force-generating capacity for data 
analysis.  
 
 
Figure 4.2 A rat training on a metal mesh grid that attached to a force transducer. Each rat was 
habituated to the grip strength testing “rig”. The measuring range of the force transducer (Lorenz 
Messtechnik GmbH, Germany) is 0.02 to 50 N with a sensitivity of 2 mV/V. 
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4.2.3. Prolonged eccentric exercise  
 
The rats in the eccentric exercise group undertook intermittent downhill running exercise on a 
motorized treadmill, at a speed of 16 m.min-1 and a gradient of 16° decline for a total of 90 
min: 5 min running interspersed with 2 min recovery for a total of 18 bouts (Figure 4.3). This 
downhill running protocol has previously been shown to result in skeletal muscle damage in 
the hindlimbs of rats (Armstrong et al., 1983b; Chen et al., 2007d). Rats were encouraged to 
keep on running through audible and physical stimulus (e.g. hand prodding or brushing the 
tail). It is essential to ensure the rats run at a steady pace at the front of the treadmill, because 
any changes in their running pattern would significantly affect the metabolic steady-state 
conditions (Armstrong et al., 1983a). 
 
 
Figure 4.3 A rat running on the motor-driven treadmill at 16 m.min-1 and −16°, room temperature was 
21-22°C during the night cycle. To obtain the downhill grade, the rear axle of the treadmill was 
elevated using several step boxes with the aid of a digital inclinometer (accuracy ±0.1°). 
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4.2.4. Preparation of tissues samples  
 
Upon euthanasia, muscle tissues of both hindlimbs of the rats were promptly harvested, snap 
frozen in a container of liquid nitrogen and stored at −80°C until later biochemical analysis 
(Figure 4.4 and 4.5). The red vastus muscles were sampled for biochemical enzymatic 
analysis, and qualitative electron microscopy analysis. Previous studies have shown that this 
deeply located, predominantly slow-twitch muscle group (red vastus) of rats is damaged most 
in downhill and uphill, but not level running (Armstrong et al., 1983b; Komulainen et al., 
1994; Salminen and Vihko, 1983). 
 
 
Figure 4.4 At the end point of the experiment, each rat was anaesthetized by an intraperitoneal 
injection of sodium pentobarbital prior to harvesting of tissues sample before, at 24 and 48 h following 
the downhill running. 
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Figure 4.5 Once the rat was anaesthetized, blood was taken via cardiac puncture and then the rat was 
sacrificed by removal of the heart. These were followed by dissection and sampling of red vastus 
muscle as shown in the photo. 
 
4.2.5. Heat shock protein analysis  
 
Skeletal muscle HSP72 was analyzed by an ELISA method (R and D, kit DYC1663, 
Minneapolis, MN, USA) according to the manufacturer’s instructions. Tissues were 
homogenised in Tris-buffered saline, pH 7.5 (TBS) with a Miccra D-1 homogeniser 
(Germany), then an extraction buffer was added to give a final concentration of 0.15 M NaCl, 
50 mM Tris, 5 mM EDTA, 2 mM ethylmaleimide, 2 mM PMSF, 1% Igepal, 1 µg.mL-1 
leupeptin, and 1 µg.mL-1 pepstatin (Noguchi et al., 1997). The homogenate was then 
centrifuged at 12,000 g for 20 min at 4°C. Before analysis, an aliquot was analyzed for 
protein concentration (Markwell et al., 1978). 
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4.2.6. Qualitative ultrastructural analysis  
 
Transmission electron microscopy was performed to qualitatively analyze the microscopic 
disruption of myofibrils in red vastus muscles as previously described (Chen et al., 2007d). 
Briefly, the removed muscle tissues were fixed in modified Karnovsky’s fixative overnight, 
then washed in buffer, followed by postfixation with 2% osmium tetroxide and dehydrated 
through an ascending series of ethanol, then subsequently embedded in TAAB TLV epoxy 
resin. Semi-thin sections (0.5 µm) were cut using a Leica Ultracut UCT ultramicrotome and 
stained with 1% methylene blue in 1% borax. These sections were used to select areas for 
subsequent ultrastructural examination. Ultrathin sections (~60 nm) of muscle tissues were 
cut using Leica UC-6rt or UCT ultramicrotomes (Figure 4.6) and collected on 300 mesh 
copper grids, which were double stained with 2% uranyl acetate in 50% ethanol followed by 
Reynold’s lead citrate, then viewed (at 100 kV) and photographed with a Philips CM120 
BioTwin transmission electron microscope equipped with a SIS Morada digital camera. Only 
two rats from each experimental group were included for ultrastructural analysis due to 
constraints of funding, time, technical assistance and laboratory availability. 
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Figure 4.6 Ultrathin sections (~60 nm) of muscle tissues were cut using Leica UC-6rt ultramicrotome. 
 
4.2.7. SR Ca2+-ATPase activity  
 
Approximately 70 mg of muscle sample freed from fat and connective tissue was weighed, 
diluted 1:10 (weight:volume) in cold homogenizing buffer (40 mM Tris, 0.3 M sucrose, pH 
7.9) and then homogenized on ice at 18,000 rpm three times for ~15 s interspersed with 15 s 
rest interval. This process resulted in a suspension of fragmented SR membranes, which 
resealed into numerous small vesicles allowing for direct measurement of Ca2+-ATPase 
activity. The SR Ca2+-ATPase activity was determined in triplicate on homogenized muscle 
samples with techniques previously employed in our laboratory and described in detailed 
elsewhere (Chen et al., 2007d; Ruell et al., 1995; Simonides and van Hardeveld, 1990). In 
short, the enzyme-linked reaction was assayed at 37°C using a spectrophotometer 
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(UV1601PC, Shimadzu, Japan) at 340 nm. The assay buffer consisted of 18 mM Hepes buffer 
pH 7.5, 180 mM KCI, 13 mM MgCl2, 1 mM EGTA, 9 mM NaN3, 0.3 mM NADH, 9 mM 
phosphoenolppyruvate, 22 U.mL-1 lactate dehydrogenase, 16 U.mL-1 pyruvate kinase, and 4 
mM ATP. To evaluate SR vesicles integrity, 2.6 µM Ca2+ ionophore A23187 was used and 
the ratio of Ca2+-ATPase activities in the presence and absence of A23187 was computed. 
Eight µL of muscle homogenate were added to 1 mL assay buffer and the reaction was 
initiated by adding 12 µL of CaCl2 (100 mM). The basal Ca2+-ATPase activity was then 
measured after the addition of 15 µL of 2 mM CaCl2, which gave a final concentration of 26.8 
mM CaCl2 that completely inhibited the Ca2+-ATPase activity. The SR Ca2+-ATPase activity 
was determined from the difference between total and basal activities, normalized for protein 
content in the muscle homogenates, and expressed as nM.min-1.mg of muscle protein. On any 
given day, six muscle samples from each experimental group (DMSO-treated: Non-EX, 
EX+24h, EX+48h; 17-AAG-treated: Non-EX, EX+24h, EX+48h) were analyzed together in 
random order and all measurements were completed within 60 min after thawing of the 
samples. 
 
4.2.8. Muscle calpain analysis  
 
Total muscle calpain activity was determined by the fluorescence method described 
previously (Kanzaki et al., 2010). In brief, muscle samples of approximately 50 mg were 
diluted in 9x volume of ice-cold homogenizing buffer composed of 5 mM EDTA, 5mM 
EGTA, 20 mM Tris, 10 µg.mL-1 pepstatin A, 10 µg.mL-1 4-(2-aminoethyl)-benzenesulfony-
fluoride (AEBF), 1 mM dithiothreitol (DTT), and 0.5 mM phenylmethylsulfonylfluoride (pH 
7.4) and homogenized on ice for 4 x 15 s at 5,000 rpm using a Miccra D-1 homogeniser 
(Germany). After centrifuging at 2,000 g for 10 min at 4°C, the supernatant was collected and 
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total calpain activity was measured using the assay of Sultan et al. (2000). Briefly, 1 ml assay 
buffer containing 20 mM Tris-HCl pH 7.4, 5mM CaCl2, 1mM DTT, 10 µg AEBF, 10 µg 
pepstatin A was warmed to 37°C. Muscle extract (7.5 µl) was added to the assay buffer, and 
SLY-AMC (N-Succinyl-Leu-Tyr-7-amido-4-methylcoumarin) (2.5 µl of a 50 mM solution) 
was added to initiate the reaction. An assay blank consisted of the same solution without 
added calcium and the addition of 10 mM EDTA and EGTA. Cuvettes were incubated at 
37°C for 15 min before reading in a fluorimeter (Aminco Bowman Series 2, SLM 
Instruments, IL, USA) at 380 nm excitation and 460 nm emission wavelengths. The 
fluorescence of standard AMC solutions was also read and the calpain activity was calculated 
as AMC concentration (corrected for the blank) in pmol.min-1.mg-1 protein. 
 
4.2.9. Statistical analysis 
 
All data are presented as mean and standard deviation or otherwise stated. A two-way 
between-groups analysis of variance (ANOVA) was used in detecting the significant 
interaction effect of treatment and exercise. When a significant F value was observed, the 
LSD post-hoc analysis was run to identify the differences between the non-exercise and 
eccentric exercise groups. Significance of the difference between the treatment groups was 
assessed through the Student’s independent t-test. Statistical analysis was conducted using 
SPSS Version 19 and the level of significance was set at p < 0.05 for all comparisons. 
 
4.3. Results 
 
We initially aimed to confirm that treating the rats with 17-AAG would result in increased 
skeletal muscle HSP70 level as previously demonstrated in mice (Kayani et al., 2008a) and 
  77 
hence, we speculated that the 17-AAG-treated rats subjected to low-intensity prolonged 
eccentric exercise would experience less myofibrillar disruption (i.e. fewer signs of muscle 
damage) in the early stage of exercise-induced muscle damage as evidenced by histological 
analysis. Our results show that there was a 33% increase in the HSP72 level of red vastus of 
17-AAG-treated Non-EX rats when compared to DMSO-treated controls, but this difference 
was not statistically significant (Figure 4.7). Interestingly, HSP72 content in the red vastus 
muscles of both DMSO and 17-AAG-treated rats was significantly (p < 0.01) elevated at 24 h 
and 48 h when compared with their littermates in non-exercised groups following the 
prolonged eccentric exercise. In addition, the HSP72 content of 17-AAG-treated rats was 
significantly (p = 0.031) less than that of the DMSO-treated rats at the 24 h time point. The 
result implies that there was a treatment effect within 24 h following the eccentric exercise 
bout. 
 
 
Figure 4.7 HSP72 content of red vastus muscles of DMSO and 17-AAG-treated rats (n=8 each group) 
before, 24 and 48 h following the prolonged eccentric exercise. The asterisk indicates significant 
difference (* p < 0.01; one-way ANOVA) when compared with Non-EX groups; the hash indicates 
significant difference (# p = 0.031; t-test) between EX+24h DMSO and 17-AAG-treated groups. 
Values are mean ± standard deviation. 
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Transmission electron micrographs of the red vastus muscles are presented in Figure 4.8. 
Focal myofibrillar damage is seen in the muscle samples of the rats 24 h following the 
prolonged eccentric exercise bout for both DMSO and 17-AAG-treated rats. However, such 
disruption of myofilaments and streaming of Z-lines were not evident in the muscle samples 
of the rats at 48 h after the acute eccentric exercise for both DMSO and 17-AAG-treated 
animals (Figure 4.8). Ultrastructural abnormalities were visible only in the muscle samples 
taken from DMSO-treated rats at 24 h following the exercise (Figure 4.9 (a), (b) and (c)). 
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Figure 4.8 Electron micrographs of longitudinal section of red vastus muscles of DMSO and 17-
AAG-treated rats before, 24 and 48 h following a prolonged eccentric exercise. Bars indicate 2 µm. 
17-AAG protects against ultrastructural abnormalities but not maintenance of myofibrillar integrity as 
focal myofibrillar disruption still can be seen in the red vastus of 17-AAG treated rat at 24 h following 
the eccentric exercise. 
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Figure 4.9 Electron micrographs of ultrastructural abnormalities (in white arrows) found in the red 
vastus muscles of DMSO-treated rats at 24 h following a prolonged eccentric exercise. (a) 
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Accumulation of glycogen granules. Bar indicates 1 µm. (b) Mild swelling of mitochondria and SR. 
Bar indicates 2 µm. (c) Mild dilation of transverse tubules. Bar indicates 1 µm. 
 
 
Maximal grip strength (isometric force-generating capacity) of the conscious rats was 
measured before they were sacrificed, and the values were normalized to their total body mass 
(Figure 4.10 (a) and (b)). There were no significant differences between the grip strength of 
DMSO and 17-AAG-treated rats at any time point following the prolonged eccentric exercise 
bout. However, the grip strength of the DMSO-treated rats tended to decrease progressively 
after the eccentric exercise although it was otherwise in 17-AAG-treated rats. 
 
SR Ca2+-ATPase activity was evaluated in muscle homogenates of rats with and without 
adding the ionophore A23187, and subsequently the ratio of the total Ca2+-ATPase activity in 
the presence of the ionophore to that in the absence of ionophore was computed to provide an 
index of SR membrane integrity (Figure 4.11). We did not observe any changes in SR 
membrane integrity across the experimental groups, implying that SR function was not 
influenced by the prolonged, low intensity eccentric exercise and the treatment of 17-AAG in 
the present study. Total calpain activity in red vastus of the rats is presented in Figure 4.12; 
the prolonged eccentric exercise appeared to have no significant effect on calpain activity.  
 
 
 
 
 
 
 
 
 
  82 
 (a) 
 
 
(b) 
 
Figure 4.10 (a) Maximal grip strength generated by hindlimbs of DMSO and 17-AAG-treated rats 
(n=8 each group) before, 24 and 48 h following the prolonged eccentric exercise. (b) The grip strength 
values were normalized to total body mass of the rats at the time of testing. Values are mean ± 
standard deviation. 
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Figure 4.11 SR membrane integrity (a ratio of SR Ca2+-ATPase activity in the presence of Ca2+ 
ionophore A23187 to that in the absence of Ca2+ ionophore A23187) of DMSO and 17-AAG-treated 
rats (n=8 each group) before, 24 and 48 h following the prolonged eccentric exercise. Values are mean 
± standard deviation. 
 
 
 
Figure 4.12 Total calpain activity of red vastus muscles of DMSO and 17-AAG-treated rats (n=8 each 
group) before, 24 and 48 h following the prolonged eccentric exercise. Values are mean ± standard 
deviation. 
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4.4. Discussion 
 
In the present study, we show that a single intraperitoneal injection of 17-AAG at a dose of 40 
mg.kg-1 body weight did not significantly enhance HSP72 induction in rat red vastus muscle 
at 24 h following the treatment. Our finding was contrary to the findings in the mice study of 
(Kayani et al., 2008a). They showed that the mean increase in HSP70 content of EDL 
muscles of adult mice was approximately 230-250% higher at 1 to 3 days after the treatment 
(personal communication – Anna Kayani) and remained elevated for the following 10 days 
compared with the muscles of control mice (Kayani et al., 2008a). This discrepancy may be 
explained by the tissue specificity of the HSP70 response in slow-twitch red vastus and fast-
twitch EDL muscles (Manzerra et al., 1997; Nosek et al., 2000). Potentially, physiological 
differences between mice and rats could be an explanation for differing skeletal muscle 
HSP70 responses. A recent study showed that several HSPs are up-regulated by functional 
overload of the soleus and plantaris muscles in mice and rats, and the observed time-
dependent HSPs responses are impacted by both animal species and muscle type (Huey et al., 
2010). Similarly, it is likely that 17-AAG treatment changes the protein expression levels of 
HSP72 in a time-, species-, and muscle-specific manner in the present study. 
 
Interestingly and more importantly, we found that a single dose of 17-AAG significantly 
blunted the skeletal muscle HSP72 response at 24 h following a low-intensity prolonged bout 
of eccentric exercise. This attenuation of eccentric exercise-induced skeletal muscle HSP72 
response coincided with the 48 h time point following the 17-AAG treatment. Induction of 
skeletal muscle HSP70 following acute exercise has been well documented in human (Morton 
et al., 2009c) as well as animal studies (Milne and Noble, 2002; Noble et al., 2006). Of these 
studies, an acute bout of eccentric rather than concentric contractile activity seems to induce a 
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substantially higher level of HSP70 protein and mRNA expression in skeletal muscle of both 
humans (Vissing et al., 2009; Yamada et al., 2008) and rodents (Bombardier et al., 2009). 
Numerous studies have shown that factors such as muscle glycogen store (Febbraio et al., 
2002b), antioxidant supplementation (Fischer et al., 2006; Khassaf et al., 2003), sex hormones 
(Bombardier et al., 2009; Paroo et al., 2002), age (Vasilaki et al., 2002; Vasilaki et al., 2006) 
and repeated-bout effect (Vissing et al., 2009) are associated with a reduction in exercise-
induced heat shock response. It is not entirely clear what the exact mechanism underlying 
these findings is. However, it is proposed that contractile strain and oxidative stress induced 
by exercise are the key contributors to the heat shock response and hence, the limited 
expression of HSP70 may represent a reduction in the magnitude of mechanical and cellular 
stress in the active motor units. This hypothesis is supported by evidence that exercise-
induced increase in HSP70 in both human (Liu et al., 2000) and rodent (Milne and Noble, 
2002) skeletal muscle is dependent on relative exercise intensity, while the eccentric-biased 
exercise results in a greater increase in HSP70 response than concentric exercise (Bombardier 
et al., 2009; Milne and Noble, 2002). Moreover, the heat shock response to eccentric exercise 
was attenuated concurrently with attenuation in muscle damage when eccentric exercise was 
repeated 8 weeks later (Vissing et al., 2009). Thus, we suggest that the reduced post-exercise 
HSP72 in the 17-AAG-treated animals implies a relatively low degree of mechanical and 
cellular stress inflicted by eccentric exercise in the present study. Likewise, it could be 
interpreted as an enhanced tolerance in 17-AAG-treated animals to eccentric stress imposed 
by downhill running and the inducible HSP72 might be much needed during the initial phase 
of cytoprotection in this context (Paulsen et al., 2009). Cellular changes such as activation of 
myoblasts and immune cell infiltration could have had an impact on the muscle HSP72 
response. There is evidence that proliferating myoblasts may contain substantially more heat 
shock proteins than mature myofibres (Maglara et al., 2003). It could be speculated that the 
  86 
mature myofibres were preserved in 17-AAG-treated animals while proliferating myoblasts 
were activated in the placebo-controlled group in the present study. 
 
17-AAG, the HSP90 inhibitor that was once well-known as an antitumor agent (Kim et al., 
2009; Usmani et al., 2009), primarily functions by binding with the N-terminal ATPase 
domain of HSP90 to inhibit the ATP/ADP exchange, which is essential for the formation of 
the mature HSP90 chaperone complex (Roe et al., 1999). As a result, this leads to the 
molecular signature of HSP90 inhibition: proteasomal degradation of HSP90 client proteins 
that do not achieve their functional conformation, and dissociation of HSF1 complexes 
followed by a robust induction of co-chaperone HSP70 (Kamal et al., 2004; Powers and 
Workman, 2007; Taipale et al., 2010; Whitesell et al., 2003). These cellular effects of 17-
AAG have generated the interest of many researchers to hypothesize that 17-AAG treatment 
should provide a new therapeutic agent for clinical use beyond oncological disease (Kamal et 
al., 2004). To our knowledge, an investigation of the cytoprotective effects of 17-AAG on 
neurodegenerative disorders has only been attempted in three animal studies (Kayani et al., 
2008a; Lomonosova et al., 2012; Waza et al., 2005). Whether the induction of HSP72 in 
skeletal muscle by 17-AAG treatment confers functional and structural protection against 
damaging eccentric exercise remains unresolved. In addressing this issue, Kayani et al. 
(2008a) was the first to show that treating (24-26 months) old mice 17-AAG resulted in 
improved recovery of EDL muscle force generation in situ, but not in the number of 
regenerating fibres in the muscle. The study suggested that the recovery of force generating 
capacity was associated with an increase in EDL muscle HSP70 content (Kayani et al., 
2008a). In our study, we observed no difference in muscle contractile function of 17-AAG 
and DMSO-treated adult rats before and after the acute bout of prolonged downhill running. 
Apart from the animal species and age dependent factors, this discrepancy may be explained 
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as follows. The muscle damage elicited by indirect electrical stimulation is a high-force 
lengthening protocol (Kayani et al., 2008a) that is likely to induce injury in the dorsiflexors 
(i.e. EDL), which usually yield the most degree of myofibrillar ruptures for a given repetition 
of contractions and hence a resultant chronic functional deficit (Kayani et al., 2008a). 
However, our study employed low-intensity prolonged downhill running to predispose the 
antigravity muscle groups to injury, i.e. extensors such as the relative fatigue-resistant red 
vastus. The degree of myofibrillar ruptures in our animal species (Sprague-Dawley) appears 
to be associated with body size and age (Kasperek and Snider, 1985). Since the animals used 
in the present study weighed 339.8 ± 10.6 g at 9.6 ± 0.1 weeks old when the muscle 
contractile function test was undertaken, we propose that the moderate degree of localized 
myofibrillar disruption would have only a minor transient impact on the contractile function 
of the hindlimbs in these consciously intact animals in vivo. While the in situ study of (Kayani 
et al., 2008a) demonstrated a therapeutic benefit of 17-AAG in recovery from muscle damage 
in old mice, our study provides a physiologically relevant insight into the effect of the 
treatment of 17-AAG on prolonged damaging eccentric exercise in intact young adult 
animals.  
 
The transmission electron microscopy showed focal disruption of myofibrils in both the 17-
AAG and DMSO-treated rats’ red vastus after exercise. However, there were some 
ultrastructural irregularities that were visible only in the DMSO-treated rats at 24 h following 
the downhill running bout: (1) an abnormally high accumulation of glycogen granules; (2) 
mild swelling of mitochondria and SR; and (3) mild dilation of transverse tubules. These 
ultrastructural changes following eccentric exercise in naïve rats are in agreement with the 
observation of previous studies (Chen et al., 2007d; Friden and Lieber, 1996; Takekura et al., 
2001). Whilst the 17-AAG-altered heat shock response seems to protect the myofibrils against 
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the intramyofibrillar micro-environmental irregularities, this did not extend to the 
maintenance of myofibrillar integrity. It should be noted that no functional deficit was 
observed in animals from both experimental groups following the eccentric exercise. Hence, it 
is difficult to identify the potential effect of 17-AAG on muscle contractile characteristics in 
the present study. In addition, sarcolemma and SR vesicle membrane stability appear to be 
unaffected by downhill running as previously reported (Chen et al., 2007d) although contrary 
to another report (Yasuda et al., 1997). Our data showed no significant changes in SR Ca2+-
ATPase and muscle homogenate proteolytic calpain activity. Taken together, these 
observations suggest that there might be a threshold for eccentric load to cause physiological 
disturbance in intramyofibrillar homeostasis or functional deficit in the affected skeletal 
muscle. Otherwise, the eccentric exercise protocol in the present study was insufficient to 
provoke the classic events of muscle damage (Proske and Morgan, 2001) but more likely a 
remodeling of myofibrillar architectures (Barash et al., 2002; Yu et al., 2003). The 
myofibrillar remodeling hypothesis seems plausible in view of the prophylactic effect of 
eccentric contractions against muscle damage from a repeated bout of similar exercise 
(McHugh, 2003; McHugh et al., 1999) as well as the importance of an eccentric component in 
skeletal muscle training adaptation (Morgan, 1990). There is a growing body of evidence 
concerning the involvement of HSP27, αB-crystallin or HSP70 in this “repeated-bout effect” 
(Paulsen et al., 2009; Thompson et al., 2002; Vissing et al., 2009) and long term training 
adaptation (Kayani et al., 2008b; Morton et al., 2009a; Morton et al., 2009b; Morton et al., 
2008; Ogata et al., 2009). 
 
In summary, the main finding of the present study suggests that a single dose of 17-AAG (40 
mg.kg-1 body weight) did not induce a significant amount of HSP72 in rat red vastus at 24 h 
following the intraperitoneal injection. However, the treatment did significantly reduce 
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skeletal muscle HSP72 response at 24 h following a bout of low-intensity prolonged downhill 
running exercise, which coincided with the 48 h post 17-AAG injection. The treatment also 
appeared to protect against eccentric exercise-induced intramyofibrillar microenvironmental 
irregularities at 24 h following exercise. Nevertheless, no change in post-exercise muscle 
contractile function, SR vesicle membrane integrity, and total calpain activity were evident 
between the 17-AAG and DMSO treatment. Collectively, 17-AAG-treated rats could have 
experienced lesser mechanical strain and cellular stress at 24 h following the prolonged 
eccentric exercise in the present study. 
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CHAPTER 5 – STUDY 2 
 
5.1. Introduction 
 
Glutamine is a conditionally essential and functionally versatile amino acid, which can be 
readily synthesized de novo in the body. It is abundantly stored in virtually all tissues in the 
body (Newsholme et al., 2003) and released from the skeletal muscle into the circulation 
following metabolic stress or cellular injury. Hence, it has a central role in physiological 
functions such as nitrogen transport, cellular redox regulation, protein and nucleotide 
biosynthesis (Curi et al., 2007; Hall et al., 1996; Labow and Souba, 2000). Recent evidence 
suggests that glutamine supplementation is associated with improved clinical outcomes in 
both surgical and critically ill patients (Bongers et al., 2007; Fürst et al., 2004; Griffiths, 
2001; Kelly and Wischmeyer, 2003; Melis et al., 2004; Novak et al., 2002; Wischmeyer, 
2003) although there is a conflicting result in critically ill patients with multi-organ failure 
(Heyland et al., 2013). The pioneering work on critically ill patients showed that glutamine-
mediated increase in serum HSP70 level was significantly correlated with decreased length of 
intensive care unit stay and days on mechanical ventilation (Ziegler et al., 2005).  
 
Several mechanisms underlying the glutamine-mediated cellular HSP72 response have been 
proposed by using different experimental models (Singleton and Wischmeyer, 2008; Wang et 
al., 2012). For instance, in a mouse study using an experimental sepsis model, the results 
showed that the molecular pathway by which glutamine leads to HSP72 induction in lung 
tissue appears to involve: (1) the activation of O-GlcNAc pathway; (2) subsequent HSF1 and 
Sp1 nuclear translocation; (3) promoter binding; and, (4) gene activation via reciprocal 
phosphorylation (Singleton and Wischmeyer, 2008). In a rodent study using the experimental 
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hyperthermia, it was shown that a prior induction of HSP72 in the liver with heat stress is 
necessary for subsequent glutamine-mediated hsp72 gene activation (Wang et al., 2012). 
Hence, it is plausible that the glutamine-mediated HSP72 response is tissue-specific. In 
addition, the induction of HSP72 is also dependent on whether the tissues are exposed to the 
external insults prior to, during or following the glutamine treatment. 
 
To our knowledge, published research investigating the in vivo effect of glutamine and its 
association with cellular or systemic increase in HSP72 content in intact and unstressed 
animals have been limited (Wischmeyer et al., 2001). Further, a proven mechanistic link 
between glutamine treatment and HSP72 induction in skeletal muscle has yet to be 
demonstrated. Therefore, the purposes of the present study were to investigate whether: (1) 
glutamine treatment would increase HSP72 content in plasma and skeletal muscle of intact 
animals; (2) the increase in HSP72 content was dependent on the dosage of glutamine; and, 
(3) multiple doses of glutamine treatment increase HSP72 content in tissues more than a 
single dose.  
 
We hypothesized that multiple treatments of glutamine at a higher dosage would be required 
to increase HSP72 content in various rat tissues (i.e. plasma, skeletal and cardiac muscles). A 
further hypothesis was that the increased HSP72 content would be associated with an increase 
in plasma glutamine availability, as well as skeletal muscle HSP25 and HSF1 contents. 
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5.2. Materials and Methods 
 
5.2.1. Animal handling and experimental protocol 
 
A total of 30 adult male Sprague-Dawley rats (Rattus norvegicus, 7 weeks old) with a body 
weight of ~300 g were used in this study. The rats were kept in a temperature-controlled 
(~22°C) animal house with a reverse 12 h light-dark cycle, fed with standard rat chow and 
ingested tap water ad libitum. Environment enrichment was provided in the form of cardboard 
rolls for tearing as well as PVC piping for tunneling and sleeping in the caged space. The rats 
were acclimatized to this new environment for at least 5 to 7 days. Thereafter, the animals 
were randomly divided into six experimental groups: each group of rats was treated with a 
placebo (water) or glutamine solution at a dose of either 0.5 or 0.9 g.kg-1.day-1 for only a day 
or a total of five consecutive days via oral gavage. Glutamine solution was freshly prepared 
prior to administration, using the L-alanyl-L-glutamine dipeptide (Sigma-Aldrich, MO, USA). 
We used the dipeptide form of alanyl-glutamine due to the poor solubility and instability of 
the free-form glutamine in solution (Fürst et al., 1997), as well as the practicality in preparing 
the solution for oral gavage. A gram of L-alanyl-L-glutamine dipeptide is equivalent to 0.67 g 
of glutamine. Therefore, for a dose of 0.5 and 0.9 g glutamine, 0.75 and 1.34 g of L-alanyl-L-
glutamine respectively, was mixed in aqueous solution at a concentration of 0.4 g.mL-1. For a 
rat of 350 g body weight in the high-dosage group, this amounted to the gavage of 1.18 mL of 
solution containing 0.47 g of L-alanyl-L-glutamine dipeptide. 
 
Approximately 24 h following the last treatment, rats were anaesthetized with an intra-
peritoneal injection of sodium pentobarbital (200 mg.kg-1 body weight). Once the rats were 
anaesthetized, approximately 4 mL of blood was taken via cardiac puncture into heparinized 
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test tubes and immediately the animals were sacrificed by removal of the heart. Red vastus 
muscle of the hindlimb and a portion of cardiac muscle (at the apex of the heart) of the rats 
were promptly harvested, snap frozen in a container of liquid nitrogen and stored at −80°C 
until later biochemical analysis.  
 
A schematic design of the study is presented in Figure 5.1. The study was conducted in 
compliance with the Australian Code of Practice for the Care and Use of Animals for 
Scientific Purpose. The experimental protocol was approved by the Animal Ethics Committee 
of the University of Sydney (Approval Number: C42/4-2012/1/5720).  
 
 
Figure 5.1 The schematic outline of experimental design. Note: “S” in the diamond shape denotes the 
time point at which the animals were sacrificed for both blood and muscle tissues sampling. 
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5.2.2. Plasma glutamine analysis 
 
Plasma glutamine concentration was determined using the spectrophotometric method (Lund, 
1986) and the assay kit (Cat No: GLN-1) according to the procedures recommended by the 
manufacturer (Sigma-Aldrich, MO, USA). Briefly, 300 µL plasma was added to an equal 
volume of cold 10% perchloric acid, vortexed and centrifuged for 5 min at 7,000 rpm. The 
clear supernatant was removed and 400 µL was neutralized with 58 µL KOH (5 M). The 
reaction was performed in 2 steps with unknown samples and standards (0, 0.5, 1 and 2 mM 
glutamine).  
 
In step 1, the sample (37.5 µL) was added to 30 µL of acetate buffer (0.5 M, pH 5), 15 µL 
glutaminase (10 U.mL-1) and made to a final volume of 150 µL with MilliQ water, mixed and 
incubated for 1 h at 37°C. The blank tube had no added glutaminase. In step 2, 75 µL of 
sample from step 1 was added to a solution containing Tris-EDTA-hydrazine buffer pH 9.0, 
1.5 mM NAD, 0.5 mM ADP and MilliQ water to a final volume of 300 µL in a microplate 
well. The plate was mixed and read at 340 nm using a Bio-Rad Benchmarch Plus microplate 
reader (Bio-Rad, CA, USA) (A0). Following addition of 2.8 U.mL-1 glutamate dehydrogenase 
to each well and mixing, the plate was incubated for 40 min and read again (A40). A0 was 
subtracted from A40 and the glutamine value was calculated using the standard curve, then 
the value in the blank solution that represents glutamate concentration was subtracted. 
Finally, a correction for dilution of the plasma sample was made (2 x (458 ÷ 400) = 2.29). 
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5.2.3. Plasma and muscle heat shock protein analysis 
 
Plasma, skeletal and cardiac muscles HSP72 and HSP25 were analyzed by ELISA methods 
(R and D, kit DYC1663, Minneapolis, MN, USA and Enzo Life Sciences, kit ADI-960-075, 
Farmingdale, NY, USA respectively) according to the manufacturer’s instructions. Muscle 
tissues were homogenised in Tris-buffered saline, pH 7.5 (TBS) with a Miccra D-1 
homogeniser (Germany), then an extraction buffer was added to give a final concentration of 
0.15 M NaCl, 50 mM Tris, 5 mM EDTA, 2 mM ethylmaleimide, 2 mM PMSF, 1% Igepal, 1 
µg.mL-1 leupeptin, and 1 µg.mL-1 pepstatin (Noguchi et al., 1997); the homogenate was then 
centrifuged at 12,000 g for 20 min at 4°C. Before analysis, an aliquot was analyzed for 
protein concentration (Markwell et al., 1978). 
 
5.2.4. Skeletal muscle HSF1 Western blot 
 
Briefly, red vastus muscle was homogenized using a Miccra D-1 homogeniser (Germany) in a 
10:1 (volume-to-weight) ratio of ice-cold extraction buffer containing 10 mM Tris-HCl (pH 
7.4); 100 mM NaCl; 1 mM each of EDTA, EGTA, NaF and phenylmethylsulfonyl fluoride; 2 
mM Na3VO4; 20 mM Na4P2O7; 1% Triton X-100; 10% glycerol; 0.1% SDS; 0.5% 
deoxycholate; and 10 µL.mL-1 Sigma P8340 protease inhibitor cocktail. Following 
homogenization, samples were kept on ice for 30 min with vortexing at 10 min intervals. 
Extracted red vastus samples were added to the sample buffer (3.8 mL milliQ water, 1.0 mL 
0.5 M Tris pH 6.8, 0.8 mL glycerol, 1.6 mL 10% SDS, 0.4 mL 2-mercaptoethanol, 0.4 mL 
1% bromophenol blue) to dilute all the samples to 1 mg.mL-1 and heated for 20 min at 65°C. 
The extracts were then applied to an acrylamide gel (10% gel with a 4% stacking gel). 
Electrophoresis was performed at 200 V for 1 h. The proteins were then transferred to 
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nitrocellulose at 100 V for another hour at 4°C. Thereafter, the nitrocellulose was blocked 
with 5% non-fat milk in TBS for 1 h, washed with TBS plus 0.05% Tween-20, and incubated 
with an antibody specific for HSF1 (HSF1 Cat No ADI-SPA-950, Enzo Life Sciences Inc., 
Farmingdale, NY, USA) in 1% non-fat milk in TBS overnight at 4°C. The following day, the 
blot was washed and incubated with peroxidase-anti rat conjugate A9044 (Sigma, St. Louis, 
MO, USA) in 1% non-fat milk in TBS for 2 h at room temperature. Next, the bands were 
visualized by chemiluminescence (Immobilon HRP substrate at No WBKLSO100 Millipore, 
MA, USA) using a Bio-Rad XRS+ Chemidoc System and quantitated using Image Lab 
Version 3.0 software (Bio-Rad, CA, USA). The six experimental conditions for the red vastus 
tissue were run on the same blot in duplicate, and the extract from one rat was included on all 
gels as a positive control so that a comparison could be made between the samples. 
 
5.2.5. Statistical analysis 
 
All data are presented as mean and standard deviation or otherwise stated. Data from the 
sham-controlled rats were pooled, as we did not expect any placebo effect in response to a 
single and multiple water treatments in terms of circulatory as well as cellular heat shock 
response. A one-way between-groups analysis of variance (ANOVA) was used to determine 
the effect size of the experimental treatments on tissue specific physiological adjustments. 
When a significant F value was observed, the LSD post-hoc analysis was run to identify the 
differences between the treatment groups. Correlations between each test variables were also 
tested and the correlation coefficient was compared using the Pearsons r value to determine 
the significance. Statistical analysis was conducted using SPSS Version 21 and the level of 
significance was set at p < 0.05 for all comparisons. 
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5.3. Results 
 
The physical characteristics of the animals and the treatment they received are shown in 
Table 5.1. The mean age of the animals and the final body weight prior to euthanasia did not 
differ between the groups.  
 
Table 5.1 Physical characteristics of the animals treated with placebo (Control), a single dose (1x) or 
five daily (5x) doses of glutamine at 0.5 g (Low) or 0.9 g (High) per kilogram of body weight. Values 
are mean ± standard deviation. 
 Control 1x Low 1x High 5x Low 5x High 
N 6 6 6 6 6 
Age (weeks) 8.5±0.5 9.2±0.8 9.2±0.8 9.0±0.9 9.0±0.9 
Weight (g) 335.2±30.7 344.6±13.9 355.3±25.9 336.6±30.9 325.9±22.9 
 
 
This study aimed to determine if glutamine treatment would increase plasma, skeletal and 
cardiac muscles HSP72 level in intact animals. Our results show that there were no significant 
changes in plasma, red vastus and heart HSP72 level in glutamine-treated rats when compared 
with placebo-controlled animals (Figure 5.2, 5.3 and 5.4).  
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Figure 5.2 Plasma HSP72 concentration of rats treated with placebo (Control), a single dose (1x) or 
five daily (5x) doses of glutamine at 0.5 g (Low) or 0.9 g (High) per kilogram of body weight. Values 
are mean ± standard deviation, n = 6 for each group. 
 
 
 
Figure 5.3 Red vastus HSP72 content of rats treated with placebo (Control), a single dose (1x) or five 
daily (5x) doses of glutamine at 0.5 g (Low) or 0.9 g (High) per kilogram of body weight. Values are 
mean ± standard deviation, n = 6 for each group. 
 
0.0 
0.5 
1.0 
1.5 
2.0 
2.5 
3.0 
Control 1x Low 1x High 5x Low 5x High 
Pl
as
m
a 
H
SP
72
 (n
g.
m
L-
1 )
 
0.000 
0.005 
0.010 
0.015 
0.020 
0.025 
0.030 
Control 1x Low 1x High 5x Low 5x High 
R
ed
 V
as
tu
s 
H
SP
72
 (n
g.
µg
-1
 p
ro
te
in
) 
  99 
 
Figure 5.4 HSP72 content in the heart of the rats treated with placebo (Control), a single dose (1x) or 
five daily (5x) doses of glutamine at 0.5 g (Low) or 0.9 g (High) per kilogram of body weight. Values 
are mean ± standard deviation, n = 6 for each group. 
 
 
Interestingly, a one-way between groups ANOVA revealed that there was a statistically 
significant difference in plasma glutamine concentration between the five different 
experimental treatment groups: F (4, 25) = 3.2, p = 0.029, with a large effect size of 0.34. 
Post-hoc comparisons using the LSD test indicated that plasma glutamine concentration of the 
rats were significantly elevated following 5 consecutive days of treatments at both low 
(0.80±0.12 mM, p = 0.017) and high (0.79±0.12 mM, p = 0.028) dosages when compared 
with their littermates treated with purified water as placebo controls (Figure 5.5). In addition, 
we observed that plasma glutamine concentration of rats administrated with a single high dose 
(0.9 g.kg-1.day-1; 0.76±0.03 mM, p = 0.099) rather than low dose (0.5 g.kg-1.day-1; 0.68±0.06 
mM, p = 0.931) of glutamine treatment tended to be higher than control rats (0.67±0.09 mM). 
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Figure 5.5 Plasma glutamine concentration of rats treated with placebo (Control), a single dose (1x) or 
five daily (5x) doses of glutamine at 0.5 g (Low) or 0.9 g (High) per kilogram of body weight. The 
asterisk indicates a significant difference was evident (p < 0.05; post-hoc LSD) when compared with 
Control and 1x Low groups. Values are mean ± standard deviation, n = 6 for each group. 
 
 
We subsequently examined the in vivo effects of glutamine treatment on the HSP25 protein 
content in the red vastus and heart of the rats. There was no significant difference in the red 
vastus HSP25 content across the experimental groups of rats (Figure 5.6). However, the 
results showed there was statistically significant difference in cardiac HSP25 levels between 
each group: F (4, 25) = 4.3, p = 0.08, with a large effect size of 0.33 (Figure 5.7). Post-hoc 
comparisons using LSD test revealed that when compared with the cardiac HSP25 of control 
rats (0.063±0.013 ng.µg-1), oral glutamine administration suppressed the HSP25 protein 
induction in cardiac muscle of rats treated with a single high dosage (0.046±0.005 ng.µg-1, p = 
0.001) as well as both five daily treatments of glutamine at low (0.049±0.009 ng.µg-1, p = 
0.007) and high (0.047±0.005 ng.µg-1, p = 0.003) doses. 
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Figure 5.6 Red vastus HSP25 content of rats treated with placebo (Control), a single dose (1x) or five 
daily (5x) doses of glutamine at 0.5 g (Low) or 0.9 g (High) per kilogram of body weight. Values are 
mean ± standard deviation, n = 6 for each group. 
 
 
 
Figure 5.7 HSP25 content in the heart of rats treated with placebo (Control), a single dose (1x) or five 
daily (5x) doses of glutamine at 0.5 g (Low) or 0.9 g (High) per kilogram of body weight. The double-
asterisk indicates significant difference (p < 0.01; post-hoc LSD) when compared with Control group. 
Values are mean ± standard deviation, n = 6 for each group. 
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Lastly, we found that there was a statistically significant difference in the red vastus HSF1 
content of the rats across all groups following the glutamine treatment: F (4, 25) = 3.1, p = 
0.032, with a considerable large effect size of 0.50 (Figure 5.8). Post-hoc comparisons using 
the LSD test indicated that the red vastus HSF1 induction of the rats was significantly 
inhibited following a single high (0.44±0.26 AU, p = 0.023) and five daily low (0.35±0.10 
AU, p = 0.008) dosages of glutamine treatment when compared with their littermates treated 
with purified water as placebo controls (0.93±0.57 AU). Further, the red vastus HSF1 content 
of the rats administrated with a low dose of glutamine was significantly lower in the five daily 
doses than a single treatment group (0.85±0.38 AU, p = 0.021). 
 
 
 
Figure 5.8 Red vastus HSF1 content (arbitrary unit relative to a standard control) of rats treated with 
placebo (Control), a single dose (1x) or five daily (5x) doses of glutamine at 0.5 g (Low) or 0.9 g 
(High) per kilogram of body weight. The asterisk indicates a significant difference (p < 0.05; post-hoc 
LSD) when compared with the Control group and the hash indicates a significant difference (p < 0.05; 
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post-hoc LSD) when compared with 1x Low group. Upper panel is a representative immunoblot of 
HSF1. Values are mean ± standard deviation, n = 6 for each group. 
 
 
5.4. Discussion 
 
The major finding of this study was that circulating, as well as skeletal and cardiac muscles 
HSP72 levels were unchanged in vivo with oral glutamine treatment, despite plasma 
glutamine concentration being elevated by multiple treatments of glutamine at both low and 
high doses in intact animals. While skeletal muscle HSP25 was not responsive to circulatory 
glutamine availability, the cardiac HSP25 and skeletal muscle HSF1 protein induction were 
suppressed with a single high dose as well as multiple low or high doses of glutamine 
treatment in rats. Interestingly, red vastus HSF1 of the rats treated with multiple high doses of 
glutamine was not blunted even though their plasma glutamine concentrations were equally 
elevated as those animals treated with multiple low doses of glutamine. This finding may 
imply that the skeletal muscle HSF1 response in intact animals was: (1) dependent on plasma 
glutamine concentration when glutamine was enterally administrated; and (2) not associated 
with the HSP72 induction in other tissues such as plasma, skeletal or cardiac muscles. In 
addition, the suppressing effect of multiple low doses of glutamine on skeletal muscle HSF1 
protein induction disappears as doses increase. 
 
Our finding of increased plasma glutamine availability in the intact and healthy rats at 24 h 
following the oral glutamine treatment was, in agreement with previous studies in humans 
(Boza et al., 2000a; Hankard et al., 1995; Valencia et al., 2002), horses (Harris et al., 2006), 
and rodents (Meynial-Denis et al., 2013; Rogero et al., 2004), but contrary to another rat 
study (Boza et al., 2000b). The discrepancy between the results of the present study and 
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previous findings (Boza et al., 2000b), firstly, could be due to the dose and method of 
glutamine administration as well as the age of the animals used in the experiment. Boza et al. 
(2000b) found that feeding the weaning Wistar rats with 15% glutamine-supplemented diet 
for 3 weeks, did not lead to an increase in plasma glutamine concentration at 24 h following 
the last treatment. Secondly, the timing of glutamine administration may have also 
contributed to the difference in the peaking of plasma glutamine concentration following the 
treatment. It has been reported that animals acutely supplemented with free and dipeptide 
forms of glutamine showed an increase in resting plasma glutamine concentration within 90 
to 120 min of administration (Rogero et al., 2004). In addition, the same study also showed 
that a 21-day L-alanyl-L-glutamine dipeptide supplementation significantly increase 
glutamine level in gastrocnemius muscle as well as liver tissue (Rogero et al., 2004).  
 
An unexpected finding of the present study was that oral glutamine treatment and ensuing 
increased circulating glutamine availability had no impact on plasma as well as striated 
muscle HSP72 level. Several factors may contribute to the discrepancy of our findings and the 
results of another study (Wischmeyer et al., 2001), with particular regard to the cardiac 
muscle HSP72 and HSP25 induction in the unstressed animals. First, the effect of oral 
glutamine treatment may be tissue specific. Previously, a similar dose (five once-daily dose of 
0.5 g.kg-1) of oral glutamine administration has been shown to significantly enhance lung 
HSP72 protein induction in rodents (Singleton and Wischmeyer, 2006). Second, the route of 
glutamine administration may influence the action of plasma glutamine on heat shock 
response. Glutamine was administrated to the conscious animals in ~1 mL aqueous solution 
via oral gavage in our study; whereas, it was infused in a 3% lactated Ringer solution via the 
lateral tail vein of anesthetized animals at a rate of 0.5 mL.min-1 for 10 to 20 min 
(Wischmeyer et al., 2001). Third, it is possible though unlikely that the preparation of 
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glutamine in dipeptide (i.e. L-alanyl-L-glutamine) or free form (i.e. mixture of L-alanine and 
L-glutamine) would yield different results with the skeletal muscle HSP72 response. It has 
been shown that, in the trained rats, chronic oral supplementation with glutamine both in 
dipeptide or free form represents an effective means in elevating the skeletal muscle 
glutamine stores as well as HSP72 and HSF1 content (Petry et al., 2014). Finally, in contrast 
to heat-stressed animals in previous studies, animals in our study were not exposed to any 
external stressors. Other physiological insults that are commonly known to induce a heat 
shock response that is observed with hyperthermia (Singleton and Wischmeyer, 2006; Wang 
et al., 2012; Xue et al., 2012) include ischemia-reperfusion (Murphy et al., 2007), sepsis 
(Wischmeyer et al., 2001), or physical exercise (Petry et al., 2014).  
 
Our finding of blunted red vastus HSF1 induction in untrained animals treated with a single 
high dose (1.34 g.kg-1) and five once-daily low doses (0.75 g.kg-1) glutamine dipeptide, 
appears to contradict the results of previous study (Petry et al., 2014). In that study, 21 days of 
oral glutamine supplementation at a dose of 1.5 g.kg-1 in dipeptide form, significantly 
increased cytosolic and nuclear HSF1 in both soleus and gastrocnemius muscles of the trained 
rats (Petry et al., 2014). This discrepancy, nevertheless, provides further insight that the 
glutamine-mediated skeletal muscle HSF1 response is independent of the glutamine 
availability in the muscle rather than circulation. In addition, exercise training seems to play a 
role in the glutamine-dependent HSF1 response, probably by reciprocal enhancement of O-
GlcNac pathway and subsequent O-Glycosylation and phosphorylation of other proteins in 
the skeletal muscle (Singleton and Wischmeyer, 2008). On the other hand, HSF1 is 
responsible for mediating the HSP72 induction in response to whole body stress (Pirkkala et 
al., 2001). Hence, the lack of HSF1 induction in the glutamine-treated and non-stressed 
animals in the present study may account for negative induction of HSP72 in plasma as well 
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as striated muscles. Nevertheless, it has been shown that oral glutamine treatment up-
regulated colonic mucosal HSF1 induction in healthy rats (Xue et al., 2012).  
 
The suppression of cardiac HSP25 induction following the oral glutamine treatment was 
unexpected and contrary to a previous study (Chamney et al., 2013). In both sham-controlled 
and spinal cord injured mice, Chamney et al. (2013) observed no effect of seven once-daily 
parental glutamine treatments on cardiac HSP25 content. The reduced cardiac HSP25 content 
in the present study suggests that oral glutamine administration can be effective in reducing 
the stress experienced by cardiac muscle in healthy and sedentary animals. However, the 
reason this beneficial effect of glutamine did not extrapolate to red vastus muscle HSP25 
response remains unknown. 
 
In conclusion, a higher dose of oral glutamine treatment does not enhance plasma or striated 
muscles HSP72 protein induction; and, further treatment with more small doses does not 
necessarily translate to an increase in HSP72 content either. However, multiple oral glutamine 
treatment, regardless of dose, results in increased plasma glutamine availability and is 
associated with reduced skeletal muscle HSF1 as well as cardiac HSP25 induction. Future 
research should investigate the effects of multiple oral glutamine treatment and the heat shock 
response during the mechanical stress such as eccentrical-biased exercise. 
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CHAPTER 6 – STUDY 3(A) 
 
6.1. Introduction 
 
Our preliminary study (Chapter 5) found that multiple aliquots of glutamine administration 
was more effective in increasing circulating glutamine concentration than a single treatment. 
This was despite the fact that no enhancement in circulating or striated muscle HSP72 
induction evident in sedentary unstressed rats. Thus, the present study was designed to 
investigate the effect of multiple oral glutamine administration on circulating and skeletal 
muscle HSP72 response in intact animals following prolonged eccentric exercise.  
 
In vitro and in vivo studies have shown that glutamine treatment can protect striated muscles 
and/or connective tissues against injuries of various forms, such as sepsis (Meador and Huey, 
2009), heat stress (Morrison et al., 2006; Peng et al., 2006), ischemia-reperfusion (Alves et 
al., 2010; Khogali et al., 1998; Khogali et al., 2002; Murphy et al., 2007; Prem et al., 1999; 
Sufit et al., 2012; Wischmeyer et al., 2003), orthopedic surgery (Murphy et al., 2012), and 
spinal cord transection (Chamney et al., 2013). Of interest to us was the research reporting 
that glutamine supplementation was effective in attenuating the magnitude of functional 
impairment and other adverse physiological changes. These beneficial effects of glutamine 
were observed following eccentric exercise in a human study (Street et al., 2011) as well as 
exhaustive exercise in experimental animal studies (Cruzat et al., 2010; Cury-Boaventura et 
al., 2008; Lagranha et al., 2008a; Lagranha et al., 2005; Lagranha et al., 2007; Lagranha et al., 
2008b; Lagranha et al., 2004). In contrast to these findings, other studies showed that 
glutamine supplementation does not affect the muscle damage profiles in healthy untrained 
male subjects following a session of resistance exercise (Candow et al., 2001; Mero et al., 
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2009; Ramallo et al., 2013). The discrepancy between the findings on the effects of glutamine 
on muscle damage is not entirely understood but could be possibly linked to the action of 
glutamine and cellular HSP72 response in skeletal muscle (Lightfoot et al., 2009). 
 
The HSP70 family of heat shock proteins are evolutionary conserved functional proteins in all 
eukaryotes and prokaryotes cell; their expression is increased when cells are exposed to heat 
shock or other stress-induced states (Feder and Hofmann, 1999; Parsell and Lindquist, 1993). 
The increase in the inducible form of HSP70, i.e. HSP72, has a thermotolerance or cross-
protection effect, e.g. increase in HSP72 content in heart tissue following heat stress confers 
protection in the heart against ischemic injury (Benjamin and McMillan, 1998; Latchman, 
2001). It has been proposed that glutamine is a potent enhancer of HSP72 induction in vitro 
(Nissim et al., 1993; Sanders and Kon, 1991) and in vivo (Wischmeyer, 2002; Wischmeyer et 
al., 2001). There are several possible explanations for the mechanisms by which glutamine 
enhances cellular HSP72 induction: (1) increased HSP70 promoter activity; (2) increased 
stability of HSP70 mRNA and hence increased translation; and (3) decreased stress protein 
turnover (Wischmeyer, 2002). Nevertheless, a proven mechanistic link between glutamine-
mediated HSP72 induction and cellular protection in skeletal muscle has yet to be 
demonstrated. 
 
It has been well documented that intramuscular glutamine stores are depleted following 
catabolic insults such as traumatic injury or sepsis (Biolo et al., 2005; Hall et al., 1996; 
Labow and Souba, 2000), and are an indication that the de novo synthesis of intramuscular 
glutamine to meet the severe stressful conditions is compromised. Hence, it is plausible that 
glutamine administration would increase the extracellular glutamine level while maintaining 
the intracellular store, leading to enhanced HSP72 induction in skeletal muscle following a 
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bout of damaging exercise. Eventually, the glutamine-enhanced HSP72 response should 
provide resistance against the EIMD. In the present study, we hypothesized that glutamine-
mediated skeletal muscle protection and improved recovery following damaging exercise is 
dependent on HSP72 expression and associated with increased HSP25 and HSF1 levels. 
 
6.2. Materials and Methods 
 
6.2.1. Animal handling and experimental protocol 
 
A total of 45 adult male Sprague-Dawley rats (Rattus norvegicus, ~11 weeks old) with a body 
weight of ~345 g were used in this study. Rats were kept in a temperature-controlled (~22°C) 
animal house with a reverse 12 h light-dark cycle, fed with standard rat chow and tap water ad 
lib. Environmental enrichment was provided in the form of cardboard rolls for tearing as well 
as PVC piping for tunneling and sleeping in the caged space. The rats were acclimatized to 
this new environment for at least 5 to 7 days.  
 
Thereafter, the animals were randomly divided into two experimental treatment groups: half 
the rats were treated with glutamine solution at a dose of 0.9 g.kg-1.day-1 (Cruzat et al., 2010; 
Singleton and Wischmeyer, 2006) for five consecutive days via oral gavage (GLN), whereas 
the other group served as a placebo control and was gavaged with purified water of equivalent 
volume (H2O). Glutamine solution was freshly prepared prior to the administration, using L-
alanyl-L-glutamine dipeptide (Sigma-Aldrich, MO, USA). A gram of L-alanyl-L-glutamine 
dipeptide is equivalent to 0.67 g of glutamine. Therefore, for a dose of 0.9 g glutamine, 1.34 g 
of L-alanyl-L-glutamine was mixed in aqueous solution at a concentration of 0.4 g.mL-1. For 
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a rat of 350 g body weight, this amounted to the gavage of 1.18 mL of solution containing 
0.47 g of L-alanyl-L-glutamine dipeptide. 
 
An hour after the last glutamine or placebo treatment, rats from each of the experimental 
treatment groups were further assigned into one of the three sub-groups: which were 
euthanized before (non-exercise, Non-EX), or at 4 h (4 h post exercise, EX+4h) or 24 h (24 h 
post exercise, EX+24h) following a prolonged bout of eccentric exercise. In addition, all rats 
were subjected to a grip strength test before they were euthanized for subsequent blood and 
tissues sampling.  
 
A schematic design of the study is presented in Figure 1. The study was conducted in 
compliance with the Australian Code of Practice for the Care and Use of Animals for 
Scientific Purpose. The experimental protocol was approved by Animal Ethics Committee of 
the University of Sydney (AEC Approval Number: C42/11-2012/1/5865). 
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Figure 6.1 The experimental design of the study. Note: “S” in the diamond shape denotes the time 
point at which the animals were sacrificed for both blood and muscle tissue sampling; “EX” in the 
oval shape denotes prolong eccentric exercise bout, i.e. downhill treadmill running.  
 
 
6.2.2. Prolonged eccentric exercise  
 
The rats in the eccentric exercise group undertook intermittent downhill running exercise on a 
motorized treadmill, at a speed of 20 m.min-1 and a gradient of 20° decline for a total of 90 
min: 5 min running interspersed with 2 min recovery for a total of 18 bouts (Armstrong et al., 
1983b; Chen et al., 2007d). Rats were encouraged to keep on running through audible and 
physical stimulus (e.g. hand prodding or brushing the tail). It is essential to ensure the rats run 
at steady pace at the front of the treadmill, because any changes in their running pattern would 
significantly affect the metabolic steady-state conditions (Armstrong et al., 1983a). The 
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exercise performance of the rats on the treadmill was subjectively evaluated; the rats’ 
enthusiasm and preparedness to run as well as the amount of encouragement required to 
motivate them to sustain running was rated on a scale of 0 to 2 (poor, average and good, 
respectively). A score of two points was given for each 5-min bout when the rats were 
voluntarily running with minimal encouragement; one point was given for those animals that 
needed constant encouragement; and no point for those that did not finish the 5-min bout even 
with the strong and constant encouragement. A similar index has been used in a previous 
study to quantify the downhill running performance in rats (Dawson et al., 2002). 
 
6.2.3. Assessment of muscle contractile function 
 
Please refer to Chapter 4, Section 4.2.2.  
 
6.2.4. Preparation of blood and tissues samples  
 
Approximately 4 mL of blood was sampled via open cardiac puncture into a heparinized tube. 
The sample was centrifuged at 3,400 rpm for 10 min at room temperature and the plasma 
obtained was stored at −80°C until later analysis for selected blood markers. Upon euthanasia, 
muscle tissues of both hindlimbs of the rats were promptly harvested, rinsed in saline, blotted 
dry and snap frozen in a container of liquid nitrogen and stored at −80°C until later 
biochemical analysis. The red vastus muscles were sampled for the analysis of heat shock 
response (HSP72, HSP25 and HSF1). Previous studies have shown that this deeply located, 
predominantly slow-twitch muscle group (red vastus) of rats is damaged most in downhill and 
uphill, but not level running (Armstrong et al., 1983b; Komulainen et al., 1994; Salminen and 
Vihko, 1983). 
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6.2.5. Plasma and skeletal muscle heat shock proteins analysis 
 
Please refer to Chapter 5, Section 5.2.3. 
 
6.2.6. Skeletal muscle HSF1 Western blot 
 
Please refer to Chapter 5, Section 5.2.4. 
 
6.2.7. Histological analysis 
 
Red vastus of the hindlimb was dissected and the mid-belly portion of each muscle was cut 
transversely to the long axis of the muscle. Then, the muscle was immediately frozen in 
isopentane cooled by liquid nitrogen. Transverse cross sections (~8 µm thick) of the muscle 
were cryo-sectioned using a cryostat (Leica CM1900UV, Germany) at −20°C. The specimens 
were then collected on a slide and warmed at 37°C for 5 min before staining with 
hematoxylin and eosin. Histological features of myofibrillar damage on the stained specimen 
were viewed at 20x magnification and photographed using a light microscope (Olympus 
BX51/DP71, Japan). Thereafter, muscle morphological changes were analyzed qualitatively 
on the muscle specimens of rats from each experimental group (two rats for each group due to 
technical constraint) using analySiS Life Science Series software (Soft Imaging System, 
Olympus, Japan).  
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6.2.8. Statistical analysis 
 
All data are presented as mean and standard deviation or otherwise stated. A two-way 
between-groups analysis of variance (ANOVA) was used in detecting the significant 
interaction effect of two treatments (placebo and glutamine) and three exercise conditions 
(non-exercise, 4 h and 24 h post eccentric exercise). Equality of variance was determined 
using Levene’s test. When a significant F value was observed for the main effects and their 
interaction, the one-way between-groups ANOVA with LSD post-hoc analysis was run to 
identify the differences between the non-exercise and eccentric exercise groups; whereas, 
significance of the difference between the treatment groups was assessed through the 
Student’s independent t-test. Pearson product-moment correlation coefficient was used to 
determine the relationships between the plasma HSP72 and heat shock response in red vastus 
muscle. Statistical analysis was conducted using SPSS Version 21 (IBM Inc, USA) and the 
level of significance was set at p < 0.05 for all comparisons. In cases in which the 
homogeneity of variance assumption was violated (e.g. in red vastus HSP72 and HSP25 data), 
the statistical significance level was set at p < 0.01 for the LSD post-hoc test, whereas the t-
value for unequal variance adjustment was used in the t-test. 
 
6.3. Results 
 
The physical characteristics of the animals are shown in Table 6.1. The mean age of the 
animals and the final body mass prior to euthanasia did not differ between the experimental 
treatment groups. In addition, the subjective rating of exercise performance (EX Score) of rats 
undertaking downhill treadmill running was not different between the groups. There was no 
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significant difference in maximal hindlimb grip strength (Figure 6.2) between any of the 
experimental groups.  
 
Table 6.1 Physical characteristics and exercise performance of the animals treated with an equivalent 
amount of purified water (Placebo) or five once-daily gavage of glutamine (0.9 g.kg-1), without 
exercise (Non-EX) as well as exercise with 4 h (EX+4h) and 24 h (EX+24h) recovery. Values are 
mean ± standard deviation. 
 Placebo Glutamine 
 Non-EX EX+4h EX+24h Non-EX EX+4h EX+24h 
N 7 8 8 8 8 6 
Age (wks) 11.1±1.7 11.4±1.6 11.6±1.4 10.9±1.6 11.0±1.4 11.8±1.5 
Mass (g) 342.8±42.5 339.1±54.2 339.1±42.3 364.8±40.1 346.9±46.6 332.7±42.2 
EX Score - 1.7±0.3 1.6±0.2 - 1.7±0.3 1.7±0.3 
 
 
 
Figure 6.2 Maximal hindlimb grip strength of placebo and glutamine-treated rats (n = 6 to 8 each 
group) before, 4 and 24 h following the prolonged eccentric exercise. Values are mean ± standard 
deviation. 
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The light micrographs of hematoxylin and eosin stained muscle specimens revealed a normal 
pattern in all Non-EX rats (Figure 6.3 (a) and (b)). Myofibrillar abnormalities such as 
infiltration of mononuclear cells, fibre enlargement and degenerating fibres (Figure 6.3 (b)) 
were observed under the light micrographs in EX+4h and EX24h rats of both placebo- and 
glutamine-treated rats. Interesting, myofibre degeneration was observed in one of the 
glutamine-treated rats (Series 6) at 24 h following the eccentric exercise (Figure 6.3 (b)).  
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Figure 6.3 (a) Light micrographs of cross sections of red vastus muscles of placebo and glutamine-
treated rats (Series 5) before, 4 and 24 h following prolonged eccentric exercise. Magnification = 20x. 
 
 
 
  118 
 
 Placebo-treated Rats (Series 6) Glutamine-treated Rats (Series 6) 
N
on
-E
X
 
  
E
X
+4
h 
  
E
X
+2
4h
 
  
Figure 6.3 (b) Light micrographs of cross section of red vastus muscles of placebo and glutamine-
treated rats (Series 6) before, 4 and 24 h following prolonged eccentric exercise. Magnification = 20x. 
Arrows indicate degenerating fibres. 
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We observed a statistically significant main effect of eccentric exercise on plasma HSP72 
concentration: F (2, 39) = 4.50, p = 0.017, with a small effect size of 0.19 (Figure 6.4). 
Further analysis using one-way ANOVA indicated that the mean plasma HSP72 
concentration for placebo-treated rats was significantly different (p = 0.035) between 4 h and 
24 h following the downhill treadmill running. There was also a trend (p = 0.067) for the 
plasma HSP72 concentration to be higher 4 h following the downhill running compared with 
the non-exercising control rats. 
  
 
Figure 6.4 Plasma HSP72 concentration of placebo and glutamine-treated rats (n = 6 to 8 each group) 
before, 4 and 24 h following the prolonged eccentric exercise. The dagger mark indicates significant 
difference († p < 0.05; one-way ANOVA) when compared with the EX+4h group. Values are mean ± 
standard deviation. 
 
 
The main effect for eccentric exercise on red vastus HSP72 content was observed: F (2, 38) = 
26.98, p < 0.001, with a substantially large effect size of 0.59 (Figure 6.5). When examined 
separately using one-way ANOVA, we found that HSP72 content in red vastus of placebo-
treated rats was significantly elevated (p ≤ 0.005) at both 4 h and 24 h following the downhill 
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treadmill running, while the HSP72 content was higher (p = 0.048) at 24 h than 4 h post 
exercise. On the other hand, HSP72 content in red vastus of glutamine-treated rats was higher 
at 24 h following the downhill running when compared with non-exercising controls (p < 
0.001) and those exercising rats with 4 h recovery period (p = 0.001). There were no 
differences in red vastus HSP25 (Figure 6.6) or HSF1 (Figure 6.7) induction between any of 
the experimental groups. 
 
 
Figure 6.5 Red vastus HSP72 content of placebo and glutamine-treated rats (n = 6 to 8 each group) 
before, 4 and 24 h following the prolonged eccentric exercise. The asterisk marks indicate significant 
difference (** p < 0.01; one-way ANOVA) when compared with the Non-EX groups; the dagger 
marks indicate significant difference († p < 0.05 and ‡ p < 0.01; one-way ANOVA) when compared 
with the EX+4h group. Values are mean ± standard deviation.  
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Figure 6.6 Red vastus HSP25 content of placebo and glutamine-treated rats (n = 6 to 8 each group) 
before, 4 and 24 h following the prolonged eccentric exercise. Values are mean ± standard deviation.  
 
 
 
Figure 6.7 Red vastus HSF1 content of placebo and glutamine-treated rats (n = 6 to 8 each group) 
before, 4 and 24 h following the prolonged eccentric exercise. A representative immunoblot is shown 
in the upper panel. Values are mean ± standard deviation. 
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6.4. Discussion 
 
This study aimed to investigate if glutamine treatment would alter plasma and skeletal muscle 
HSP72 level in intact animals (rodents) subjected to a prolonged bout of eccentric exercise, 
i.e. downhill treadmill running. We hypothesized that oral glutamine administration would 
increase the plasma and red vastus HSP72 level in the rats, in which the induced HSP72 
would protect against EIMD. We also hypothesized that the protective effect of HSP72 would 
be associated with a parallel increase in skeletal muscle HSP25 and HSF1 content. The 
primary finding of the study was that a prolonged bout of moderate-intensity eccentric 
exercise does not necessarily manifest any signs of muscle damage (e.g. reduced muscle 
contractile strength or increased plasma creatine kinase level), despite it increases HSP72 
induction in red vastus muscle within 24 h following the exercise. Interestingly, the highest 
plasma HSP72 concentration was only observed in placebo-treated rats at 4 h following the 
eccentric exercise, which was significantly decreased from the peak level about ~20 h later. In 
addition, oral glutamine treatment does not seem to have any discernible effect on cellular 
heat shock response in healthy animals subjected to prolonged eccentric exercise. 
 
The increased red vastus HSP72 induction following eccentric exercise was in line with the 
results of our previous study (Chapter 4) as well as others (Milne and Noble, 2002; Morton et 
al., 2009c; Noble et al., 2006). Interestingly, we found an inverse reduction in the plasma 
HSP72 concentration at 24 h post exercise, during which the red vastus HSP72 content was at 
the peak in the placebo-controlled rats. The presence of post-exercise extracellular HSP72 has 
been implicated as a signal of danger to cellular insults (De Maio, 2011; De Maio and 
Vazquez, 2013), an immune response (Whitham and Fortes, 2008) and a fatigue sensor in the 
central nervous system (Heck et al., 2011). The trend of post-exercise plasma HSP72 
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response in our study seemed to resemble the finding of the pioneering human study that 
examined the effect of acute exercise on HSP72 level in the blood (Walsh et al., 2001). The 
exact mechanism underlying the release of HSP72 into the extracellular compartment is not 
entirely understood. However, in the present study we observed that the peaking of plasma 
HSP72 response in the placebo-controlled rats preceded the increase in their skeletal muscle 
HSP72 response. This observation appeared to be in agreement with the evidence that 
hepatosplanchnic tissues release HSP72 during exercise and partly contribute to the elevated 
circulating HSP72 in human (Febbraio et al., 2002a). The significant reduction in plasma 
HSP72 concentration was not detected in glutamine-treated rats within 4 to 24 h following the 
eccentric exercise, thus we speculate that the effect of eccentric exercise-mediated release of 
extracellular HSP72 could had been blunted in the glutamine-treated rats when compared with 
placebo-controlled rats. Alternatively, it is possible that glutamine treatment mediates a 
decrease in the stress protein turnover (Wischmeyer, 2002) within the 4 h duration following 
the eccentric exercise, leading to no apparent increase in plasma as well as red vastus HSP72 
levels of placebo-controlled rats. 
 
Contrary to a previous study (Petry et al., 2014), we observed no enhancing effect of 
glutamine treatment on plasma or skeletal muscle HSP72 induction. We further observed no 
protective effect of glutamine on functional impairment and adverse physiological changes 
following the eccentric exercise (Cruzat et al., 2010; Cury-Boaventura et al., 2008; Lagranha 
et al., 2008a; Lagranha et al., 2005; Lagranha et al., 2007; Lagranha et al., 2004; Street et al., 
2011). The discrepancy could be due to the following factors. First, we used animals that 
were naïve to treadmill exercise in our study whereas others used well-trained rats (Cruzat et 
al., 2010; Cury-Boaventura et al., 2008; Lagranha et al., 2005; Lagranha et al., 2007; 
Lagranha et al., 2004). In these studies, animals were subjected to an hour of physical 
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exercise (swim or treadmill run), five times a week for 6 to 8 weeks in parallel with daily 
glutamine administration during the last 3 weeks of training. It has been well documented that 
prolonged exercise training increases basal skeletal muscle HSP70 content (Kayani et al., 
2008b; Liu et al., 2000; Morton et al., 2008; Ogata et al., 2009) and it is possible that the 
enhancement of HSP72 induction is ameliorated by the glutamine administration. Several 
studies on other tissues have shown that glutamine treatment is more effective in enhancing 
HSP72 expression in animals with prior exposure to heat shock (Fujita et al., 2012; Wang et 
al., 2007; Wang et al., 2012). Thus, the protective effect of glutamine treatment in previously 
mentioned studies could have been partly due to the training-induced heat shock response or 
the synergistic effects between training and glutamine ingestion, rather than glutamine per se. 
Second, in the present study we focused on HSP72 response in red vastus muscle while the 
other study examined the soleus or gastrocnemius muscle groups (Petry et al., 2014). It is 
plausible that the effect of glutamine on HSP72 and HSP25 induction as well as HSF1 
response is dependent on muscle fibre types. While slow-twitch red vastus muscle with high 
oxidative capacity is known to have a greater and faster HSF activation than predominantly 
fast-twitch fibres (Locke and Tanguay, 1996), it is intriguing that there was no interaction 
effect of glutamine treatment and eccentric exercise on the red vastus heat shock response of 
the animals in the present study. Lastly, it should be noted that the eccentric exercise 
employed in the present study did not actually result in substantial loss of muscle grip 
strength, hence it is impossible to reach a conclusion as to whether glutamine treatment per se 
is effective in protecting the skeletal muscle from EIMD.  
 
In conclusion, our results suggest that a five-day glutamine administration at 0.9 g.kg-1.day-1 
via gavage, does not affect in vivo heat shock response in intact animals within 24 h following 
eccentric exercise. Future studies should investigate the effect of glutamine administration on 
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the heat shock response and its protective effect against muscle damage in heat-
preconditioned animals. 
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CHAPTER 7 – STUDY 3(B) 
 
7.1. Introduction 
 
This study was designed to investigate the effect of oral glutamine administration on HSP72 
response in plasma and skeletal muscle of heat-preconditioned animals. Subsequently, the aim 
was to investigate if there was a cross-protection against the adverse changes of eccentric 
exercise-induced muscle damage. Furthermore, the study aimed to investigate the 
relationships between the passive heating intervention and circulatory as well as skeletal 
muscle heat shock response following a prolonged bout of eccentric exercise. 
 
Our previous study (Chapter 6) found that there was no main effect of glutamine treatment on 
HSP72 induction in plasma and skeletal muscle of healthy and intact animals. Hence, it is 
possible that either the glutamine-mediated skeletal muscle protection is independent of 
HSP72 expression, or that various tissues respond differently to glutamine treatment, or that 
pre heat-shock or other sub-lethal stressors are required to facilitate the enhancing effect of 
glutamine on HSP72 response. One line of evidence pointed to glutamine as being effective in 
inducing in vivo hepatic HSP72 synthesis only when the animals were heat-shocked or 
stressed previously (Wang et al., 2007; Wang et al., 2012). Another study showed that the 
combination of microwave irradiation and glutamine injection substantially increased the 
HSP72 response in articular cartilage when compared with glutamine treatment alone, and 
subsequent suppression of osteoarthritis progression in a rat osteoarthritis model (Fujita et al., 
2012). In an experimental hyperthermia model, it has been shown that rats treated with enteral 
glutamine 5 days before heat exposure had an improved survival rate. The improved organ 
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functions were correlated with enhanced gut HSP70 response following exposure to 
hyperthermic conditions (Singleton and Wischmeyer, 2006).  
 
Effects of heat preconditioning on cellular protection against exercise-induced muscle damage 
have been previously demonstrated (Kojima et al., 2007; Shima et al., 2008; Touchberry et 
al., 2012). However, whether the combination of glutamine and heat treatment is superior in 
protecting skeletal muscle from eccentric exercise-induced muscle damage when compared 
with heat preconditioning alone, is largely unknown. Current observations provide the 
rationale for incorporating a short sub-lethal bout of heat stress together with glutamine 
treatment, which we speculate would result in substantial enhancement in circulating as well 
as skeletal muscle HSP72 induction. To date, the additive effect of glutamine administration 
and heat preconditioning on HSP72 response has not been investigated.  
 
We hypothesized that (1) oral glutamine administration along with heat preconditioning 
would induce circulating and skeletal muscle HSP72 response in adult male rats, (2) 
consequently, the increased HSP72 response would be associated with a greater resistance to 
the adverse changes (i.e. myofibrillar disruption and muscle force deficit) resulting from 
eccentric exercise, (3) skeletal muscle HSP25 and HSF1 content would be elevated following 
the eccentric exercise as mediators of the cellular stress response, and (4) glutamine 
administration and ensuing HSP72 induction would be associated with suppressing the 
cellular stress response following eccentric exercise.  
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7.2. Materials and Methods 
 
7.2.1. Animal handling and experimental protocol 
 
A total of 44 adult male Sprague-Dawley rats (Rattus norvegicus, 9 to 11 weeks old) with a 
body weight of ~310 g were used in this study. Rats were kept in a temperature-controlled 
(~22°C) animal house with a reverse 12 h light-dark cycle, fed with standard rat chow and tap 
water ad lib. Environment enrichment was provided in the form of cardboard rolls for tearing 
as well as PVC piping for tunneling and sleeping in the caged space. The rats were 
acclimatized to this new environment for at least 5 to 7 days.  
 
Thereafter, the animals were randomly divided into two experimental treatment groups: half 
the rats were treated with glutamine solution at a dose of 0.9 g.kg-1.day-1 for five consecutive 
days via oral gavage (GLN+HEAT), whereas the other group served as a placebo control and 
received the gavage of purified water of equivalent volume (H2O+HEAT). Glutamine 
solution was freshly prepared prior to the administration, using the L-alanyl-L-glutamine 
dipeptide (Sigma-Aldrich, MO, USA). A gram of L-alanyl-L-glutamine dipeptide is 
equivalent to 0.67 g of glutamine. Therefore, for a dose of 0.9 g glutamine, 1.34 g of L-
alanyl-L-glutamine was mixed in aqueous solution at a concentration of 0.4 g.mL-1. For a rat 
of 300 g body weight, this amounted to the gavage of 1.01 mL of solution containing 0.4 g of 
L-alanyl-L-glutamine dipeptide. 
 
All rats were subjected to a session of passive heat preconditioning (i.e. rectal temperature 
was elevated and maintained at ~42°C for 20 min) at 1 h following the penultimate treatment 
of the glutamine or placebo. This timing of passive heat exposure was chosen because 
  129 
previous studies have shown that it is effective in increasing skeletal muscle HSP72 content at 
24 h and 48 h following the heating (Baumeister et al., 2004; Frier and Locke, 2007; Gupte et 
al., 2011; Lille et al., 1999; Thomas and Noble, 1999). Rats were heated by wrapping them in 
a small electrical blanket (Breville HP500, Australia) under anaesthesia of an intraperitoneal 
injection of ketamine/xylazine solution at 83/12 mg.kg-1 body mass.  
 
Approximately 24 h after the passive heating episode, which coincided with 1 h after the last 
glutamine or placebo treatment, rats from each of the experimental treatment groups were 
further randomly assigned into one of three sub-groups: which were euthanized before (non-
exercise, Non-EX), or at 4 h (4 h post exercise, EX+4h) or 24 h (24 h post exercise, EX+24h) 
following a prolonged bout of eccentric exercise. In addition, all rats were subjected to a 
muscle strength test before they were euthanized for subsequent blood and tissues sampling.  
 
A schematic design of the study is presented in Figure 7.1.The study was conducted in 
compliance with the Australian Code of Practice for the Care and Use of Animals for 
Scientific Purpose. The experimental protocol was approved by Animal Ethics Committee of 
the University of Sydney (Approval Number: C42/11-2012/1/5865). 
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Figure 7.1 The experimental design of the study. Note: “HS” in the explosion shape denotes passive 
heating preconditioning session; “S” in the diamond shape denotes the time point at which the animals 
were sacrificed for both blood and muscle tissues sampling; “EX” in the oval shape denotes prolong 
eccentric exercise bout, i.e. downhill treadmill running. 
 
 
7.2.2. Passive heating and heat load estimation  
 
The heating was performed under the anaesthetic in order to restrict the movement and to 
minimize the stress of the animals. Therefore, the anaesthetic was “topped up” during the 
course of the heating when required. Colonic and muscle (hindlimb) temperatures were 
monitored continuously. Rats were “unwrapped” from the heated blanket if the rectal 
temperature was higher than 42°C. The rectal temperature was recorded by a temperature 
probe consisting of a thin thermocouple wire threaded into a flexible 2.5 mm rubber tube and 
was inserted 5 cm beyond the anal sphincter of the rats. Muscle temperature was recorded by 
placing a thermocouple (Mon-a-therm Myocardiac, Mallinckrodt, MO, USA) through a small 
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incision in the skin covering the vastus muscle groups and inserting it deep (~1.5 CM) into 
the exposed muscle. The thermocouples were connected to a DataTaker (Melbourne, 
Australia) and the temperatures were recorded every second. Calibration of the thermocouples 
with a platinum resistance probe (Leeds & Northrup Australia Pty. Ltd., NSW Australia) was 
conducted over four points (37, 40, 42 and 45°C) spanning the temperature range measured 
during the whole body heating process. The rectal and muscle temperatures recorded and used 
to ascertain the rat’s temperatures during passive heating were corrected to the true values 
based on the calibration of the thermocouples. Heating rate or thermal load (°C.min-1) was 
computed as the area under the rectal temperature curve, above 41.5°C, and based on the time 
the animal was heated above 41.5°C, and multiplying this value by the average temperature 
during that time period (Hubbard et al., 1977; Ruell et al., 2004). All animals were carefully 
monitored for their well-being until they were awake and alert. 
 
7.2.3. Prolonged eccentric exercise  
 
Please refer to Chapter 6, Section 6.2.2. 
 
7.2.4. Assessment of muscle contractile function 
 
Please refer to Chapter 4, Section 4.2.2. 
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Figure 7.2 Photos showing the setup of equipments for passive heating procedure (top, panel a) and a 
rat was “wrapped” with an electrical blanket for the heating process (bottom, panel b). 
 
 
 
a 
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7.2.5. Preparation of blood and tissues samples  
 
Please refer to Chapter 6, Section 6.2.4.  
 
7.2.6. Plasma and skeletal muscle heat shock protein analysis 
 
Please refer to Chapter 5, Section 5.2.3. 
 
7.2.7. Skeletal muscle HSF1 Western blot 
 
Please refer to Chapter 5, Section 5.2.4. 
 
7.2.8. Histological analysis 
 
Please refer to Chapter 6, Section 6.2.7.  
 
7.2.9. Statistical analysis 
 
All data are presented as mean and standard deviation or otherwise stated. A two-way 
between-groups analysis of variance (ANOVA) was used in detecting the significant 
interaction effect of two treatments (placebo and glutamine) and three exercise conditions 
(non-exercise, 4 h and 24 h post eccentric exercise). Equality of variance was determined 
using Levene’s test. When a significant F value was observed for the main effects and their 
interaction, the one-way between-groups ANOVA with LSD post-hoc analysis was run to 
identify the differences between the non-exercise and eccentric exercise groups; whereas, 
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significance of the difference between the treatment groups was assessed through the 
Student’s independent t-test. Pearson product-moment correlation coefficient was used to 
determine the relationships between the plasma HSP72 and heat shock response in red vastus 
muscle, while controlling for passive heat load. Statistical analysis was conducted using SPSS 
Version 21 (IBM Inc, USA) and the level of significance was set at p < 0.05 for all 
comparisons. In cases in which the homogeneity of variance assumption was violated (e.g. in 
plasma and red vastus HSP72 data), the statistical significance level was set at p < 0.01 for the 
LSD post-hoc test, whereas the t-value for unequal variance adjustment was used in the t-test. 
 
7.3. Results 
 
The physical characteristics and experimental conditions of the animals are shown in Table 
7.1. The mean age of the animals subjected to eccentric exercise in placebo groups were 
significantly different from those in glutamine treatment groups (p = 0.041 for EX+4h groups, 
p = 0.028 for EX+24h groups; t-test). However, the final body mass prior to euthanasia did 
not differ between the experimental groups. In addition, passive heat load of all rats as well as 
the subjective rating of exercise performance (EX Score) of the rats, which were subjected to 
downhill treadmill running were not different between the groups. There was no significant 
difference in maximal hindlimb grip strength (Figure 7.3) between any of the experimental 
groups. 
 
Light micrographs of the red vastus cross-sections showed no sign of abnormality in all Non-
EX rats (Figure 7.4 (a) and (b)). Interestingly, no obvious myofibrillar anomalies were 
observed in the muscle specimens taken from rats in H2O+HEAT or GLN+HEAT group, 
within 4 h following the eccentric exercise. However, degenerating fibres were observed in 
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the red vastus muscle of rats at 24 h following the eccentric exercise, regardless of treatment 
(Figure 7.4 (a) and (b)). 
 
Table 7.1 Physical characteristics, heat load and exercise performance of the heat-preconditioned 
animals treated with an equivalent amount of purified water (Placebo) or five once-daily gavage of 
glutamine (0.9 g.kg-1), without exercise (Non-EX) as well as exercise with 4 h (EX+4h) and 24 h 
(EX+24h) recovery. The hash mark indicates significantly different (p < 0.05; t-test) from placebo 
groups. Values are mean ± standard deviation. 
 Placebo and Passive Heating Glutamine and Passive Heating 
 Non-EX EX+4h EX+24h Non-EX EX+4h EX+24h 
N 7 7 8 7 8 7 
Age (wk) 9.4±0.9 9.9±0.7 9.5±0.9 10.4±1.3 10.9±1.0# 11.3±1.6# 
Mass (g) 315.6±13.2 309.3±11.0 321.2±11.3 327.3±51.6 316.6±31.8 325.6±44.9 
Heat Load 
(°C.min-1) 
 
11.5±3.2 14.3±1.9 14.0±2.0 12.5±6.5 10.6±2.4 11.9±5.4 
EX Score - 1.9±0.2 1.7±0.3 - 1.7±0.3 1.7±0.1 
 
 
 
Figure 7.3 Maximal hindlimb grip strength of placebo and glutamine-treated rats (n = 7 or 8 each 
group) before, 4 and 24 h following the eccentric exercise. Values are mean ± standard deviation. 
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Figure 7.4 (a) Light micrograph of cross section of rats in H2O+HEAT and GLN+HEAT groups 
(Series 5) before, 4 and 24 h following the prolonged eccentric exercise. Magnification = 20x. Arrow 
indicates degenerating fibre. 
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Figure 7.4 (b) Light micrograph of cross section of rats in H2O+HEAT and GLN+HEAT groups 
(Series 6) before, 4 and 24 h following the prolonged eccentric exercise. Magnification = 20x. Arrow 
indicates degenerating fibre. 
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We observed an interaction effect of glutamine treatment and eccentric exercise on plasma 
HSP72 concentration: F (2, 38) = 6.71, p = 0.003, with an effect size of 0.26 (Figure 7.5). 
There was a statistically significant main effect for eccentric exercise on plasma HSP72 
concentration: F (2, 38) = 6.01, p = 0.005, with an effect size of 0.24. Subsequent analysis 
using one-way ANOVA with LSD post-hoc test indicated that the mean plasma HSP72 
concentration for glutamine-treated rats was significantly higher in Non-EX group when 
compared with EX+4h (p = 0.007) and EX+24h (p = 0.005) groups. There was also a 
significant main effect for glutamine treatment: F (1, 38) = 5.08, p = 0.03, with an effect size 
of 0.12. Further analysis using independent t-test indicated that the mean plasma HSP72 
concentration in glutamine-treated rats was significantly higher (p = 0.05) than the placebo-
controlled rats within the Non-EX group. 
 
 
Figure 7.5 Plasma HSP72 concentration of placebo and glutamine-treated rats (n = 7 or 8 each group) 
before, 4 and 24 h following the prolonged eccentric exercise. The hash mark indicates significant 
treatment effect of glutamine (# p = 0.05; t-test); the asterisk marks indicate significant difference (** 
p < 0.01; one-way ANOVA) when compared with the Non-EX group. Values are mean ± standard 
deviation. 
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The main effect for eccentric exercise on red vastus HSP72 content was observed: F (2, 38) = 
23.46, p < 0.001, with a substantially large effect size of 0.55 (Figure 7.6). When examined 
separately using one-way between-groups ANOVA with LSD post hoc test, we found that 
HSP72 induction in red vastus of both placebo and glutamine-treated rats were significantly 
elevated (p ≤ 0.001) in EX+24h group. 
 
 
Figure 7.6 Red vastus HSP72 content of placebo and glutamine-treated rats (n = 7 or 8 each group) 
before, 4 and 24 h following the prolonged eccentric exercise. The asterisk marks indicate significant 
difference (** p < 0.01; one-way ANOVA) when compared with the Non-EX and EX+4h groups. 
Values are mean ± standard deviation. 
 
 
There was a significant main effect of glutamine treatment on red vastus HSP25 content: F (1, 
38) = 10.75, p = 0.002, with an effect size of 0.22 (Figure 7.7). The significant difference in 
red vastus HSP25 content between placebo and glutamine-treated rats was observed for 
EX+4h group (p = 0.033; t-test) while there was a marginal difference for EX+24h group (p = 
0.055; t-test). 
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Figure 7.7 Red vastus HSP25 content of placebo and glutamine-treated rats (n = 7 or 8 each group) 
before, 4 and 24 h following the prolonged eccentric exercise. The hash mark indicates significant 
treatment effect of glutamine (# p < 0.05; t-test). Values are mean ± standard deviation. 
 
 
The main effect for eccentric exercise on red vastus HSF1 content was observed: F (2, 34) = 
6.40, p = 0.004, with an effect size of 0.27 (Figure 7.8). When examined further using one-
way between-groups ANOVA with LSD post hoc test, we observed that the HSF1 content in 
red vastus of both placebo-controlled (p = 0.038) and glutamine-treated (p = 0.023) rats were 
significantly elevated in EX+24h group. On the other hand, the main effect for glutamine 
treatment on red vastus HSF1 content was also detected: F (1, 34) = 4.43, p = 0.043 with an 
effect size of 0.12. When further examined with independent t-test, it showed that glutamine 
treatment significantly (p = 0.017) increase red vastus HSF1 content in EX+24h rats.  
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Figure 7.8 Red vastus HSF1 content of placebo and glutamine-treated rats (n = 5 to 8 each group) 
before, 4 and 24 h following the prolonged eccentric exercise. The hash mark indicates significant 
treatment effect of glutamine (# p < 0.05; t-test); the asterisk mark indicates significant difference (* p 
< 0.05; one-way ANOVA) when compared with the Non-EX group. A representative immunoblot is 
shown in the upper panel. Values are mean ± standard deviation. 
 
 
Significant correlations were observed between heat load and plasma HSP72 (r = 0.315, p < 
0.05) as well as red vastus HSP25 content (r = 0.401, p < 0.01) (Table 7.2). In addition, red 
vastus HSP72 induction was strongly correlated with HSF1 content in red vastus (r = 0.457, p 
< 0.01). We further explored these relationships by controlling for the heat load, the results 
showed that there was a negative partial correlation between the plasma HSP72 and red vastus 
HSP25 (r = -0.351, p < 0.05) as well as a strong-positive partial correlation between the red 
vastus HSP72 and HSF1 (r = 0.454, p < 0.01). These data suggest that heat stress had very 
little effect on the strength of the association between red vastus HSP72 and HSF1 induction 
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in the rats of the present study, whereas it had an impact on the relationship between plasma 
HSP72 and red vastus HSP25 response. 
 
Table 7.2 Pearson product-moment correlations between passive heat load and heat shock response in 
heat-preconditioned rats with and without eccentric exercise. Correlation and partial correlation are 
significant at * p < 0.05 and ** p < 0.01 (2-tailed). 
  Heat 
Load 
Plasma 
HSP70 
Red 
Vastus 
HSP70 
Red 
Vastus 
HSP25 
Red 
Vastus 
HSF1 
 
Heat Load 1.000 0.315* -0.069 0.401** -0.119 
Plasma HSP70  1.000 -0.127 -0.179 -0.166 
Red Vastus HSP70   1.000 0.041 0.457** 
Red Vastus HSP25    1.000 -0.017 
Correlation 
Red Vastus HSF1     1.000 
       
Plasma HSP70  1.000 -0.111 -0.351* -0.136 
Red Vastus HSP70   1.000 0.075 0.454** 
Red Vastus HSP25    1.000 0.034 
Partial 
Correlation 
(Controlling 
for Heat 
Load) 
Red Vastus HSF1     1.000 
       
 
 
7.4. Discussion 
 
This study aimed to investigate whether glutamine treatment would alter plasma and skeletal 
muscle HSP72 content in heat-preconditioned animals subjected to a prolonged bout of 
eccentric exercise, i.e. downhill treadmill running. We hypothesized that oral glutamine 
administration on top of passive heating would increase the plasma and red vastus HSP72 
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level in the rats, in which the induced HSP72 response would protect against the eccentric 
exercise-induced muscle damage. We also hypothesized that the protective effect of HSP72 
would be associated with parallel increase in skeletal muscle HSP25 and HSF1. The novel 
finding of the present study was that oral glutamine administration along with a short session 
of passive heating significantly increased plasma HSP72 concentration in vivo in rats at 24 h 
following thermal preconditioning. Interestingly, this effect of glutamine was diminished 
within ~7 h by a 1.5-h bout of eccentric exercise, implying an interaction effect of glutamine 
administration and eccentric exercise. On the other hand, the treatment significantly reduced 
the red vastus HSP25 content at 4 h following the eccentric exercise, whereas the muscle 
HSF1 response was augmented by the treatment at 24 h post eccentric exercise. These 
observations support the essential role of glutamine during physiological insults (i.e. thermal 
stress, mechanical strain) in regulating circulating HSP72 response, as well as HSP25 and 
HSF1 induction in skeletal muscle exposed to eccentric-contractile strain.  
 
The additive effects between glutamine and thermal stress on HSP72 response have been 
previously shown in other murine tissues in vivo such as liver (Wang et al., 2007; Wang et al., 
2012), articulate cartilage (Fujita et al., 2012), lung and gut (Singleton and Wischmeyer, 
2006), as well as in vitro in articular chondrocytes (Tonomura et al., 2006), embryonic 
fibrolasts (Morrison et al., 2006) and skeletal myotubes (Zhou and Thompson, 1997). 
However, to our knowledge, the finding in the present study provides the first evidence that 
oral glutamine administration combined with passive heat preconditioning is effective in 
enhancing in vivo plasma HSP72 response in healthy adult male rodents prior to exercise. In a 
human study, elevated circulating HSP70 concentration has been correlated with improved 
clinical outcome of critically ill patients parenterally supplemented with glutamine (Ziegler et 
al., 2005). In a subsequent animal study, the same research group reported that five-daily oral 
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glutamine treatment prior to 30-min heat stress, significantly enhanced lung and gut HSP70 
expression post hyperthermia and associated with decreased mortality within the following 72 
h (17% versus 58% in controls, (Singleton and Wischmeyer, 2006)). Recently, another rodent 
study suggested a combined microwave irradiation and intra-articular glutamine 
administration-induced articular cartilage HSP70 expression maybe implicated in the 
suppression of osteoarthritis (Fujita et al., 2012). Taken together, it was reasonable to 
hypothesize that the induced plasma HSP72 response following concurrent treatment of 
glutamine and sub-lethal hyperthermia should provide cross-protection to skeletal muscle 
against acute eccentric exercise-induced muscle damage.  
 
In the present study we observed an increase in plasma HSP72 concentration, however, we 
did not find any induction of HSP72 in red vastus following the concurrent treatment. It has 
recently been proposed that the effects of glutamine on HSP25 and HSP72 expression differ 
not only between the muscle and non-muscle tissues, but also within the subtypes of striated 
muscles e.g. cardiac and skeletal muscle (Chamney et al., 2013). It was thus plausible that, the 
enhancing effect of combined glutamine and heat treatment on plasma HSP72 response is not 
necessarily extrapolated to skeletal muscle in the present study. This speculation was further 
supported by our observation of blunted HSP25 response by glutamine treatment at 4 h post 
eccentric exercise; which coincided with ~7 h following the last oral glutamine 
administration, and ~30 h post heat treatment. In addition, red vastus HSF1 induction was 
significantly augmented at 24 h post eccentric exercise in glutamine-treated rats but not the 
placebo-controlled group. We have ruled out the influence of heat stress on red vastus HSF1 
response in the present study (Table 7.2) and subsequently have shown that the effect of 
glutamine on skeletal muscle HSF1 response is likely to be time-dependent following the 
eccentric exercise.  
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Despite the finding of significant increase in plasma HSP72 concentration in glutamine-
treated rats prior to exercise, we failed to observe any cross-protective effect as initially 
anticipated. This is primarily due to the fact that no discernible changes in the markers of 
eccentric exercise-induced muscle damage, i.e. reduced muscle strength and increased plasma 
creatine kinase concentration (data not shown) were detected in the exercised-animals. In this 
study, we employed a slightly higher running intensity (20 m.min-1 treadmill speed and −20° 
gradient) in relation to the common downhill running protocol for rodent model (i.e. 16 
m.min-1 treadmill speed and −16° gradient, (Armstrong et al., 1983b)). Albeit a 25% increase 
in eccentric load and high compliance of the animals to exercise requirements (Table 7.1), we 
found no evidence of the post-exercise reduction in muscle grip strength or increase in plasma 
creatine kinase concentration as reported in previous studies (Armstrong et al., 1983b; 
Schwane and Armstrong, 1983). Since the muscle contractile function and plasma creatine 
kinase concentration were measured at 4 h and 24 h following the eccentric exercise, we 
propose that the discrepancy could be due to: (1) the degree of localized myofibrillar 
disruption induced by downhill running in the present study would have only a minor and 
transient impact (< 4 h) on the hindlimb grip strength of the animals (Warren et al., 2002), 
and (2) plasma creatine kinase concentration would have only been elevated more than 48 h 
following the downhill running or it may not be a reliable marker for muscle damage induced 
by the downhill running (Komulainen et al., 1995).  
 
Interestingly, our results showed that an eccentric exercise bout inhibits the plasma HSP72 
response in the glutamine-treated rats (Figure 7.5) while significantly enhancing the 24 h 
post-exercise red vastus HSP72 induction in both placebo controls and glutamine treatment 
groups (Figure 7.6). If the elevated plasma HSP72 is an indication of physiological 
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dysfunction or cellular stress response, it is tempting to speculate that a bout of moderate-
intensity eccentric exercise is effective in abolishing this adverse condition in glutamine-
treated rats. Current knowledge suggests that the presence of HSP72 in the extracellular 
compartment is implicated in cellular communication or signalling, such as modulation of the 
immune system, rather than traditional chaperone activity (De Maio, 2011; De Maio and 
Vazquez, 2013). On the other hand, a reduced extracellular HSP72 response is associated with 
neuro-degenerative disorders (Krause and Rodrigues-Krause, 2011). Data on plasma HSP72 
of the present and previous study (see Chapter 6 – Study 3(a)) provided a unified view that 
glutamine has an additive effect on heat-preconditioned animals. The speculation could be 
that elevated glutamine is necessary for the extracellular role of HSP72 as a signalling 
molecule during heat stress. In addition, it could further be speculated that the reduced plasma 
HSP72 concentration following the eccentric exercise is associated with exercise-induced 
muscle degeneration. 
 
The increase in red vastus HSP72 content at 24 h following eccentric exercise was consistent 
with our previous findings (see Chapter 4 – Study 1 and Chapter 6 – Study 3(a)) as well as the 
results from other animal studies (Bombardier et al., 2009; Milne and Noble, 2002; Noble et 
al., 2006) in a non heat-shocked condition. More importantly, we demonstrated that the 
increased HSP72 content in red vastus is strongly associated with augmented HSF1 induction, 
independent of the thermal stress. This finding provides a further insight to the stress-induced 
transcriptional regulatory role of HSP72 in heat-preconditioned skeletal muscle following a 
bout of eccentric exercise, with a possible involvement of glutamine. The classic model of 
HSF1 regulation (Morimoto, 1993) suggested that the activation of HSF1 is inversely 
regulated by HSP70 in vitro, i.e. increase in accumulation of intracellular HSP70 reduces 
further activation of HSF. However, evidence from in vivo study proposes a different 
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perspective. In a rodent model, HSF activation was examined in various hindlimb muscle 
groups, which differ in the constitutive expression of HSP70 family, with and without the 
heat shock (Locke and Tanguay, 1996). The study found that HSF activation was detectable 
in all the muscles extracts following the heat shock, independent of HSP70 protein content 
(Locke and Tanguay, 1996). Other similar in vivo evidence further addressed a caution to 
avoid over-interpreting or over-extending the in vitro data, which may not be applicable to the 
in vivo study (Sarge, 1998). Hence, we speculate that our finding of increased HSF1 content 
in vivo in skeletal muscle of heat-preconditioned animals was partly associated with eccentric 
exercise-induced HSP72 expression, and to a larger extent, likely to be attenuated by 
glutamine treatment. 
 
Collectively, our findings suggest that in heat-preconditioned animals, glutamine availability 
plays a role in regulating HSP72 response in plasma and skeletal muscle following prolonged 
eccentric exercise. The mechanism underlying the enhancing effect of glutamine 
administration and ensuing HSP72 response, may involve the activation of HSF1 (Pirkkala et 
al., 2001). Additionally, the glutamine-mediated circulating HSP72 response in heat-
preconditioned animals in the present study may have practical relevance for individuals 
exposed to repeated bouts of heat stress and physical activity, e.g. military exercises. 
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CHAPTER 8 – CONCLUSION 
 
8.1. Summary of the Studies 
 
The studies presented in this thesis investigated skeletal muscle heat shock response and 
EIMD. A small animal experimental model was employed to demonstrate HSP72 response 
mainly in red vastus muscle prior to and following a bout of prolonged downhill treadmill 
running, which is eccentric-biased in nature. The focus of the studies has been on 
investigating the effect of commonly known HSP72-inducing drugs, i.e. 17-AAG and 
glutamine, on muscle and plasma HSP72 induction of the rodents and subsequently, whether 
the HSP72 induction would have any beneficial effects towards the adverse events in EIMD. 
The major findings of this thesis are summarized below. 
 
Study 1 aimed to replicate the reported beneficial effect of 17-AAG on skeletal muscle 
HSP72 induction in mice, and its protection against force deficit following high force 
eccentric exercise. In this study, we demonstrated that 17-AAG significantly reduced HSP72 
response in red vastus muscle of rats at 24 h following prolonged eccentric exercise. The 
treatment also appeared to protect against eccentric exercise-induced intramyofibrillar 
microenvironment irregularities 24 h post exercise. Hence, the effect of 17-AAG on skeletal 
muscle HSP72 response is time- and species-dependent, and in a muscle-specific manner.  
 
Studies reporting the effect of oral glutamine administration on skeletal muscle HSP72 
response have been limited, and the results inconclusive. With that, Study 2 was undertaken 
and in that study we showed that multiple oral glutamine administration (i.e. at least 5 once-
daily), regardless of dose, resulted in an increase in plasma glutamine availability. The 
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increase in plasma glutamine concentration, to our surprise, had no effect on plasma or 
striated muscle HSP72 response in the sedentary intact rats. However, it is associated with a 
reduction in heart HSP25 as well as red vastus HSF1 content.  
 
In Study 3(a) as reported in Chapter 6, we observed that glutamine administration per se, does 
not affect in vivo plasma or red vastus HSP72 response in intact and healthy animals before or 
within 24 h following eccentric exercise. This negative finding has prompted an additional 
study of the additive effect of glutamine and heat preconditioning. 
 
In Study 3(b) as described in Chapter 7, we found that in heat-preconditioned animals, 
glutamine availability significantly increased plasma HSP72 concentration at 24 h post 
heating, which coincided with 1 h following the last of five daily oral glutamine 
administration. Strikingly, the post eccentric exercise plasma HSP72 response in glutamine-
treated rats was significantly reduced when compared with those in non-exercising group at 
all times. There was no additive effect of glutamine administration and passive heating on red 
vastus HSP72 response. However, eccentric exercise significantly increased red vastus 
HSP72 content in both glutamine and placebo-treated rats at 24 h post exercise. The additive 
effect of glutamine administration was observed on red vastus HSP25 and HSF1 response at 4 
h and 24 h following eccentric exercise, respectively. Similarly, eccentric exercise 
significantly increased red vastus HSF1 content in both glutamine and placebo-treated rats at 
24 h post exercise. Interestingly, we also found that there was a strong correlation between 
red vastus HSP72 and HSF1 response. The correlation between HSP72 and HSF1, 
unexpectedly, was independent of heat stress. On the other hand, plasma HSP72 and red 
vastus HSP25 response are very much impacted by the presence of heat stress. 
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8.2. Perspectives and Implications 
 
The findings of this thesis have achieved several outcomes that provide interesting 
perspectives and practical implications for age-related musculoskeletal injury, clinical 
rehabilitation, as well as exercise performance enhancement. 
 
First, our studies confirmed that an acute bout of low to moderate-intensity low-force 
eccentric exercise such as downhill walking/running could increase HSP72 content in 
exercising muscle. A significant increase in HSP72 in the muscle was observed immediately 
after the downhill run, which peaked at 24 h after exercise and remained elevated up to 48 h 
recovery period. HSP72 induction appears to reduce with aging, and may explain, in part, the 
functional deficit of skeletal muscle in the elderly. It would be interesting to see whether the 
manipulation of sub-maximal intensity downhill walking model with its ensuing HSP70 
response, is safe and effective in reducing the functional loss in old muscles and the 
susceptibility to age-related musculoskeletal injury. An association between high-force 
eccentric exercise and muscle damage has been well established. However, the risks and 
benefits of long-term submaximal-intensity eccentric exercise training are still under 
investigation in age-related functional impairment or injury (Kasuga and Takemori, 2014; 
Lovering and Brooks, 2014). Hence, further research is warranted in the area of submaximal-
intensity eccentric exercise training-induced HSP70 response and maintenance of 
musculoskeletal health during aging. 
 
Secondly and interestingly, we found that HSP70 inducers such as glutamine, influence 
cardiac muscle HSP25 and skeletal muscle HSF1 response in a dose-dependent manner. The 
HSP25 and HSF1 response were observed albeit without seeing any changes in the plasma 
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and skeletal muscle HSP72. It can be postulated that the heat shock response, induced by 
either non-exercise or exercise modalities, might not be limited to the exercising muscle and 
might have non-localized effects on other body tissues or organs. This speculation is partly 
supported by a recent rodent study showing that an electrical-stimulated muscle contraction 
on the tibialis anterior elicits HSP25 and HSP70 response in the contralateral muscle group, 
EDL, diaphragm, kidney as well as brain tissues (Jammes et al., 2012). It has been 
documented that the cellular stress response plays an important role in treating diverse 
pathological complications. These include type 2 diabetes mellitus (Hooper et al., 2014), 
vascular inflammation (Noble and Shen, 2012), and neurological diseases (Brownell et al., 
2012). Manipulating the inducible HSP25 and HSP72 response via its exogenous 
administration or endogenous induction may provide a viable avenue of therapy for comorbid 
clinical pathologies. It is exciting to see in the near future if training a locomotive muscle 
group with eccentric exercise, would mend the heart and protect the brain? 
 
Lastly, our data on the additive effect of glutamine on passive heating-induced HSP72 
response in the extracellular compartment of the body is the first and can be seen as 
preliminary to future research. Ruell et al. (2014) recently reported in athletes (with/without 
prior exertional heat illness) serial data points every 10 min of exercise in the heat. Over the 
course of an hour exercise period, the plasma HSP72 increased in a linear function (Ruell et 
al., 2014). Further studies are warranted to determine the kinetics of plasma HSP72 during 
submaximal-intensity eccentric exercises and its interaction with the glutamine 
administration. The role of glutamine in the plasma HSP72 response during exercise in the 
heat could also be a field of further interest. 
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CHAPTER 10 – APPENDICE 
 
10.1. Appendix 1 – Individual Data of Study 1 
Treatment  
 
Rat ID Age 
(week) 
Mass 
(g) 
Grip Strength 
(N) 
Plasma CK 
(IU.L-1) 
RV HSP70 
(ng.µg-1) 
SR Ca2+ ATPase 
(Ratio) 
RV Calpain 
(pmoles.min-
1.mg-1 protein) 
         
C-0d1 9 330.8 17.7 333.3 0.037 2.21 133.9 
C-0d2 9 315.5 18.4 340.0 0.020 1.97 86.5 
C-0d3 9 323.3 24.3 215.0 0.015 1.83 88.1 
C-0d4 10 392.0 21.1 448.3 0.030 2.32 97.7 
C-0d5 9 303.8 19.3 433.3 0.014 2.09 78.3 
C-0d6 10 424.7 18.8 296.6 0.009 2.16 133.7 
C-0d7 10 285.1 28.9 193.3 0.027 2.00 71.1 
DMSO – Non-
exercising 
Control 
C-0d8 11 349.3 28.6 175.0 0.038 2.91 118.6 
Mean  9.6 340.6 22.1 304.3 0.024 2.19 101.0 
SD  0.7 46.7 4.6 104.6 0.011 0.33 24.6 
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10.1. Appendix 1 – Individual Data of Study 1 (Continued) 
Treatment  
 
Rat ID Age 
(week) 
Mass 
(g) 
Grip Strength 
(N) 
Plasma CK 
(IU.L-1) 
RV HSP70 
(ng.µg-1) 
SR Ca2+ ATPase 
(Ratio) 
RV Calpain 
(pmoles.min-
1.mg-1 protein) 
         
C-1d1 8 302.0 20.8 271.6 0.232 2.71 94.0 
C-1d2 10 370.2 20.1 203.3 0.039 1.51 143.1 
C-1d3 9 357.0 24.7 380.0 0.152 2.63 143.1 
C-1d4 10 320.3 18.6 586.6 0.072 2.31 107.7 
C-1d5 9 382.3 24.4 893.3 0.115 2.22 145.8 
C-1d6 10 317.7 17.3 315.0 0.131 2.41 86.3 
C-1d7 10 325.7 25.5 226.6 0.177 1.88 96.9 
DMSO – 
Exercise with 
24 h Recovery 
C-1d8 11 382.3 26.1 285.0 0.068 1.66 162.5 
Mean  9.6 344.7 22.2 395.2 0.123 2.17 122.4 
SD  0.9 31.9 3.4 234.2 0.064 0.44 29.2 
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10.1. Appendix 1 – Individual Data of Study 1 (Continued) 
Treatment  
 
Rat ID Age 
(week) 
Mass 
(g) 
Grip Strength 
(N) 
Plasma CK 
(IU.L-1) 
RV HSP70 
(ng.µg-1) 
SR Ca2+ ATPase 
(Ratio) 
RV Calpain 
(pmoles.min-
1.mg-1 protein) 
         
C-2d1 9 304.8 17.5 448.3 0.037 2.90 101.2 
C-2d2 10 356.7 18.6 300.0 0.074 1.82 80.7 
C-2d3 9 281.0 19.9 540.0 0.211 2.12 91.4 
C-2d4 10 354.9 21.4 326.6 0.046 3.18 134.5 
C-2d5 9 359.2 22.8 738.3 0.099 2.21 136.1 
C-2d6 10 359.2 18.2 601.6 0.077 2.09 95.8 
C-2d7 10 368.8 26.3 193.3 0.122 1.86 132.3 
DMSO – 
Exercise with 
48 h Recovery 
C-2d8 11 355.7 27.6 223.3 0.093 2.49 100.5 
Mean  9.8 342.5 21.5 421.4 0.095 2.33 109.0 
SD  0.7 31.6 3.8 193.7 0.055 0.49 21.9 
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10.1. Appendix 1 – Individual Data of Study 1 (Continued) 
Treatment  
 
Rat ID Age 
(week) 
Mass 
(g) 
Grip Strength 
(N) 
Plasma CK 
(IU.L-1) 
RV HSP70 
(ng.µg-1) 
SR Ca2+ ATPase 
(Ratio) 
RV Calpain 
(pmoles.min-
1.mg-1 protein) 
         
A-0d1 8 316.2 14.6 541.6 0.020 2.26 87.5 
A-0d2 9 333.0 22.0 638.1 0.023 1.97 145.6 
A-0d3 9 274.9 17.9 349.9 0.028 2.11 79.7 
A-0d4 10 329.5 22.1 988.3 0.021 3.05 59.2 
A-0d5 9 327.4 19.1 245.0 0.034 3.00 89.9 
A-0d6 10 396.0 17.0 411.6 0.018 3.40 87.5 
A-0d7 10 333.4 23.5 258.3 0.043 1.93 69.2 
17-AAG – 
Non-exercising 
Control 
A-0d8 11 383.3 26.3 361.6 0.064 2.92 128.0 
Mean  9.5 336.7 20.3 474.3 0.032 2.58 93.3 
SD  0.9 37.9 3.8 246.9 0.016 0.57 29.1 
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10.1. Appendix 1 – Individual Data of Study 1 (Continued) 
Treatment  
 
Rat ID Age 
(week) 
Mass 
(g) 
Grip Strength 
(N) 
Plasma CK 
(IU.L-1) 
RV HSP70 
(ng.µg-1) 
SR Ca2+ ATPase 
(Ratio) 
RV Calpain 
(pmoles.min-
1.mg-1 protein) 
         
A-1d1 9 318.7 19.4 279.9 0.086 1.75 97.9 
A-1d2 10 331.0 21.9 283.3 0.035 1.64 98.5 
A-1d3 9 335.2 17.1 972.8 0.076 2.18 130.1 
A-1d4 10 344.7 22.7 390.6 0.054 3.73 94.6 
A-1d5 9 349.3 21.5 548.3 0.046 2.46 176.9 
A-1d6 10 319.1 16.9 220.0 0.069 2.58 80.3 
A-1d7 10 337.5 23.2 211.6 0.081 1.94 105.9 
17-AAG – 
Exercise with 
24 h Recovery 
A-1d8 11 367.2 26.3 253.3 0.075 1.75 103.6 
Mean  9.8 337.8 21.1 395.0 0.065 2.25 111.0 
SD  0.7 16.1 3.2 258.4 0.018 0.69 30.0 
         
 
 
 
 
 
  
191 
10.1. Appendix 1 – Individual Data of Study 1 (Continued) 
Treatment  
 
Rat ID Age 
(week) 
Mass 
(g) 
Grip Strength 
(N) 
Plasma CK 
(IU.L-1) 
RV HSP70 
(ng.µg-1) 
SR Ca2+ ATPase 
(Ratio) 
RV Calpain 
(pmoles.min-
1.mg-1 protein) 
         
A-2d1 9 330.2 22.9 203.3 0.133 2.09 122.4 
A-2d2 9 296.1 19.7 524.9 0.047 1.45 121.9 
A-2d3 9 297.2 22.2 333.3 0.090 1.61 190.9 
A-2d4 10 377.4 20.2 711.6 0.055 2.90 117.6 
A-2d5 9 334.2 24.2 1134.9 0.045 2.55 70.5 
A-2d6 10 303.6 17.3 443.1 0.038 2.13 92.1 
A-2d7 10 340.1 18.9 - 0.065 2.87 97.9 
17-AAG – 
Exercise with 
48 h Recovery 
A-2d8 11 414.2 27.9 236.6 0.095 1.82 134.9 
Mean  9.6 336.6 21.7 512.5 0.071 2.18 118.5 
SD  0.7 41.5 3.4 325.5 0.033 0.55 35.8 
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10.2. Appendix 2 – Individual Data of Study 2 
Treatment  
 
Rat ID Age (wks) Mass (g) Plasma Red Vastus Heart 
    GLN 
(mM) 
 
HSP70 
(ng.mL-1) 
HSP70 
(ng.µg-1) 
HSP25 
(ng.µg-1) 
HSF1 
(AU) 
HSP70 
(ng.µg-1) 
HSP25 
(ng.µg-1) 
           
1C-1 8 350.3 0.671 2.16 0.019 0.003 0.30 0.020 0.089 
1C-2 9 314.2 0.639 2.74 0.022 0.004 0.87 0.028 0.060 
1C-3 9 377.1 0.567 2.56 0.013 0.004 1.89 0.023 0.062 
5C-1 8 294.5 0.705 2.39 0.017 0.003 1.26 0.019 0.051 
5C-2 8 319.7 0.822 2.21 0.016 0.003 0.79 0.022 0.055 
Control, 1x 
or 5x 
Purified 
Water of 
Equivalent 
Volume 
5C-3 9 355.1 0.628 2.31 0.022 0.004 0.49 0.026 0.089 
Mean  8.5 335.2 0.672 2.39 0.018 0.003 0.93 0.023 0.063 
SD  0.5 30.7 0.087 0.22 0.004 0.001 0.57 0.003 0.013 
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10.2. Appendix 2 – Individual Data of Study 2 (Continued) 
Treatment  
 
Rat ID Age (wks) Mass (g) Plasma Red Vastus Heart 
    GLN 
(mM) 
 
HSP70 
(ng.mL-1) 
HSP70 
(ng.µg-1) 
HSP25 
(ng.µg-1) 
HSF1 
(AU) 
HSP70 
(ng.µg-1) 
HSP25 
(ng.µg-1) 
           
1L-1 8 348.8 0.715 2.20 0.024 0.001 0.42 0.021 0.062 
1L-2 9 351.8 0.673 2.28 0.019 0.002 1.15 0.023 0.050 
1L-3 9 339.6 0.639 1.93 0.028 0.003 0.70 0.020 0.060 
1L-4 9 322.8 0.753 2.33 0.023 0.005 1.45 0.019 0.055 
1L-5 10 340.3 0.582 2.63 0.019 0.003 0.70 0.021 0.057 
1x Low 
Glutamine 
1L-6 10 364.1 0.643 2.42 0.014 0.003 0.67 0.019 0.058 
Mean  9.2 344.6 0.667 2.29 0.021 0.003 0.85 0.021 0.055 
SD  0.8 13.9 0.060 0.23 0.005 0.001 0.38 0.002 0.005 
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10.2. Appendix 2 – Individual Data of Study 2 (Continued) 
Treatment  
 
Rat ID Age (wks) Mass (g) Plasma Red Vastus Heart 
    GLN 
(mM) 
 
HSP70 
(ng.mL-1) 
HSP70 
(ng.µg-1) 
HSP25 
(ng.µg-1) 
HSF1 
(AU) 
HSP70 
(ng.µg-1) 
HSP25 
(ng.µg-1) 
           
1H-1 8 303.8 0.809 2.03 0.014 0.002 0.15 0.021 0.053 
1H-2 9 366.8 0.789 2.22 0.022 0.002 0.83 0.020 0.046 
1H-3 9 367.7 0.729 2.19 0.026 0.004 0.35 0.025 0.047 
1H-4 9 365.7 0.730 2.36 0.014 0.004 0.50 0.020 0.042 
1H-5 10 372.8 0.766 2.16 0.015 0.002 0.47 0.019 0.039 
1x High 
Glutamine 
1H-6 10 354.7 0.741 2.10 0.011 0.004 0.36 0.023 0.052 
Mean  9.2 355.3 0.761 2.17 0.017 0.003 0.44 0.021 0.046 
SD  0.8 25.9 0.033 0.11 0.006 0.001 0.23 0.002 0.005 
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10.2. Appendix 2 – Individual Data of Study 2 (Continued) 
Treatment  
 
Rat ID Age (wks) Mass (g) Plasma Red Vastus Heart 
    GLN 
(mM) 
 
HSP70 
(ng.mL-1) 
HSP70 
(ng.µg-1) 
HSP25 
(ng.µg-1) 
HSF1 
(AU) 
HSP70 
(ng.µg-1) 
HSP25 
(ng.µg-1) 
           
5L-1 8 277.3 0.826 2.36 0.019 0.002 0.18 0.021 0.048 
5L-2 8 333.0 0.628 2.19 0.015 0.001 0.41 0.021 0.043 
5L-3 9 338.4 0.818 2.05 0.017 0.005 0.37 0.025 0.055 
5L-4 9 355.6 0.932 2.67 0.020 0.006 0.37 0.028 0.060 
5L-5 10 358.1 0.709 2.26 0.013 0.005 0.46 0.021 0.037 
5x Low 
Glutamine 
5L-6 10 357.2 0.916 2.08 0.010 0.003 0.32 0.024 0.054 
Mean  9.0 336.6 0.805 2.27 0.016 0.004 0.35 0.023 0.049 
SD  0.9 30.9 0.118 0.23 0.004 0.002 0.10 0.003 0.009 
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10.2. Appendix 2 – Individual Data of Study 2 (Continued) 
Treatment  
 
Rat ID Age (wks) Mass (g) Plasma Red Vastus Heart 
    GLN 
(mM) 
 
HSP70 
(ng.mL-1) 
HSP70 
(ng.µg-1) 
HSP25 
(ng.µg-1) 
HSF1 
(AU) 
HSP70 
(ng.µg-1) 
HSP25 
(ng.µg-1) 
           
5H-1 8 305.5 0.837 2.39 0.016 0.002 1.00 0.020 0.049 
5H-2 8 293.1 0.895 2.22 0.021 0.002 0.40 0.026 0.041 
5H-3 9 327.5 0.776 2.45 0.021 0.004 0.53 0.026 0.046 
5H-4 9 346.1 0.612 2.32 0.015 0.004 0.15 0.020 0.054 
5H-5 10 352.5 0.709 2.21 0.011 0.003 0.57 0.019 0.042 
5x High 
Glutamine 
5H-6 10 330.7 0.927 2.85 0.009 0.003 0.71 0.020 0.052 
Mean  9.0 325.9 0.793 2.40 0.015 0.003 0.56 0.022 0.047 
SD  0.9 22.9 0.118 0.24 0.005 0.001 0.29 0.003 0.005 
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10.3. Appendix 3 – Individual Data of Study 3(a) 
Treatment 
 
Rat ID Age (wks) Mass (g) Run Score Grip 
Strength 
(N) 
Plasma CK 
(IU.L-1) 
Plasma 
HSP72 
(ng.mL-1) 
RV 
HSP72 
(ng.µg-1) 
RV 
HSP25 
(ng.µg-1) 
RV  
HSF1 
(AU) 
           
H2O-CON-1 10 340.4 - 23.9 841.6 0.680 0.018 0.006 0.11 
H2O-CON-2 9 257.2 - 21.3 406.6 1.055 0.021 0.011 - 
H2O-CON-3  - - - 361.6 - 0.188 0.006 - 
H2O-CON-4 10 337.8 - 25.5 343.3 0.895 0.025 0.003 0.21 
H2O-CON-5 11 368.6 - 30.6 331.7 0.770 0.013 0.005 0.12 
H2O-CON-6 11 344.3 - 28.4 408.3 0.765 0.016 0.003 0.18 
H2O-CON-7 12 357.9 - 30.2 604.9 0.950 0.030 0.003 0.06 
Placebo, 
Non-
exercising 
Control 
H2O-CON-8 14 393.7 - 31.0 689.9 1.005 0.018 0.005 0.27 
Mean  11 342.8 - 27.3 518.0 0.874 0.020 0.005 0.16 
SD  2 42.5 - 3.8 196.4 0.139 0.006 0.003 0.08 
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10.3. Appendix 3 – Individual Data of Study 3(a) (Continued) 
Treatment 
 
Rat ID Age (wks) Mass (g) Run Score Grip 
Strength 
(N) 
Plasma CK 
(IU.L-1) 
Plasma 
HSP72 
(ng.mL-1) 
RV 
HSP72 
(ng.µg-1) 
RV 
HSP25 
(ng.µg-1) 
RV 
HSF1 
(AU) 
           
H2O-E04-1 10 342.7 0.6 DNF 27.5 829.9 - 0.078 0.015 - 
H2O-E04-2 9 261.7 2.0 20.8 628.3 0.690 0.107 0.013 - 
H2O-E04-3 11 266.7 1.6 23.7 764.9 0.920 0.210 0.005 0.04 
H2O-E04-4 10 301.2 1.8 22.2 470.0 0.895 0.172 0.002 0.06 
H2O-E04-5 11 378.4 1.2 31.1 564.9 2.495 0.118 0.003 0.24 
H2O-E04-6 12 353.7 1.7 29.4 351.6 0.895 0.252 0.003 0.22 
H2O-E04-7 13 381.5 1.9 29.9 275.0 1.375 0.046 0.002 0.04 
H2O-E04-8 14 393.3 1.4 30.9 410.0 1.220 0.041 0.002 0.43 
Placebo, 
Exercise 
With 4 h 
Recovery 
H2O-E04-9 11 376.4 2.0 27.7 969.9 1.580 0.025 0.008 0.32 
Mean  11 339.1 1.7 26.9 554.3 1.259 0.121 0.005 0.19 
SD  2 54.2 0.3 4.1 229.8 0.579 0.084 0.004 0.15 
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10.3. Appendix 3 – Individual Data of Study 3(a) (Continued) 
Treatment 
 
Rat ID Age (wks) Mass (g) Run Score Grip 
Strength 
(N) 
Plasma CK 
(IU.L-1) 
Plasma 
HSP72 
(ng.mL-1) 
RV 
HSP72 
(ng.µg-1) 
RV 
HSP25 
(ng.µg-1) 
RV  
HSF1 
(AU) 
           
H2O-E24-1 10 281.5 0.6 DNF 22.4 608.3 - 0.128 0.016 - 
H2O-E24-2 10 269.5 1.5 25.3 305.0 0.650 0.133 0.010 - 
H2O-E24-3 11 333.2 1.8 15.0 558.3 0.680 0.263 0.003 0.12 
H2O-E24-4 10 297.9 1.6 21.8 196.6 0.635 0.277 0.003 0.23 
H2O-E24-5 12 353.2 1.7 31.7 208.3 0.895 0.151 0.003 0.46 
H2O-E24-6 12 376.1 1.7 33.5 265.0 0.855 0.135 0.003 0.37 
H2O-E24-7 13 374.4 1.3 35.1 336.6 1.040 0.174 0.004 0.17 
H2O-E24-8 14 390.7 1.5 35.7 939.9 1.320 0.182 0.004 0.44 
Placebo, 
Exercise 
With 24 h 
Recovery 
H2O-E24-9 11 317.7 2.0 28.4 246.6 0.520 - 0.009 0.33 
Mean  12 339.1 1.6 28.3 382.0 0.824 0.188 0.005 0.30 
SD  1 42.3 0.2 7.2 252.7 0.261 0.059 0.003 0.13 
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10.3. Appendix 3 – Individual Data of Study 3(a) (Continued) 
Treatment 
 
Rat ID Age (wks) Mass (g) Run Score Grip 
Strength 
(N) 
Plasma CK 
(IU.L-1) 
Plasma 
HSP72 
(ng.mL-1) 
RV 
HSP72 
(ng.µg-1) 
RV 
HSP25 
(ng.µg-1) 
RV  
HSF1 
(AU) 
           
GLN-CON-1 9 351.8 - 25.0 375.0 1.005 0.038 0.013 - 
GLN-CON-2 9 352.9 - 25.3 345.0 0.490 0.037 0.012 - 
GLN-CON-3 10 364.6 - 24.3 425.0 1.475 0.028 0.012 0.23 
GLN-CON-4 10 303.3 - 25.6 376.6 0.905 0.032 0.001 0.10 
GLN-CON-5 12 337.5 - 19.6 405.0 0.940 0.024 0.005 0.13 
GLN-CON-6 12 438.8 - 28.9 296.6 0.705 0.021 0.002 0.14 
GLN-CON-7 12 393.6 - 26.3 406.6 1.155 0.022 0.003 0.06 
Glutamine, 
Non-
exercising 
Control 
GLN-CON-8 13 375.7 - 27.5 393.3 0.950 0.028 0.004 0.13 
Mean  11 364.8 - 25.3 377.9 0.953 0.029 0.007 0.13 
SD  2 40.1 - 2.7 40.9 0.291 0.006 0.005 0.06 
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10.3. Appendix 3 – Individual Data of Study 3(a) (Continued) 
Treatment 
 
Rat ID Age (wks) Mass (g) Run Score Grip 
Strength 
(N) 
Plasma CK 
(IU.L-1) 
Plasma 
HSP72 
(ng.mL-1) 
RV 
HSP72 
(ng.µg-1) 
RV 
HSP25 
(ng.µg-1) 
RV  
HSF1 
(AU) 
           
GLN-E04-1 10 349.6 1.2 24.2 803.3 1.250 0.065 0.012 0.43 
GLN-E04-2 9 290.8 1.3 18.6 395.0 0.870 0.029 0.009 - 
GLN-E04-3 10 308.8 1.9 22.7 266.6 0.625 0.108 0.013 - 
GLN-E04-4 10 298.8 1.5 27.9 443.3 0.600 0.082 0.002 0.17 
GLN-E04-5 12 372.2 1.8 27.8 871.6 1.205 0.046 0.003 0.37 
GLN-E04-6 12 423.1 1.8 34.4 584.9 1.470 0.094 0.002 0.53 
GLN-E04-7 12 389.5 2.0 28.0 361.6 0.730 0.061 0.005 0.03 
Glutamine, 
Exercise 
With 4 h 
Recovery 
GLN-E04-8 13 342.4 1.7 26.9 396.6 1.240 0.026 0.003 0.16 
Mean  11 346.9 1.6 26.3 515.4 0.999 0.064 0.006 0.28 
SD  1 46.6 0.3 4.6 218.4 0.332 0.030 0.005 0.19 
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10.3. Appendix 3 – Individual Data of Study 3(a) (Continued) 
Treatment 
 
Rat ID Age (wks) Mass (g) Run Score Grip 
Strength 
(N) 
Plasma CK 
(IU.L-1) 
Plasma 
HSP72 
(ng.mL-1) 
RV 
HSP72 
(ng.µg-1) 
RV 
HSP25 
(ng.µg-1) 
RV  
HSF1 
(AU) 
           
GLN-E24-1 11 379.5 1.5 X 27.5 563.3 1.820 0.180 0.013 0.13 
GLN-E24-2 9 299.3 1.5 X 23.9 593.3 0.965 0.259 0.020 - 
GLN-E24-3 11 299.3 1.8 25.0 806.6 0.495 0.231 0.018 - 
GLN-E24-4 10 285.7 1.9 23.2 255.0 0.500 0.312 0.003 0.14 
GLN-E24-5 12 357.2 1.4 26.8 536.6 1.070 0.134 0.004 0.80 
GLN-E24-6 12 397.6 0.8 DNF 28.9 330.0 - 0.110 0.004 - 
GLN-E24-7 13 393.1 1.9 32.6 261.6 0.665 0.174 0.005 0.16 
GLN-E24-8 14 356.4 1.2 29.4 778.3 0.880 0.130 0.003 0.08 
Glutamine, 
Exercise 
With 24 h 
Recovery 
GLN-E24-9 11 304.7 1.9 29.0 211.6 0.465 0.050 0.019 0.14 
Mean  12 332.7 1.7 27.7 474.9 0.679 0.172 0.009 0.24 
SD  1 42.2 0.3 3.4 271.7 0.247 0.091 0.008 0.27 
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10.4. Appendix 4 – Individual Data of Study 3(b) 
Treatment 
 
Rat ID Age 
(wks) 
Mass 
(g) 
Run 
Score 
Heat 
Load 
(°C.min-1) 
Rectal 
Temperat
ure (°C) 
Muscle 
Temperat
ure (°C) 
Grip 
Strength 
(N) 
Plasma 
HSP72 
(ng.mL-1) 
RV 
HSP72 
(ng.µg-1) 
RV 
HSP25 
(ng.µg-1) 
RV 
HSF1 
(AU) 
 
             
HS-CON-1 8 304.6 - 4.7 41.7 40.4 23.4 6.34 0.041 0.005 0.06 
HS-CON-2 9 306.9 - 10.8 42.0 42.1 25.0 7.14 0.032 0.008 0.02 
HS-CON-3 9 304.6 - 13.0 42.1 41.6 27.4 3.91 0.044 0.010 0.03 
HS-CON-4 9 332.4 - 14.2 42.1 41.8 25.7 4.15 0.036 0.011 0.15 
HS-CON-5 10 316.2 - 12.2 42.0 41.7 28.4 11.20 0.038 0.011 0.07 
HS-CON-6 10 308.7 - 12.8 42.1 41.4 23.7 4.22 0.026 0.008 0.05 
Placebo, 
Passive 
Heating, 
Non-
exercising 
Control 
HS-CON-8 11 335.8 - 13.1 42.1 41.8 26.6 3.21 0.024 0.006 0.10 
Mean  9.4 315.6 - 11.5 42.0 41.5 25.7 5.74 0.034 0.008 0.07 
SD  1.0 13.3 - 3.2 0.1 0.5 1.9 2.79 0.007 0.002 0.04 
             
 
 
 
 
 
  
204 
10.4. Appendix 4 – Individual Data of Study 3(b) (Continued) 
Treatment 
 
Rat ID Age 
(wks) 
Mass 
(g) 
Run 
Score 
Heat 
Load 
(°C.min-1) 
Rectal 
Temperat
ure (°C) 
Muscle 
Temperat
ure (°C) 
Grip 
Strength 
(N) 
Plasma 
HSP72 
(ng.mL-1) 
RV 
HSP72 
(ng.µg-1) 
RV 
HSP25 
(ng.µg-1) 
RV 
HSF1 
(AU) 
 
             
HS-E04-1 8 296.9 0.1 DNF 12.7 42.1 41.7 21.4 - 0.046 0.013 - 
HS-E04-2 9 286.8 2.0 10.8 42.0 42.1 22.2 3.50 0.041 0.008 0.04 
HS-E04-3 9 306.1 1.1 DNF 14.3 42.1 41.8 24.6 - 0.056 0.007 - 
HS-E04-4 9 314.3 2.0 15.2 42.2 41.7 24.7 6.76 0.021 0.004 0.18 
HS-E04-5 10 313.1 2.0 16.8 42.2 41.9 25.0 4.26 0.059 0.014 0.12 
HS-E04-6 10 303.9 1.8 14.7 42.1 42.0 25.2 27.30 0.047 0.011 0.11 
HS-E04-7 10 320.2 2.0 15.0 42.2 41.9 26.0 27.90 0.065 0.011 0.11 
HS-E04-8 11 311.5 2.0 14.9 42.1 41.8 30.2 6.40 0.055 0.009 0.25 
Placebo, 
Passive 
Heating, 
Exercise 
with 4 h 
Recovery 
HS-E04-9 10 315.1 1.6 13.1 42.1 41.8 27.8 8.46 0.039 0.009 0.38 
Mean  9.9 309.3 1.9 14.3 42.1 41.9 25.9 12.08 0.047 0.009 0.17 
SD  0.7 11.0 0.2 1.9 0.1 0.1 2.5 10.73 0.015 0.003 0.11 
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10.4. Appendix 4 – Individual Data of Study 3(b) (Continued) 
Treatment 
 
Rat ID Age 
(wks) 
Mass (g) Run 
Score 
Heat 
Load 
(°C.min-1) 
Rectal 
Temperat
ure (°C) 
Muscle 
Temperat
ure (°C) 
Grip 
Strength 
(N) 
Plasma 
HSP72 
(ng.mL-1) 
RV 
HSP72 
(ng.µg-1) 
RV 
HSP25 
(ng.µg-1) 
RV 
HSF1 
(AU) 
 
             
HS-E24-1 8 320.3 1.1 14.6 42.1 41.8 22.2 4.72 0.133 0.014 0.24 
HS-E24-2 9 306.7 1.6 12.1 42.1 42.0 26.5 2.08 0.073 0.009 0.09 
HS-E24-3 9 325.2 1.7 14.8 42.1 41.4 25.3 4.22 0.124 0.014 0.13 
HS-E24-4 9 320.9 1.6 12.5 42.0 41.9 25.9 2.92 0.124 0.013 0.31 
HS-E24-5 10 337.7 1.6 14.8 42.2 41.6 25.4 4.74 0.130 0.012 0.09 
HS-E24-6 10 334.6 1.6 16.6 42.2 41.5 21.5 15.06 0.080 0.012 0.19 
HS-E24-7 10 307.3 2.0 15.8 42.2 41.8 25.9 2.14 0.060 0.008 0.04 
Placebo, 
Passive 
Heating, 
Exercise 
with 24 h 
Recovery 
HS-E24-8 11 316.9 2.0 10.7 42.0 42.0 30.2 2.50 0.064 0.010 0.35 
Mean  9.5 321.2 1.7 14.0 42.1 41.7 25.4 4.80 0.099 0.012 0.18 
SD  0.9 11.3 0.3 2.0 0.1 0.2 2.7 4.29 0.032 0.002 0.11 
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10.4. Appendix 4 – Individual Data of Study 3(b) (Continued) 
Treatment 
 
Rat ID Age 
(wks) 
Mass (g) Run 
Score 
Heat 
Load 
(°C.min-1) 
Rectal 
Temperat
ure (°C) 
Muscle 
Temperat
ure (°C) 
Grip 
Strength 
(N) 
Plasma 
HSP72 
(ng.mL-1) 
RV 
HSP72 
(ng.µg-1) 
RV 
HSP25 
(ng.µg-1) 
RV 
HSF1 
(AU) 
 
             
GHS-CON-1 10 294.5 - 4.7 41.7 40.4 19.8 6.20 0.026 0.009 - 
GHS-CON-2 9 262.9 - 25.4 42.1 41.0 20.2 185.75 0.042 0.014 - 
GHS-CON-3 10 306.6 - 11.6 42.0 41.1 23.4 20.40 0.027 0.011 0.06 
GHS-CON-4 9 328.9 - 8.4 41.9 40.9 28.2 4.60 0.056 0.002 0.15 
GHS-CON-5 12 306.7 - 10.9 42.0 41.5 26.9 39.16 0.027 0.004 0.01 
GHS-CON-6 11 411.8 - 11.8 42.1 41.5 30.3 160.90 0.085 0.002 0.06 
GHS-CON-7 12 379.8 - 15.0 42.1 41.6 31.6 197.85 0.037 0.003 0.03 
GHS-CON-8 12 404.1 - 16.3 42.1 41.9 30.3 518.75 0.047 0.004 0.12 
Glutamine, 
Passive 
Heating, 
Non-
exercising 
Control 
GHS-CON-9 13 313.1 - 13.2 42.0 41.7 - - - - 0.17 
Mean  10.4 327.3 - 12.5 42.0 41.3 25.8 87.84 0.043 0.006 0.06 
SD  1.3 51.6 - 6.5 0.1 0.5 4.7 89.01 0.021 0.005 0.05 
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10.4. Appendix 4 – Individual Data of Study 3(b) (Continued) 
Treatment 
 
Rat ID Age 
(wks) 
Mass (g) Run 
Score 
Heat 
Load 
(°C.min-1) 
Rectal 
Temperat
ure (°C) 
Muscle 
Temperat
ure (°C) 
Grip 
Strength 
(N) 
Plasma 
HSP72 
(ng.mL-1) 
RV 
HSP72 
(ng.µg-1) 
RV 
HSP25 
(ng.µg-1) 
RV 
HSF1 
(AU) 
 
             
GHS-E04-1 11 353.7 1.3 - - - 28.0 1.25 0.048 0.008 0.94 
GHS-E04-2 - - DNS 22.95 42.1 41.8 - - - - - 
GHS-E04-3 10 289.8 1.8 8.45 41.9 41.6 21.5 1.00 0.032 0.010 0.21 
GHS-E04-4 9 281.8 2.0 7.01 41.9 41.5 25.7 0.43 0.068 0.002 0.30 
GHS-E04-5 12 299.8 1.3 9.64 41.9 41.5 27.3 4.56 0.042 0.002 0.20 
GHS-E04-6 11 432.5 0.7 DNF 13.39 42.1 41.5 31.4 - 0.070 0.002 - 
GHS-E04-7 12 373.5 1.7 13.52 42.2 41.9 28.0 45.0 0.025 0.002 0.15 
GHS-E04-9 11 317.5 2.0 10.73 42.0 41.9 30.0 0.68 0.029 0.003 0.07 
GHS-E04-10 11 315.9 2.0 13.39 42.1 41.8 25.5 4.18 0.026 0.008 0.09 
Glutamine, 
Passive 
Heating, 
Exercise 
with 4 h 
Recovery 
GHS-E04-11 11 301.1 1.4 11.46 42.1 41.9 25.8 3.02 0.039 0.008 0.24 
Mean  10.9 316.6 1.7 10.6 42.0 41.7 26.5 7.52 0.039 0.005 0.28 
SD  1.0 31.8 0.3 2.4 0.1 0.2 2.5 15.24 0.014 0.003 0.28 
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10.4. Appendix 4 – Individual Data of Study 3(b) (Continued) 
Treatment 
 
Rat ID Age 
(wks) 
Mass (g) Run 
Score 
Heat 
Load 
(°C.min-1) 
Rectal 
Temperat
ure (°C) 
Muscle 
Temperat
ure (°C) 
Grip 
Strength 
(N) 
Plasma 
HSP72 
(ng.mL-1) 
RV 
HSP72 
(ng.µg-1) 
RV 
HSP25 
(ng.µg-1) 
RV 
HSF1 
(AU) 
 
             
GHS-E24-1 10 352.0 1.4 7.31 41.9 40.9 28.2 0.67 0.122 0.011 0.21 
GHS-E24-2 9 261.2 1.9 22.53 42.4 41.7 18.8 0.65 0.108 0.015 - 
GHS-E24-3 10 306.1 1.5 9.86 42.0 41.1 22.2 0.40 0.166 0.014 0.45 
GHS-E24-4 10 278.1 1.6 7.44 41.9 39.8 23.6 0.28 0.314 0.003 - 
GHS-E24-5 12 377.5 1.8 7.57 41.9 41.6 28.7 2.28 0.104 0.005 0.41 
GHS-E24-6 12 369.8 1.7 12.77 42.1 41.7 31.6 2.54 0.079 0.003 0.22 
GHS-E24-7 13 346.4 1.8 8.47 42.1 41.4 31.8 2.16 0.083 0.002 0.27 
Glutamine, 
Passive 
Heating, 
Exercise 
with 24 h 
Recovery 
GHS-E24-8 13 340.2 1.6 15.00 42.1 41.9 29.1 1.52 0.208 0.002 0.68 
Mean  11.3 325.6 1.7 11.9 42.0 41.3 26.5 1.40 0.152 0.006 0.41 
SD  1.6 44.9 0.2 5.4 0.2 0.7 5.0 0.96 0.086 0.006 0.18 
             
 
 
 
